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Animal trypanosomosis is a major constraint in livestock production in Sub-Saharan Africa. 
With the emergence of resistance against trypanocidal drugs, the cost and environmental 
concerns raised by vector control, and the challenge of antigenic variation in vaccine 
development, alternative control measures are being sought. An anti-disease strategy, 
whereby the immune response or chemotherapy is aimed towards pathogenic factors rather 
than the parasite itself, constitutes such a novel approach. Congopain is the major cysteine 
protease in Trypanosoma congolense, and upon release in the bloodstream of infected cattle, 
acts as a pathogenic factor.  It is therefore an attractive candidate for an anti-disease vaccine. 
It was hence deemed necessary to investigate the variability of congopain-like cysteine 
proteases before attempting to design drugs and vaccines based on the inhibition of 
congopain. 
Most congopain-like cysteine protease genes of T. congolense exist in a single locus of 12-14 
copies organised as tandem repeats of 2 kb gene units. A gene unit library of 120 clones was 
constructed out of several cosmid clones selected in a previous study that contained various 
lengths of the congopain locus. Some 24 gene unit clones were sequenced, and it was found 
that congopain genes cluster in three sub-families, named CP1 (8 clones), CP2 (12 clones) 
and CP3 (4 clones). The latter most characteristically shows a substitution of the active site 
cysteine by a serine. Isoform specific primers were designed and used to verify the 
proportions of the three isoforms (one third CP1, half CP2 and a sixth CP3) in the remaining 
clones of the library. Since this first study was conducted in one isolate, IL 3000, the results 
were subsequently validated in a large array of isolates, of T. congolense, as well as T. vivax 
and T. brucei subspecies, by a PCR approach. Finally, to gain access to copies of congopain 
genes that are not present in the locus, but rather scattered in the genome, an attempt was 
made to construct a 2 kb size-restricted genomic library. Only 206 clones could be produced, 
of which a mere 8 coded for congopain-like proteases. The fact that 7 out of 8 of these clones 
belong to CP3 (thought to be inactive) suggested a cloning artefact, possibly related to the 
activity of the cloned proteases. 
Overall, all congopain genes appear very conserved in a given species, with 87-99% identity 
at protein level. The pre- and pro-region were the most conserved, while the catalytic domain 
was the most variable, especially around the active site cysteine, with frequent replacement 
by a serine residue, and in one instance by phenylalanine. The histidine residue of the 
 v 
catalytic triad was also substituted by either a serine or a tyrosine in some instances. The 
proenzyme cleavage site sequence was also variable, with APEA being the predominant N-
terminal sequence. RT-PCR analyses indicated that CP1, CP2 and CP3 mRNA are all present 
in the bloodstream forms of T. congolense, showing that these variants are likely to be 
expressed.  
The conclusion of this study is that, given the high overall conservation of congopain genes 
in the genome, for the purpose of anti-disease vaccine, it is likely that a single immunogen 
will suffice to raise antibody able to inhibit all circulating congopain-like cysteine proteases. 
For chemotherapy however, a more in-depth enzymatic characterisation of the mutants, 
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African trypanosomosis is a disease in man, domestic and wild animals caused by protozoan 
parasites called trypanosomes. African trypanosomes are generally transmitted to the 
mammalian hosts by the bite of infected tsetse flies. These parasites live in the blood, lymph 
nodes, spleen and cerebrospinal fluid of their hosts (Schmidt and Roberts, 1989). 
Trypanosomes cause sleeping sickness in humans and Nagana in livestock. The symptoms of 
the disease are chronic anaemia, emaciation, fever, infertility, immunosuppression and finally 
death. Trypanosoma brucei rhodesiense and T. b. gambiense are the aetiological agents of 
Human African Trypanosomosis. T. b. gambiense causes chronic infections in humans and is 
mainly transmitted by riverine tsetse flies belonging to the Glossina palpalis species, which 
is widely spread in West and Central Africa. T. b. rhodesiense, which is confined to Eastern 
and Southern African regions, causes an acute form of the disease.  
 
African animal trypanosomosis (Nagana) is caused by T. congolense, T. vivax and to a lesser 
extent by T. b. brucei. The three species are transmitted by tsetse flies, but T. vivax can also 
be transmitted by biting flies (Tabanids and Stomoxes), hence its presence also in South 
America. T. congolense infects cattle, horses, sheep, goats, camels, pigs and dogs. Three 
groups of T. congolense have been characterised, namely Savannah, Riverine/Forest and 
Kenyan coast/Kilifi (Gashumba et al., 1988). T. evansi, a parasite closely related to T. brucei, 
but that has lost the ability to be cyclically transmitted, causes Surra in camels, horses, 
domestic animals and wildlife. It is widely spread all over the world in the intertropical 
region. In Central and South America T. evansi is transmitted by biting flies, but also 
vampire bats and affects mainly horses. In Asia it affects camels, water buffaloes, horses and 
pigs, and is mainly transmitted by biting flies. Dourine is caused by T. equiperdum, another 
close relative to T. brucei, and is sexually transmitted in equines and camelids. Suids are 
infected by T. simiae and T. godfreyi, transmissible by tsetse flies.  
 
It is estimated that 8-11 Million/km
2
 of land in sub-Saharan Africa is infested by tsetse flies, 
a region inhabited by 260-300 million people and 45-50 million cattle (Figure 1.1). 
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Trypanosomosis impacts negatively on livestock productivity, and this translates into 1.3 to 5 























Figure 1.1 Geographical distributions of cattle and tsetse flies across Africa, acquired from University of 
Liverpool www.genomics.liv.ac.uk/tryps accessed on 01.12. 06 
 
1.2  Morphology of the African trypanosome 
The generalised anatomy of African trypanosomes is given in Figure 1.2. Trypanosomes are 
unicellular organisms which possess a single flagellum arising from the basal body 
(kinetosome) at the floor of the flagellar pocket which occurs at either the posterior or 
anterior of the body (Noble and Noble, 1982). The kinetoplast is a sausage or disc-shaped 
structure containing mitochondrial DNA; it is closely associated with and is posterior to the 
basal body. The kinetoplast is also important in cyclical transmission by the tsetse fly; it is 
absent in T. evansi, which is not cyclically transmitted. Pellicular microtubules are located 
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Figure 1.2 Morphology of Trypanosoma congolense.  The diagram shows structures of the bloodstream 
trypomastigote form of T. congolense as revealed by electron microscopy. [Vickerman, (1969) as acquired from 
Schmidt and Roberts, (1989)] 
 
1.3  Classification of African trypanosomes 
The classification of the genus Trypanosoma is given in Figure 1.3. Trypanosomes are 
unicellular protozoans belonging to the subphylum Sarcomastigophora because they possess 
a single nucleus and use flagella for locomotion. The Zoomastigophora class represents 
organisms without a chloroplast but possessing a flagellum. Members of the order 
Kinetoplastida possess a kinetoplast; in addition their flagellum is attached to the body by an 
undulating membrane, which is a characteristic of the suborder Trypanosomatida. The 
Trypanosoma genus is divided into two groups based on the site of development of the 
parasite within the insect vector. Salivarian trypanosomes develop in the anterior part of the 
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alimentary canal of the insect vector, while the stercoraria (like the Chagas‟ disease agent T. 
cruzi) develop in the posterior part and are present in faeces (Schmidt and Roberts, 1989). 
 
The Trypanosoma genus is believed to be monophyletic (a group of organisms that descend 
from a single ancestor) (Lukeš et al., 1997; Haag et al., 1998; Stevens and Gibson, 1999) 
although previously it had been suggested that this genus is paraphyletic (a taxonomic group 
which does not include all the descendants of an ancestral taxon) (Gómez et al., 1991; 
Maslov et al., 1996). All these observations were based on molecular phylogenetics of 18S 
Small-Subunit (SSU) rRNA genes. Phylogenetic studies done using genes coding for proteins 
such as glyceraldehyde phosphate dehydrogenase (GADPH) indicate that Trypanosoma is 
monophyletic (Hannaert et al., 1992, 1998; Alvarez et al., 1996). T. vivax has been shown by 
phylogenetic analyses to be the first species to diverge from the monophyletic clade of 
salivarian trypanosomes (Lukeš et al., 1997; Stevens and Gibson, 1999; Simpson et al., 
2006). The subgenus Nannomonas consists of T. congolense, T.  simiae and T. godfreyi and 
is considered monotypic (a taxonomic group with only one subgroup at the next taxonomic 
level) based on phylogenetic analyses of 18S SSU and 28 Large-Subunit (LSU) rRNA 
sequences (Lukeš et al., 1997; Hagg et al., 1998; Stevens and Gibson, 1999). T. congolense 
is also monotypic (Hagg et al., 1998) and its three subgroups (Savannah, Forest and Kilifi) 
are genetically distinct (Stevens and Gibson, 1999), however, a study on glutamate-alanine 
rich proteins (GARP) showed conservation of this gene among Savannah, Forest and Kilifi 
subgroups of T. congolense (Asbeck et al., 2000). T. simiae and T. godfreyi show a distinct 
evolutionary divergent lineage (Gibson et al., 2001). GAPDH phylogenetic studies indicated 
that T. b. brucei is monotypic. Moreover based on 18S rRNA T. b. brucei was shown to be 
closely related to T. b. rhodesiense, whereas T. evansi, T. equiperdum and T. b. gambiense 
cluster together (Stevens and Gibson, 1999). 
1.4  Life cycle of African trypanosomes 
The life cycle of T. brucei is illustrated in Figure 1.4. The short stumpy non-dividing 
trypomastigotes are acquired in the tsetse fly blood meal. This form of the parasite moves to 
the midgut and later to the hindgut as a procyclic form. The procyclic forms undergo 
developmental stages and migrate to the salivary glands, where they transform into 
epimastigotes, which attach themselves to the salivary gland epithelial lining. Epimastigotes 
transform into non-dividing metacyclic forms that are infective and located in the lumen of 
the salivary glands. The metacyclic forms are passed to a new host during a blood meal 
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(Schmidt and Roberts, 1989). The life cycle of T. congolense and T. vivax is somewhat 
simpler, as no stumpy forms are visible, and the maturation stages (epimastigote and 
metacyclic) occur essentially in the labrum. 
1.5  Pathology of African animal trypanosomosis 
Metacyclic forms of trypanosomes enter the skin of the host when an infected tsetse fly feeds 
on the host (blood meal). Here they multiply, causing skin inflammation and lesions called 
chancre, and changes in the mast cells. The parasites proceed to the lymph nodes, 
characterised by increased levels of CD4 and CD8 cells, higher ratios of lymphoblast and B 
cells and enlargement of lymph nodes. Two to three weeks after infection, trypanosomes are 
detected in the blood and by 3-4 weeks antibodies against parasite antigens are present in the 
circulation.  IgG1, IgG2 and IgM for variant surface glycoprotein (VSG) epitopes are 
detected in T. congolense infected cattle, but fail to be protective (Williams et al., 1996). 
Depletion of C3 of complement and immunosuppression are also observed in trypanosome 
infected cattle (Authié and Pobel, 1990).  There is a marked reduction in leukocytes 
(leukopaenia) and circulating platelets as well as anaemia. Erythrocyte destruction in the 
spleen, liver, lymph nodes, lungs and bone marrow contribute to anaemia in both the acute 
and chronic phases. Other clinical features of trypanosomosis include heart damage, 
infertility, low milk production, reduced capacity to do work, abortion, poor growth and 
weight loss (Murray et al., 1991).  
1.6  Genome of African trypanosomes 
Trypanosomes have two types of genomes, namely the nuclear and kinetoplast genomes.  
The nuclear genome is diploid; however some parts of the genome are haploid. In T. b. 
brucei the haploid nuclear genome is about 35 Mb and it is thought to contain as many as 
12000 genes (El-Sayed et al., 2000). Since the nuclear chromosomes of T. b. brucei have 
been shown not to condense during mitosis, they have been characterised by pulsed field gel 
electrophoresis (PFGE). When separated by PFGE, three classes of chromosomes can be 
observed, megabase chromosomes, intermediate chromosomes and minichromosomes. 
Megabase chromosomes are also called house-keeping chromosomes and account for 
approximately 80% of the nuclear genome. They contain most of the genes necessary for 
cellular activities of trypanosomes. There are 11 megabase chromosomes ranging from 1 to 6 
Mb in size and are diploid in the nucleus (Melville et al., 1998, 2000). The megabase 
chromosomes are assigned numbers I-XI according to their sizes (Turner et al., 1997; El-































Figure 1.3 Classification of trypanosomes. The illustration shows the classification of trypanosomes based on 18S SSU ribosomal RNA gene sequence analysis (Stevens 
and Gibson, 1999; Stevens et al., 2001). 
Section Stercoraria Salivaria 
T. evansi     T. brucei      
Pycnomonas Subgenus Trypanozoon Nannomonas Duttonella Herpetosoma Megatrypanum Schizotrypanum 
T. godfreyi     T. simiae T. congolense T. vivax T. lewisi T. theileri T. cruzi T. rangeli T. suis T. equiperdum Species 
T. b. gambiense T. b. rhodesiense T. b. brucei T. v. viennei T. v. ziemann 











































Figure 1.4 Life cycle of African trypanosomes (Authié, 1994)  
 
 
polymorphism in homologous chromosomes according to strains (Melville et al., 1998, 
2000). The intermediate chromosomes are 100-700 kb and do not posses the 177 bp repeated 
sequence of minichromosomes. There are about one to five intermediate chromosomes 
accounting for 0.2-1% of the nuclear genome. They contain VSG expression sites, telomeric 
sequences and some gene families. The mini-chromosomes are monoploid, 50-100 kb in size 
and account for 20% of nuclear DNA content. There are approximately 100 linear 
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minichromosomes, consisting of a 177 bp repetitive sequence, telomere repeats and a few 
variant surface glycoprotein genes (Weiden et al., 1991).  
 
Two classes of circular DNA structures characterise the kinetoplast genome, the maxicircles 
and minicircles. Maxicircles are 25-27 kb in size and a single cell contains 50 maxicircles. 
Maxicircles are composed of 9S and 12S ribosomal RNA, 17 open reading frames (ORF) and 
8 kb regions of repetitive sequences. The ORF encodes for several genes of known function, 
clustered and without introns. The minicircles are approximately 1 kb in size and 5000-10000 
minicircles make up a cell. Minicircles are composed of 3-4 guide RNAs (for editing) (Stuart 
et al., 1997), 18 bp inverted repetitive sequences, and one origin of replication. Unlike 
maxicircles, the minicircles do not encode any protein (El-Sayed et al., 2000). 
1.7  Diagnosis of African trypanosomosis 
For successful treatment and control of African trypanosomosis, cost effective, quick and 
reliable diagnostic techniques are required. Numerous methods have been used for the 
diagnosis of African animal trypanosomosis and include observation of clinical signs, 
parasitological, immunological and molecular based techniques.  
1.7.1  Clinical diagnosis  
Clinical diagnosis is the physical examination of the clinical signs of the disease. However, 
this method is not effective as the clinical signs are not specific for trypanosomosis (Rebeski 
et al., 1999). After diagnosis, infected animals are treated with trypanocides and recovery is a 
true confirmation of the diagnosis.  
1.7.2  Parasitological methods 
Detection of trypanosomes in wet blood films and Giemsa-stained blood films requires a 
high level of parasites in blood; this method has been improved by concentrating the 
parasites by centrifugation techniques i.e. the haematocrit centrifugation technique and the 
buffy coat technique. These two concentrating techniques were found to be successful in the 
detection of trypanosomes and, with highly trained personnel, to give similar sensitivity as 
PCR (Desquesnes, 1997). 
1.7.3  Immunological methods 
Several immunological methods have been developed for the diagnosis of trypanosomosis. 
The complement fixation test has been found successful in the diagnosis of T. equiperdum 
especially in countries where other members of the subgenus Trypanozoon are not found 
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(Williamson et al., 1988). The indirect fluorescent antibody test (IFAT) is limited in that it is 
not species-specific and cannot be used to determine the severity of the infection. Another 
reliable method for diagnosis is the card agglutination trypanosomosis test (CATT); it can be 
used in the field where most methods cannot be applied. CATT has been used in the 
diagnosis of T. b. gambiense sleeping sickness and in T. evansi infections in animals. 
Enzyme linked immunosorbent assay (ELISA) is a very reliable method for diagnosis 
because it does not require highly specialised equipment and can be used in the field. 
Although ELISA is a common diagnostic method, it is limited to the detection of anti-
trypanosomal antibodies and cannot determine a current or past infection as antibodies persist 
for a longer time than parasites within the host (Van den Bossche et al., 2000).  
1.7.4  Molecular based methods 
Molecular methods employed in the diagnosis of African trypanosomosis are based on the 
detection and/or amplification of nucleic acids. One of these methods exploits the existence 
of a 177 bp repetitive sequence in the trypanosome genome; a set of six primers has been 
used for the differentiation of members of the Nannomonas subgenus (Masiga et al., 1992, 
1996). Kinetoplast DNA (kDNA) has also been used as a probe in identifying trypanosomes 
because their DNA is conserved. This probe is however limited in that some trypanosome 
species do not have kDNA. A few species-specific diagnostic tools have been developed; one 
of these is based on GARP and is characteristic of the Nannomonas subgenus (Asbeck et al., 
2000). Welburn et al., (2001) developed a diagnostic technique based on the serum-
resistance associated (SRA) gene to differentiate between T. b. brucei and T. b. rhodesiense. 
Other diagnostic methods that have been developed include restriction fragment length 
polymorphism (RFLP; Hide et al., 1994), randomly amplified polymorphism DNA (RAPD) 
and amplified fragment length polymorphism (AFLP) (Masiga et al., 2000). Lately, ITS 
(Internal Transcribed Spacer of ribosomal DNA repeating units) have been used for the 
species-specific diagnostics of trypanosome. It allows with one set of primers to distinguish 
most of African trypanosome species in a single PCR reaction, based on the size-
polymorphism (Desquesnes et al. 2001). These methods require large quantities of DNA, 
highly qualify personnel, and expensive equipment, and hence are usually used for 
epidemiological studies rather than diagnosis.  
1.8 Control of African trypanosomosis 
Development of a vaccine has been hampered by the ability of trypanosomes to alter their 
VSG through the mechanism of antigenic variation (Donelson, 2003). Use of trypanocides is 
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expensive, the drugs are toxic and trypanosomes have become resistant to trypanocides. 
Vector control methods involve bush clearing, elimination of wildlife, and the use of 
insecticides, traps and screens. Successful control of trypanosomosis has to involve both 
parasite and vector control, in an integrated manner.  
1.8.1  Bush clearing and elimination of wildlife  
Bush clearing involves destruction of tsetse flies habitat and serves as a physical barrier to 
prevent reinvasion. The method is expensive, difficult to maintain and ecologically unsound. 
An improved method of bush clearing is agronomic prophylaxis, whereby bush clearing is 
followed by planting of crops (Pépin and Méda, 2001). Elimination of wildlife, that removes 
both tsetse attractant and parasite reservoir, proved to be a very effective method of control, 
but an ecological disaster. It was terminated based on ethical and environmental 
considerations (Schofield and Maudlin, 2001). 
1.8.2  Use of insecticides  
Dichloro diphenyl trichloroethane (DDT), dieldrin, endosulfan and synthetic pyrethroids are 
insecticides that have been used for the control of trypanosomosis. DDT was in use some 
decades ago and was very effective for tsetse control. However due to its perceived high 
level of toxicity its use was prohibited by many countries. Less harmful synthetic pyrethroids 
replaced the toxic organochlorides, as they are metabolised by mammals. In Nigeria 
insecticides were successfully used to eliminate tsetse fly in an area of approximately 
200,000 km
2
 (Schofield and Maudlin, 2001). Impregnated traps and screens attract tsetse 
flies because of their shape, colour or contrast between colours. 
1.8.3  Trypanotolerance 
Cattle are said to be trypanotolerant because they are able to control the pathogenic effects of 
the disease and control parasite proliferation (Murray and Dexter, 1988). Trypanotolerance is 
a genetic trait of Bos taurus breeds of West and Central Africa, particularly the N‟Dama 
longhorn and the West African short horn breeds. Cattle without this trait are called 
trypanosusceptible, which include most Bos indicus (Zebu) breeds. Trypanotolerant cattle are 
able to control anaemia and parasitaemia, hence remain productive under tsetse pressure 
(Murray et al., 1991; d‟Ieteren et al., 1998,). Cattle breeds with this trait are documented to 
also possess the ability to resist other infectious diseases such as tick-borne illness (Murray et 
al., 1982; Mattioli et al., 2000). They are however of small size and have never been adopted 
out of their region of origin. Some breeding program have been attempted to transfer 
trypanotolerance to more conventional breeds. 
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1.8.4  Use of trypanocides 
Over the last 50 years three trypanocides have been used for treating bovine trypanosomosis 
in Africa. They include isometamidium chloride, homidium (chloride and bromide) and 
diminazene aceturate. Isometamidium compounds have prophylactic properties while 
homidium have both prophylactic and therapeutic effects. Diminazene is used only as a 
therapeutic agent. No new compounds have been developed due to the high cost of 
developing and licensing new compounds and also the limited market in Africa. As a result 
many African pharmaceutical companies have developed cheap generic forms of the 
trypanocides, which are assumed to be of low quality. Due to prolonged use of trypanocides, 
resistance to one or more of these compounds has been observed in African trypanosome-
affected countries (Geerts et al., 2001). A recent study on the efficacy of antibiotic 
ascofuranone on T. vivax infected mice showed that the antibiotic has chemotherapeutic 
properties (Yabu et al., 2006). There is an urgent need to develop new chemotherapeutic 
targets. Cysteine protease inhibitors have been shown to possess chemotherapeutic properties 
against trypanosomosis (McKerrow, 1999; McKerrow et al., 1999, Caffrey et al., 2000, 
Lalmanach et al., 2002). The main problem resides in designing parasite-specific inhibitors, 
as proteases are often phylogenetically conserved.  
 
The same cysteine proteases are also targets for vaccine design. A hybrid protein vaccine 
consisting of leishmanial major cysteine proteinases Type I (CPB) and Type II (CPA) was 
found to give partial protection against leishmaniasis (Zadeh-Vakili, et al., 2004). In 
trypanosomosis, congopain, the major cysteine protease, has been shown as a potential 
vaccine candidate (Authié et al., 2001, Lalmanach et al., 2002). The knowledge on the role 
and relatedness of congopain and other related cysteine proteases is paramount in the 
development of both vaccines and chemotherapeutic drugs against trypanosomosis. 
1.9  Classification of proteases 
Proteases catalyse the breakdown of peptides and proteins by hydrolysing peptide bonds. 
They are classified into two major classes, i.e. endopeptidases and exopeptidases (Barrett, 
1994). Exopeptidases catalyse the sequential removal of amino acid residues from the amino-
(aminopeptidases) or carboxy-(carboxypeptidases) termini of peptides or proteins. 
Endopeptidases catalyse cleavage of peptide bonds within a protein. Proteinases are further 
classified into five distinct groups depending on the amino acid residues that make up the 
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catalytic unit, namely cysteine, serine, aspartic, metallo- and threonine peptidases (Barrett, 
1994; Travis and Potempa, 2000; Rawlings and Barrett, 1999, 2000). 
 
The essential amino acid residues in the active site of cysteine proteases are cysteine, 
histidine and asparagine (Storer and Ménard, 1994). Serine, aspartate and histidine form a 
catalytic triad in serine proteases (Rawlings and Barrett, 1994). Catalysis by serine proteases 
occur after formation of a tetrahedral transition state intermediate. Eukaryotes have a number 
of these serine proteases such as trypsin, chymotrypsin and oligopeptidase B (Coetzer et al., 
2008). Two aspartate residues form the catalytic triad in aspartic proteases (Rawlings and 
Barrett, 1995b). Common aspartic proteases include the digestive enzymes pepsin and 
rennin, and HIV-1 protease. Metalloproteases are a group of enzymes which require metal 
ions such as zinc for enzymatic activity (Rawlings and Barrett, 1995a). Matrix 
metalloproteases that hydrolyse collagen and gelatine are such enzymes found in eukaryotes. 
The proteasome (Rivett, 1993) is a threonine protease where the primary catalytic group is 
the hydroxyl of threonine. It is a cytoplasmic complex of multiple subunits which have three 
independent hydrolytic activities, i.e. trypsin-like, chymotrypsin-like and peptidylglutamyl-
peptide hydrolase activities (Rivett, 1993, Seemüller et al., 1995).   
1.10  Proteases of protozoan parasites 
Proteases have diverse roles in protozoan parasites, namely invasion of host cells and tissues, 
hydrolysis of host proteins, stimulation of host immune responses and involvement in 
differentiation (Rosenthal, 1999; Klemba and Goldberg, 2002; McKerrow et al., 2006). In 
African trypanosomes serine oligopeptidase B from T. b. brucei plays a major role in 
trypanosomosis pathogenesis through the degradation of peptide hormones in the 
bloodstream of infected hosts (Troeberg et al., 1996; Morty et al., 1999; Coetzer et al., 
2008). Oligopeptidase B from T. evansi inactivates atrial natriuretic factor in the bloodstream 
of infected hosts (Morty et al., 2005). Recently an aminopeptidase pyroglutamyl peptidase 
type I, from T. b. brucei has been shown to regulate the levels of peptide hormones such as 
gonadotropin-releasing hormone and thyrotrophin-releasing hormone in the plasma of 
infected host (Morty et al., 2006).  
 
Serine proteases of merozoites of Plasmodium falciparum are involved in host cell invasion 
(Blackman and Holder, 1992). Serine-rich antigen (SERA) is a group of cysteine proteases of 
Plasmodium species which possess a central domain that show homology to the papain 
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family of cysteine proteases, but exhibit an unusual cysteine to serine substitution at the 
active site of cysteine residue (Bzik et al., 1988; Knapp et al., 1991; Kiefer et al., 1996; Gor 
et al., 1998; Hodder et al., 2003). 
 
In Leishmania amazonensis zinc metalloprotease leishmanolysin (GP63) is a major surface 
glycoprotein in the infective metacyclic promastigote that is involved in invasion of 
macrophages (Frommel et al., 1990; McGwire and Chang, 1994,). This role was investigated 
in L. amazonensis by the expression of a gp63 antisense construct and led to impaired 
parasitisation of macrophages (Chen et al., 2000). GP63 has also been associated with 
resistance against host complement degradation as shown in L. major, where gp63 mutant 
parasites were more susceptible to lysis by human serum as well as delayed pathogenesis in 
susceptible mice (Joshi et al., 2002).  
 
Arginine aminopeptidases are necessary for excystation of Cryptosporidium parvum 
(Okhuysen et al., 1994). Two aspartic proteases are associated with haemoglobin catabolism 
in P. falciparum (Goldberg et al., 1991), a metalloprotease called falcilysin has the same role 
in P.  falciparum (Eggleson et al., 1999).  
1.11  Cysteine proteinase 
Cysteine proteases belonging to the papain family have been found in a wide range of 
organisms including bacteria, plants, invertebrates and vertebrates (Berti and Storer, 1995). 
They are the major proteolytic enzymes in protozoan parasites and important virulence 
factors (Sajid and McKerrow, 2002). In Leishmania, cysteine proteases are responsible for 
the destruction of histocompatibility complex class II molecules in L. amazonesis (De Souza 
Leao et al., 1995). Cysteine proteases have been characterised in L. pifanoi (Traub-Cseko et 
al., 1993), L. major (Sakanari et al., 1997), L. donovani chagasi (Omara-Opyene and 
Gedamu, 1997), L. mexicana (Mottram et al., 1992), L. donovani complex (Mundodi et al., 
2002) and L. ethiopica (Kuru et al., 2007). 
 
Trypanopain is the major cysteine protease in T. b. brucei (North et al., 1983; Lonsdale-
Eccles and Mpimbaza., 1986; Lonsdale-Eccles and Grab, 1987; Robertson and Coombs, 
1990; Troeberg et al., 1996). Trypanopain is a lysosomal cysteine protease of the papain-
family (Lonsdale-Eccles and Grab, 1987) that plays a major role in the differentiation of 
bloodstream-form trypanosomes (Pamer et al., 1989). Cruzipain (Cazzulo et al., 1989, 1990), 
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the major protease in T. cruzi is expressed in all life cycle stages (Eakin et al., 1992; Tomás 
and Kelly, 1996).  
 
A family of four papain-family cysteine proteases called falcipains has been characterised in 
P. falciparum (Sijwali et al., 2006), they include falcipain-1 (Rosenthal and Nelson, 1992), 
falcipain-2 (Shenai et al., 2000), falcipain-2' (Singh et al., 2006) and falcipain-3 (Sijwali et 
al., 2001). Falcipain-2 and falcipain-3 are associated with haemoglobin degradation in 
trophozoites (Shenai et al., 2000; Sijwali et al., 2001; Dahl and Rosenthal, 2005). Falcipain-1 
has been associated with erythrocyte invasion in Plasmodium species (Mayer et al., 1991). 
The biological role of falcipain-2' still remains unknown (Singh et al., 2006). 
 
In Entamoeba histolytica cysteine proteases are potential virulence factors (Olivos-Garcia et 
al., 2004; Bruchhaus and Tannich, 1996) and play a role in adhesion of trophozoites to the 
mucosal lining (Garcia-Rivera et al., 1999). Bruchhaus et al., (2003) reported a total of 20 
cysteine protease genes in E. histolytica with only EhCP1, EhCP2 and EhCP5 possessing 
proteolytic activity.  
 
Three cysteine proteinases of the papain family have been described in T. congolense, they 
are CP1 (Fish et al., 1995, EMBL accession number Z25813), CP2 (Jaye et al., 1994, EMBL 
accession number L25130) and CP3 (Downey and Donelson, 1999 EMBL accession no. 
AF139913). The proteases predicted by the gene sequence of CP1 and CP2 are identical in 
their pre and pro-peptides, differing with CP3 by only two amino acid residues at the signal 
peptide, their C-terminal extension shows 86-95% identity, while their catalytic domains are 
88-95% identical. However they differ in their N-terminal sequences APPA for CP1 and 
CP3, APEA for CP2. CP3 differs from CP1 and CP2 by a replacement of a cysteine residue 
at position 25 (papain numbering) by a serine residue.  
1.12  Congopain 
Congopain is a 33 kDa cysteine proteinase purified from T. congolense bloodstream form 
lysates (Authié et al., 1992).  Congopain is made up of a prepeptide followed by a 
hydrophilic propeptide, which is cleaved to give the mature enzyme consisting of the 
catalytic or central domain and the C-terminal extension (Figure 1.5). The catalytic domain is 
linked to the C-terminal extension through a polyproline hinge. Congopain shares structural 
and functional resemblance with cruzipain from T. cruzi and with mammalian cathepsin L 
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(Lalmanach et al., 2002). The C-terminal extension is trypanosome-specific and its function 
remains unknown (Stoka et al., 2000). The C-terminal extension has been shown to be 
unnecessary for enzyme activity (Eakin et al., 1993; Boulangé et al., 2001), enzyme stability 
and trafficking to the lysosomes (Huete-Pérez et al., 1999; Stoka et al., 1998, 2000). It has 
been suggested that due to its high antigenicity, it might divert the immune response from the 
functional region (Lalmanach et al., 2002).  
 
Congopain shows preference for substrates with arginine at P1, and bulky hydrophobic 
residues at the P2 position (Chagas et al., 1997) and a marked preference for a proline residue 
at P2‟ and P2 (Lalmanach et al., 2002). The fluorogenic peptide Z-Phe-Arg-NHMec, is 
routinely used to assay for activity. Congopain is inhibited by E-64, peptidyldiazomethanes 
and cystatin (Mbawa et al., 1992; Chagas et al., 1997), but forms complexes with natural 
inhibitors such as kininogen and -macroglobulin while retaining its enzymatic activity 
(Lalmanach et al., 2002).  
 
Authié (1994) observed that trypanotolerant cattle such as the N‟Dama breed (Bos taurus) 
developed a higher IgG response to congopain than trypanosusceptible cattle such as the 
African Zebu breeds (Bos indicus) during primary infection with T. congolense, suggesting 
that congopain may play a role in pathology of trypanosomosis. Furthermore after 
immunising cattle with CP1/CP2, it was also observed that anti-CP antibodies play a role in 
modulating trypanosome induced-pathology (Authié et al., 2001). In order to develop an 
anti-disease vaccine for trypanosomosis based on congopain and other related cysteine 




Figure 1.5 Structure of congopain.  The figure shows the congopain signal peptide, propeptide, central 
domain, polyproline hinge and C-terminal domain. 
 
20  aa 105  aa 218 (CP1) or 217 (CP2)  aa 97  aa 
10 (CP1) or 8 (CP2) 
C25                                       H159  N175 
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1.12.1  Organisation of congopain-like genes in T. congolense 
 The genomic organisation of congopain was studied by Southern blotting with the 
congopain coding sequence as a probe (Boulangé et al., manuscript in preparation). T. 
congolense IL 3000 genomic DNA was digested by EcoRI and HindIII restriction enzymes 
that do not cut within the genes. One strong band at approximately 25 kb was observed, 
suggesting that the gene exists at a single locus. When the genomic DNA was cut by BamHI, 
PstI and AatI, which cut once within the gene, a strong band on the blot was observed at 
approximately 2 kb, suggesting the size of the gene units. A partial digest by enzymes that 
cut once within the gene demonstrated that 12-14 copies existed in the genome in a tandem 
repeat (Boulangé et al., in preparation), a similar tandem repeat (19 copies)  of cysteine 
protease genes (lmcpb) from L. mexicana has been reported (Souza et al., 1992). The T. b. 
brucei genome has 20 copies of cysteine protease genes tandemly arranged (Mottram et al., 
1989) and in T. cruzi 6 copies of cysteine protease genes are also arranged in a tandem array 
(Eakin et al., 1992). It was also observed that longer exposure time of the blots resulted in 
other bands apart from the band designating the congopain gene locus, this led to the 
hypothesis that other congopain-like genes could be scattered in the genome but outside of 
the main locus. 
 
A better understanding of other congopain-like cysteine proteases in trypanosomes is 
required for the design of chemotherapeutic agents and the development of an anti-disease 
vaccine for trypanosomosis that will inhibit the activities of congopain and other related 
cysteine proteases.    
1.13  Objectives of the study 
Congopain has been shown to contribute to the pathology of trypanosomosis (Authié et al., 
1993, 2001; Authié, 1994; Boulangé et al., 2001). While an initial immunisation/challenge 
experiment (Authié et al., 2001) showed a promising use of congopain as an antigen for the 
design of an anti-disease vaccine, subsequent trials were disappointing (Boulangé, pers. 
comm.). One hypothesis that was put forward is that congopain exists as many variants, and 
inhibiting only one of these variants, such as CP2, may not be sufficient. Indeed, three 
papain-like cysteine proteinase genes have been described in T. congolense (Fish et al., 1995; 
Jaye et al.,1994; Downey and Donelson, 1999). For the development of an anti-disease 
vaccine based on congopain that will inhibit all congopain-like cysteine proteases, a study of 
their variability in trypanosomes is fundamental. Thus the main objective of the present study 
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was to determine the variability of congopain-like cysteine protease genes in trypanosomes 
infective to livestock (T. congolense, T. vivax and T. b. brucei).  
 
The first variability study on congopain-like cysteine protease genes was done by studying 
the clones from a library of 2 kbp congopain gene units, constructed from clones selected in a 
previous study from a T. congolense IL 3000 cosmid library (Boulangé et al., manuscript in 
preparation). In Chapter 3, the construction of the library by digestion with PstI of 15 
positive cosmid clones and cloning of the released 2 kb gene units is described. The 
variability of the clones was assessed by sequencing, and study of the polymorphism by 
PCR. 
 
In Chapter 4 a description is given of how the genetic diversity of congopain-like cysteine 
protease genes across strains and species was studied. Coding and intergenic regions of 
congopain-like cysteine protease genes from T. congolense, T. vivax, T. b. brucei, T. simiae 
and T. equiperdum were amplified by PCR using degenerate and non-degenerate primers. 
The amplified fragments were cloned and sequenced. The DNA sequences were translated 
into predicted amino acid sequences and analysed. 
 
A genomic organisation study of congopain genes prior to the reported study had revealed 
the existence of other congopain-like cysteine protease genes outside of the main locus and 
scattered in the genome (Boulangé et al., manuscript in preparation). Getting access to these 
copies is the objective covered in Chapter 5. It was reasoned that by constructing a 2 kbp 
size-restricted subgenomic library, the scattered congopain-like cysteine protease genes 
would be included in the library. Cloning of the 2 kb fragment obtained from digesting T. 
congolense IL 3000 genomic DNA with MluI, one of the very rare restriction enzymes that 
cut within the intergenic region, required the construction of a cloning vector with an MluI 
restriction site.  
 
Another general objective of the study was to determine whether the different variants, or 
family of variants of congopain-like cysteine protease genes are all expressed in 
trypanosomes.  RT-PCR was conducted on purified mRNA with primers targeting different 
variants of congopain-like cysteine protease genes.  These results are also reported in Chapter 




GENERAL MATERIALS AND METHODS 
2.1  Introduction 
A variety of common molecular biology methods and bioinformatics tools were used 
throughout the present study and are described in this Chapter. Specifics of every experiment 
are described in their appropriate sections. 
2.2  Suppliers of materials 
The suppliers of molecular biology kits (Table 2.1), restriction and other enzymes (Table 2.2) 
are detailed in the indicated tables, while primers are detailed in the respective Chapters. 
Bovine serum albumin (BSA), 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal), 
molecular weight markers, 6× loading dye, analytical grade agarose, ethidium bromide and 
adenosine tri-phosphate (ATP) were purchased from Promega (USA) and Fermentas life 
sciences (Commercialised by Inqaba, South Africa). One Shot
®
 Top10 competent cells were 
from Invitrogen life technologies (USA).
 
Ampicillin and isopropyl-β-D-
thiogalactopyranoside (IPTG) were from Roche (Germany). Standard chemicals of the purest 
grade available were purchased from Merck or Sigma (South Africa). Genomic 
deoxyribonucleic acid (DNA) samples (Table 2.3) were provided by the International 
Livestock Research Institute (ILRI), Nairobi, Kenya and the CIRDES. 
 
 19 
Table 2.1 Molecular biology kits used in the present study   
 
Name  Use Supplier  
Wizard
®










 DNA clean-up system 
 
 





-T Easy Vector System II 








Genomic DNA purification  
 
 




 DNA Polymerase with 
GeneAmp
®
 PCR kit 
 
 
PCR nucleotide mix 
 
 
SV Total RNA Isolation 
 
 






One Shot® TOP10 Chemically 
Competent Cells
 
Isolation of plasmid DNA (Section 2.11) 
 
DNA cleaning/purification (Section 2.6) 
DNA cleaning/purification (Section 
2.12) 
 
Site-directed mutagenesis (Sections 
5.2.2.3, 5.2.4, 5.2.5)  
Cloning of PCR products and 
transformation (Sections 2.7, 2.9.5) 
 
Preparation and use of competent cells 
and transformation (Sections 2.8.1, 
2.9.1)  
 
Extraction of genomic DNA (Section 
5.4.2) 
 
Ligation (Section 5.2.9) 
 
Amplification of genomic 
DNA/colonies (Sections 2.4, 2.10, 3.2.7, 
4.3, 4.4.4, 5.6, 5.8)  
 
PCR (Sections 2.4, 2.10, 3.2.7, 4.3, 
4.4.4, 5.6, 5.8)  
  
Isolation of total RNA (Sections 2.5, 
5.8.2) 
 
Amplification of mRNA (Section 2.5) 
 
Isolation and purification of RNA 
(Sections 2.5, 5.8.2) 
 


































Table 2.2 Enzymes used in the present study, their purpose and supplier 
 











T4 polynucleotide kinase 
 
T4 DNA ligase 
 





Restriction digestion (Section 
5.5.1) 
Restriction digestion (Section 
5.2.5)  
Restriction digestion (Sections 
3.2.1, 3.2.2, 3.2.6, 5.7) 
Restriction digestion (Section 5.7) 
Restriction digestion (Section 
5.2.5) 
Phosphorylation (Section 5.2.8) 
 
Ligation (section 5.2.9) 
 
Dephosphorylation (Sections 
3.2.3, 5.3, 5.6) 
Hydrolysis of proteins (Section 
5.4.1) 






Promega/ Boehringer Mannhem 
 











Table 2.3 Genomic DNA from different trypanosomal species and strains obtained from CIRDES and 
ILRI    
Lab assigned 
No. 
Name of species/strains Lab assigned 
No. 













































T. congolense forest Komoé/87/CRTA/153 
T. b. brucei Nyarafo B.1818 
T. b. brucei Farakoba/81/CRTA/4 
T. b. brucei Fol/02/CIRDES/01  
T. b. brucei Gaoua/89/CRTA/259 
T. b. brucei Komoé/87/CRTA/150 
T. vivax Satiri/87/CRTA/133.3 
T. vivax Menegué B.1643 du 7/05/96 
T. vivax Satiri/87/CTRA/123.2 
T. vivax Satiri/87/CRTA/125.1 31.10.02 
T. vivax Kanfiala (Mali) 
T. vivax Guyanne 
T. vivax Lahi/02/CIRDES/02 
T. vivax Satiri/87/CRTA/122.1 
T. vivax Zaria 
T. vivax Banan/83/CRTA/73  
T. vivax Lahi/02/CIRDES/03 
T. vivax Lahi/02/CIRDES/01 
T. vivax Satiri/87/CRTA/120.4 
T. vivax Lobi/CRTA/282.1 
T. vivax  Nyarafo/96/CIRDES/1 
T. vivax Gaoua/89/CRTA/282 
T. vivax Fol/02/CIRDES/01 
T. vivax Karankasso/CRTA/58 
T. vivax Satiri/86/CRTA/100 
T. vivax Noumousso/79/2 
T. vivax Matourkou/97/CRTA/1 
T. vivax Noronin/80/CRTA/16 
T. vivax Sarfalao/80/CRTA/1 
T. vivax Bossora/88/CRTA/249 
T. vivax Folonzo/02/CIRDES/02 
T. vivax Sarfalao/83/CRTA/54 
T. vivax Bobo/88/CRTA/243 
T. congolense Kilifi K60 
T. congolense savannah Samo/82/CRTA/51 
T. congolense savannah Samo/82/CRTA/53 
T. congolense savannah Samo/83/CRTA/66 
T. congolense savannah Samo/82/CRTA/33 
T. congolense savannah Samo/89/CRTA/253 
T. congolense savannah Bobo/40/CRTA/1 
T. congolense savannah IL 3000 












































T. congolense savannah IL 3000 27/09/00 
T. congolense savannah Samo/82/CRTA/22 
T. congolense savannah Samo/28BF 
T. congolense savannah Samo/80/CRTA/20  
T. congolense savannah Satiri/87/CRTA/129.1 
T. congolense savannah KRA/98/CIRDES/2344 
T. congolense savannah KRA/98/CIRDES/1949 
T. congolense savannah KRA/99/CIRDES/1922 
T. congolense savannah Kigoni/ILRAD/776 
T. congolense savannah Satiri/CRTA/238.1 B.752 
T. congolense savannah Satiri/CRTA/237.2 B.760 
T. congolense savannah Samo/82/CRTA/31.1 
T. congolense savannah Satiri/CRTA/197.1 B.705 
T. congolense savannah TBU/98/CIRDES/155 
T. congolense savannah FMA/98/CIRDES/1788 
T. congolense savannah SRI/98/CIRDES/146 
T. congolense savannah Bobo/82/CRTA/44.2 
T. congolense savannah Samo/89/CRTA/267 
T. congolense savannah Folonzo/02/CIRDES/01.2 
T. congolense savannah Samo/CRTA/37.3 
T. congolense savannah Fol/02/CIRDES/01  
T. congolense savannah Banan/83/CRTA/72 
T. congolense savannah Nyarafo BMI 24/05/96 
T. congolense IL3946 
T. congolense K30cl1 
T. congolense IL C66 
T. congolense IL3666 
T. congolense IL3304 
T. congolense Kilifi K60 Kenya 
T. congolense forest Komoé/87/CRTA 
T. vivax IL3638 
T. vivax IL3671 
T. vivax IL2186 
T. vivax IL3245 
T. vivax IL3769 
T. congolense IL3000 
T. simiae 
T. vivax 2160 
T. vivax 
T. vivax ILdat 1.2 
T. b. brucei ILtat 1.1 







2.3  Agarose gel electrophoresis of DNA 
Agarose is a high molecular weight polymer extracted from seaweed. It is composed of 
alternating galactose and 3,6-anhydrogalactose monosaccharides residues. Agarose DNA 
electrophoresis is the main technique used to fractionate nucleic acids based on size 
(Sambrook et al., 1989). When an electric current is applied to an agarose gel in the presence 
of buffer ions, DNA fragments move through the gel towards the anode as DNA is negatively 
charged. Due to the pore size of the agarose gel, small linear DNA fragments move more 
rapidly than larger ones. Different concentrations of agarose will allow the optimal resolution 
of fragments of different size ranges. The DNA sample is contained in a loading buffer and 
placed in wells cut into the agarose gel. The loading dye contains (i) glycerol that makes the 
DNA sample dense, allowing it to settle at the bottom of the well and (ii) tracking dye that 
does not interact with the DNA, and shows the progress of the electrophoretic separation as 
the dye migrates more rapidly than the DNA. Agarose gel electrophoresis was used to verify 
amplification of DNA by PCR (Section 2.4), RT-PCR (Section 2.5) and various cloning 
steps. 
2.3.1 Materials  
50× Tris-acetate-EDTA (TAE) buffer. Tris (242.0 g), glacial acetic acid (57.1 ml) and EDTA 
(18.612 g) were dissolved in 800 ml of dH2O. The pH was adjusted to 8.0 with acetic acid 
and the volume was made up to 1000 ml with dH2O. The solution was autoclaved (121ºC, 30 
min, RT) and allowed to cool before use. 
1× TAE working buffer solution. 50× TAE buffer (20 ml) was diluted to 1000 ml in dH2O 
and ethidium bromide was added to a final concentration of 0.5 µg/ml.    
1% (w/v) Agarose. Agarose (1.0 g) was suspended in 100 ml of 1× TAE buffer and heated in 
a microwave oven until the agarose was completely melted. The volume was adjusted with 
dH2O to 100 ml after minimal volume loss due to evaporation. 
0.8% (w/v) Agarose. Agarose (0.8 g) was suspended in 100 ml of 1× TAE buffer and heated 
in a microwave oven until the agarose was completely melted. The volume was adjusted with 
dH2O to 100 ml after minimal volume loss due to evaporation.  
2.3.2 Procedure 
The casting tray was assembled and positioned on a level surface. The sample comb was 
placed one cm from one end of the casting tray. The 1% (w/v) agarose gel was cooled to ~ 
55°C and poured carefully into the assembled casting tray. The agarose was allowed to set at 
RT, the comb carefully removed, and the casting tray placed into the electrode chamber filled 
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with 1× TAE buffer to submerge the gel. DNA samples were mixed 1:5 with 6× loading dye 
and loaded into the wells alongside molecular weight markers. Electrophoresis was carried 
out for 1-2 h at 100 V. The gel was visualised by trans-illumination under UV light and the 
electrophoregram documented using the Versa Doc
TM
 gel documentation system (Bio Rad).  
2.4  Polymerase chain reaction  
Polymerase chain reaction (PCR) is a technique for amplifying DNA sequences in vitro 
(Saiki et al., 1985; Mullis and Faloona, 1987). A pair of oligonucleotide primers is designed 
to flank the region targeted for amplification. The primers anneal to the opposite DNA 
strands and face inwards so that DNA synthesis proceeds across the central region. Typical 
PCR amplification reaction components include 5-500 ng of template DNA, a primer pair 
(forward and reverse primer), 100-200 µM deoxyribonucleotide triphosphate (dNTPs) mix, 
1.5 units of thermostable DNA polymerase, PCR reaction buffer and 1.0-4.0 mM MgCl2. 
There are three major steps in PCR namely: denaturation, annealing and polymerisation. In 
the denaturation step, the target double stranded-DNA is separated into two strands by 
heating at 94-95°C. Oligonucleotide primers anneal to the resulting single-stranded template 
at a lower temperature ranging from 35-65°C for 30-60 s. During polymerisation, the 
temperatures is raised to 68-74°C for 1-2 min for synthesis of new DNA across the target 
region, as most thermostable DNA polymerases have optimal activity at these temperatures. 
Each group of three reactions makes a PCR cycle and the amount of DNA product increases 
exponentially with every cycle; 20–40 cycles are commonly used.  
 
Taq DNA polymerase is the most commonly used thermostable DNA polymerase. It is 
isolated from Thermus aquaticus (Saiki et al., 1988). The enzyme has 5‟-3‟ exonuclease 
activity but lacks 3‟-5‟ exonuclease activity. The enzyme yields PCR products with unpaired 
3‟-deoxyadenine nucleotide (3‟-A) overhangs (Clark, 1988; Hu, 1993) which can be 
conveniently cloned into a plasmid containing 5‟-deoxythymidine nucleotide (5‟-T) 
overhangs (T-vectors). The PCR product and the T-vector are joined by a ligase. The success 
of any PCR reaction depends on the optimal concentration of reaction components. At low 
magnesium concentration Taq DNA polymerase is inactive while excess magnesium leads to 
non-specific amplifications (Williams, 1989). The use of annealing temperatures slightly 
higher than the melting temperature (Tm) of the primers will reduce non-specific annealing of 
primers, resulting in decreased amounts of unwanted products. Annealing temperatures lower 
than the melting temperatures of the primers may result in higher yields of the PCR product 
 24 
since the primers anneal more efficiently, but at the risk of losing its specificity. The length 
of the PCR product determines the extension time, generally one min of extension is 
sufficient to synthesise a 1 kb long DNA fragment.    
2.4.1  Materials  
10× PCR buffer II, (provided in the AmpliTaq
®
 DNA Polymerase with GeneAmp
®
 PCR kit, 
Table 2.1) 
25 mM MgCl2, (provided in the AmpliTaq
®
 DNA Polymerase with GeneAmp
®




 DNA polymerase, (provided in the AmpliTaq
®
 DNA Polymerase with 
GeneAmp
®
 PCR kit, Table 2.1) 
Oligonucleotide primers as described in the respective Chapters 
DNA templates as detailed in Table 2.3 
2.4.2 Method 
All pipette tips and microfuge tubes were sterilised by autoclaving [121ºC, 30 min, RT]. The 
PCR protocol was carried out on an area of the laboratory bench designated for PCR to avoid 
contamination. 
 
A master mix of the PCR reagents was prepared as shown in Table 2.4. Master mix (48 µl) 
was aliquoted into individual 0.2 ml nuclease-free thin wall PCR tubes to which 2 µl (5-500 
ng) of genomic DNA template was added. The PCR mix was subjected to PCR cycling 
conditions: denaturation at 94°C for 5 min and 94°C for 45 s, annealing at 50-60°C for 45 s, 
polymerisation at 72°C for 1-2 min (30 cycles) and final extension at 72°C for 7 min.  
  Table 2.4 PCR reaction components 
 




10× PCR buffer II 
25 mM MgCl2 
10 mM dNTPs mix 
AmpliTaq
®



















2.5  Reverse transcriptase-polymerase chain reaction (RT-PCR) 
Thermostable DNA polymerase used in basic PCR is limited to use with DNA as template. 
Due to the importance of targeting RNA, an alternative enzyme is required. For use of 
thermostable DNA polymerase in amplification of RNA, the RNA must be converted into 
DNA in a process called reverse transcription catalysed by reverse transcriptase. 
Alternatively some reverse transcriptases such as avian myloblastosis virus (AMV) or 
Moloney murine leukaemia virus (M-MLV or MuLV) can be used to produce a DNA copy 
of the RNA template using random primers, an oligo (dT) primer or a gene-specific primer. 
Currently it is possible to carry out RT-PCR using a single enzyme such as Tth or Tfl DNA 
polymerase from Thermus thermophilus or T. flavus which has a reverse transcriptase 
activity in the presence of manganese ions and a DNA polymerase activity in the presence of 
magnesium ions (Myers and Gelfand, 1991). 
 
Access RT-PCR system (Table 2.1) was used for RT-PCR on mRNA purified from T. 
congolense clone IL 3000 parasites. This system facilitates one-tube PCR, whereby AMV 
reverse transcriptase (AMV RT) catalyses synthesis of the first DNA strand and thermostable 
Tfl DNA polymerase from Thermus flavus catalyses the second strand cDNA synthesis and 
amplification. 
2.5.1 Materials 
Nuclease free water, (provided in the Access RT-PCR kit, Table 2.1)  
AMV/Tfl 5× reaction buffer, (provided in the Access RT-PCR, Table 2.1) 
10 mM dNTPs mix, 25 mM MgSO4, (provided in the Access RT-PCR, Table 2.1) 
AMV Reverse transcriptase (5U/µl), (provided in the Access RT-PCR, Table 2.1) 
Tfl DNA polymerase (5U/µl), (provided in the Access RT-PCR, Table 2.1) 
Oligonucleotide primers as detailed in the respective Chapter 
RNA templates (Section 2.5.2) 
2.5.2 Method 
All pipette tips and microfuge tubes were sterilised by autoclaving (121ºC, 30 min, RT). 
Diethylpyrocarbonate (DEPC) was used for cleaning all apparatus and the bench. PCR 
protocol was carried out at an area of the bench designated for PCR. 
 
Total RNA was isolated from T. congolense clone IL 3000 parasites using SV Total RNA 
isolation kit as described by the manufacturer (Table 2.1) and the mRNA subfraction gel 
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purified according to RNAid Kit protocol. A master mix of the RT-PCR reagents was 
prepared as shown in Table 2.5 and 24 µl of the master mix aliquoted into individual 0.2 ml 
nuclease-free thin wall PCR tubes to which 0.5 µl of both forward and reverse primers were 
added. The PCR mix was subjected to one cycle for reverse transcription at 45°C for 45 min, 
94°C for 2 min, 94°C for 30 s, 60°C for 1 min, 68°C for 2 min (40 cycles) and 68°C for 7 
min. 
Table 2.5 RT-PCR reaction components  
Components  Volume 25 µl Final concentration  
Nuclease free water 
AMV/Tfl 5× reaction buffer  
10 mM dNTPs mix  
C1, C2 and C3 Fw/Cluster 1-3 Fw primers 
C1, C2 and C3 Rev/Cluster 1-3 Rev primers 
25 mM MgSO4 
AMV Reverse transcriptase (5u/µl) 



















~ 100 ng  
 
2.6 Purification of DNA from agarose gels 
The purpose of the purification of the PCR fragments was to remove the residual DNA 
polymerases and reaction buffer, unincorporated nucleotides, primers and non-specific 
amplification products following PCR and RT-PCR. The removal of these contaminants 
enhances cloning efficiency in subsequent steps. Like all commercial nucleic acid 
purification kits, it relies on the binding of DNA excised from the agarose gel on silica 
matrix. 
2.6.1 Materials 
Isopropanol [80% (v/v)]. Isopropanol (80 ml) was made up to 100 ml with sterile dH2O and 
stored at RT. 
Wizard
®
 SV Gel and PCR clean-up system kit (Table 2.1) 
2.6.2  Procedure 
The Wizard
®
 SV Gel and PCR clean-up system kit (Table 2.1) was used according to the 
manufacturer‟s protocol to purify DNA from agarose gel. 
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2.7  Cloning of PCR products into pGEM
®
-T Easy vector  
T4 DNA ligase catalyses the joining of two DNA stands between 5‟- phosphate and 3‟- OH 
groups of adjacent nucleotides to form a phosphodiester bond (Weiss et al., 1968). The 
pGEM
®
 -T Easy vector (Figure 2.1) is engineered for cloning PCR products because it has 
3‟-T overhangs at both ends. Taq DNA polymerase adds single 3‟-A overhangs to double 
stranded DNA during the PCR reaction (Promega pGEM
®
-T Easy technical manual). The 
complementarity between the pGEM
®
-T Easy vector T-overhangs and PCR products 3‟–A 
overhangs improves the efficiency of ligation. The 3‟-T overhangs also prevent vector 
recircularisation and hence enhance ligation efficiency. pGEM
®
-T Easy is a high copy 
plasmid containing T7 and SP6 RNA polymerase promoters flanking a multiple cloning site 
(MCS) with the α-peptide coding region of the enzyme β-galactosidase. Insertional 
inactivation of the α-peptide allows recombinant clones to be directly identified by white and 
blue screening in the presence of X-gal and IPTG. The MCS is flanked by recognition sites 
for the restriction enzymes EcoRI, BstZI and NotI, thus providing three restriction enzymes 
for release of the insert. The pGEM
®
-T Easy vector also contains the origin of replication of 
filamentous phage f1 for the preparation of single-stranded DNA (ssDNA) (Promega 
pGEM
®













Figure 2.1 Map of pGEM
®





-T Easy vector kit [50 ng/µl] (Table 2.1) 
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2.7.2  Procedure 
The ligation reaction mix was prepared by combining 2× Rapid ligation buffers (5 µl), 
pGEM
®
-T Easy vector (12.5 ng), T4 DNA ligase (0.5 µl) and insert (40-100 ng) and the 
volume was adjusted to 10 µl by the addition of dH2O. Ligations were done at RT for 1h. 
 
2.8  Preparation of competent E. coli JM 109 cells  
Competency of E. coli cells is defined as the ability of the cells to take up foreign DNA and it 
is expressed as cfu (colony forming unit) per µg DNA. There are two methods for 
transforming bacterial cells: chemical transformation where bacterial cells are treated with 
divalent ions (Ca
2+
) to make them competent, and by electroporation whereby the bacterial 
cells are exposed to an electric field to create pores through which DNA enters (Dagert and 
Ehrlich, 1979). Both methods of transformation were used in the present study. Competent E. 
coli cells were obtained from Promega Corporation [pGEM
®
-T Easy Vector System II and 
Invitrogen Life Technologies (Table 2.1)]. Due to the high cost involved in purchasing 
chemically competent cells from manufacturers, these were prepared using several methods 
i.e. The TranformAid™ Bacterial transformation kit from Fermentas life sciences, calcium 
chloride and a modified TB calcium chloride method (Inoue et al., 1990). Competent cells 
prepared by TranformAid™ Bacterial transformation kit were very good for transformation, 
while those using the calcium chloride method were less competent. Although the modified 
calcium chloride method provided cells with high competence, commercial competent cells 
were preferred where large numbers of clones were required.  
2.8.1  Preparation of competent E. coli JM 109 cells using the TransformAid™ 
Bacterial Transformation kit 
 
2.8.1.1 Materials 
Ampicillin [50 mg/ml]. Ampicillin (0.5 g) was dissolved in dH2O (10 ml), filtered through 
0.45 µm filters and stored in a 15 ml conical centrifuge tube at 4°C. 
Ampicillin [100 mg/ml]. Ampicillin (1.0 g) was dissolved in dH2O (10 ml), filtered through 
0.45 µm filters and stored in a 15ml conical centrifuge tube at 4°C. 
2× YT medium. Bacto-tryptone (16.0 g), yeast extract (10.0 g) and NaCl (5.0 g) were 
dissolved by shaking in dH2O (900 ml). The pH was adjusted to 7.0 with NaOH, and made 
up to 1000 ml with dH2O. Half of the medium was sealed and autoclaved (121ºC, 30 min, 
RT) for preparation of bacterial cultures. The remaining half was used for preparation of 2× 
YT-ampicillin agar plates. 
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2× YT-ampicillin agar plates. Agar (7.5 g) was dissolved in 2× YT media (500 ml) and 
autoclaved (121ºC, 30 min, RT), cooled to 50°C before adding ampicillin to a final 
concentration of 100 µg/ml. Agar (30-35  ml) was in poured into 85  mm Petri dishes and 
allowed to solidify. 
Glycerol stocks of competent E. coli JM 109 cells  
Sterile glycerol [10%  (v/v)] Glycerol (10 ml) was made up to 100 ml with sterile dH20, 
autoclaved (121ºC, 30 min, RT) and kept at 4°C after cooling. 
 
2.8.1.2 Procedure 
Competent E. coli JM 109 cells were prepared using TranformAid™ Bacterial 
transformation kit according to the manufacturer‟s specification.  
2.8.2  Preparation of competent E. coli JM 109 cells using the calcium chloride method 
 
2.8.2.1 Materials 
Glycerol stocks of E. coli JM 109 cells  
0.1 M calcium chloride CaCl2.2H2O (14.7 g) was dissolved in 900 ml of dH2O, the volume 
adjusted to 1000 ml and autoclaved (121ºC, 30 min, RT). 
0.1 M magnesium chloride. MgCl2.6H2O (20.3 g) was dissolved in 900 ml of dH2O, the 
volumes adjusted to 1000 ml and autoclaved (121ºC, 30 min, RT). 
 
2.8.2.2 Procedure   
A fresh colony of E. coli JM 109 cells was inoculated into 5 ml of 2× YT and incubated 
overnight in a shaker at 37°C. Overnight E. coli JM 109 cell culture (1 ml) was placed in 100 
ml of fresh 2× YT in a 500 ml conical flask, and incubated at 37°C in shaker until an OD600= 
0.4-0.5 was attained. The cells were centrifuged (6000×g, 5 min, 4°C), the medium drained 
off, the pellet resuspended in 50 ml of 0.1 M ice-cold MgCl2 and incubated on ice for 30 min. 
The cells were centrifuged as before, the MgCl2 drained off and the pellet resuspended in 10 
ml of ice cold 0.1 M CaCl2. The cells were stored at -70°C after adding sterile 50% (v/v) 
glycerol to a final concentration of 20% (v/v) or immediately used for transformation. 
2.8.3  Preparation of competent E. coli JM 109 cells with modified TB  
 
2.8.3.1 Materials 
TB (CaCl2) solution: PIPES (3.021 g), CaCl2.2H2O (2.205 g) and KCl (18.637 g) were 
dissolved in dH2O (900 ml) and the pH was adjusted to 6.7 with KOH. MnCl2 (10.885 g) was 
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dissolved in the solution, the volume was made up to 1000 ml of dH2O and filtered through a 
0.45 µM membrane. The solution was stored at 4°C.  
S.O.C medium: Bacto-tryptone (20 g), Bacto-yeast extract (5 g) and NaCl (0.5 g) were 
dissolved in dH2O (900 ml). 1 M MgSO4 (10 ml), 1 M MgCl2 (2.5 ml) were added and the 
pH adjusted to 7 with NaOH and the volume made up to 990 ml with dH2O. The medium 
was autoclaved (121ºC, 30 min, RT) and filtered. Glucose (2 M, 10 ml) was added after 
cooling.   
S.O.C-ampicillin agar plates. Agar (7.5 g) was dissolved in S.O.C medium (500 ml) and 
autoclaved (121ºC, 30 min, RT), cooled to 50°C before adding glucose (2 M, 5 ml) and 
ampicillin to a final concentration of 100 µg/ml. Agar (30-35  ml) was poured into 85 mm 
Petri dishes and allowed to solidify. 
 
2.8.3.2 Procedure 
An overnight culture of E. coli JM 109 cells (100 µl) was inoculated into fresh S.O.C 
medium (50 ml) and incubated at 37°C for 1 h. The JM 109 E. coli culture was grown in a 
37°C shaker until the cells attained an OD600 of 0.5; the culture (20 ml) was transferred into 
sterile centrifuge tubes and centrifuged (6000×g, 2 min, 4°C). The medium was drained off, 
cells resuspended in cold TB (CaCl2) solution (10 ml) and incubated on ice for 25 min. This 
procedure was repeated twice and the final cell pellet resuspended in cold TB CaCl2 solution 
(2 ml). The cells were stored at -70°C after adding sterile 50% (v/v) glycerol to a final 
concentration of 20% (v/v) or immediately used for transformation.  
2.8.4  Preparation of E. coli JM 109 cells for electroporation 
 
2.8.4.1 Materials 
Glycerol stocks of competent E. coli JM 109 cells  
Sterile glycerol [10%  (v/v)] (Section 2.8.1.1) 
 
2.8.4.2 Procedure 
A fresh colony of E. coli JM 109 cells was inoculated into 2×YT medium (Section 2.8.1.1) 
and grown in a shaker overnight at 37°C. The overnight cell culture (50 ml) was diluted into 
fresh 2× YT medium (500 ml) in a 1000 ml flask, the cells grown for 2-3 h until OD600 = 0.6. 
The cells were transferred into sterile 50 ml conical centrifuge tubes and harvested by 
centrifugation (5000×g, 10 min, 4°C). The medium was poured off, the cell pellet washed in 
ice-cold sterile water (25 ml), and centrifuged as before. The water was drained carefully and 
cells washed again in ice-cold sterile water (12.5 ml) and centrifuged as before. The water 
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was drained off again and the cells were resuspended in ice-cold 10% (v/v) glycerol (6.25 
ml). After centrifugation as before, the glycerol was poured off and the cells resuspended in 
ice-cold 10% (v/v) glycerol (5 ml). Aliquots (100 µl) were used immediately or frozen at -
70°C. 
2.9 Transformation 
Various methods for preparing competent cells were described (Section 2.8), in this section 
transformation protocols for each of the methods are given. 
2.9.1 Transformation of pGEM
®
-T Easy vector containing inserts into competent E. 
coli JM 109 cells prepared by TransformAid™ Bacterial Transformation kit 
 
2.9.1.1 Materials 
TransformAid™ C-medium (provided with the TransformAid™ Bacterial Transformation 
kit, Table 2.1) 
T-Solution A and T-Solution B (provided with the TransformAid™ Bacterial Transformation 
kit, Table 2.1) 
Isopropyl-β-D-thiogalactopyranoside (IPTG) [100 mM] 
IPTG (1.2 g) was dissolved in 40 ml of dH2O, and made up to a final volume of 50 ml with 
dH2O. The IPTG was sterilized by filtration through a 0.22 µm disposable filter. 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) [50 mg/ml] 
X-gal (100 mg) was dissolved in 2 N, N‟- dimethylformamide (2 ml). 
Competent E. coli JM 109 cells (Section 2.8.2.2) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
2× YT-ampicillin agar plates (Section 2.8.1.1) 
 
2.9.1.2 Procedure 
Competent E. coli JM 109 cells were transformed by ligation mixtures according to the 
manufacturer‟s specification. The transformed cells were plated on 2× YT agar plates 
containing 100 µg/ml ampicillin, 50 mg/ml X-gal (10 µl) and 100 mM IPTG (20 µl). The 
plates were incubated overnight at 37°C. 
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2.9.2 Transformation of cloning vectors containing inserts into E. coli JM 109 cells 
prepared by calcium chloride method 
 
2.9.2.1 Materials 
Competent E. coli JM 109 cells (Section 2.8.2.2) 
2× YT media (Section 2.8.1.1) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
X-gal [50 mg/ml] (Section 2.9.1.1) 
100 mM IPTG (Section 2.9.1.1) 
2× YT-ampicillin agar plates (Section 2.8.1.1) 
 
2.9.2.2 Procedure 
Ligation mix (2 µl) was added to thawed competent cells (100 µl) in a 15 ml sterile conical 
centrifuge tube placed on ice and incubated for 30 min, this was followed by incubation at 
42°C for 2 min. 2× YT medium (900 ml) was added and the sample incubated in a shaker at 
37°C for 1 h. The transformed cells were plated on 2× YT agar plates containing 100 µg/ml 
ampicillin, 50 mg/ml X-gal (10 µl) and 100 mM IPTG (20 µl). The plates were incubated 
overnight at 37°C. 
2.9.3 Transformation of cloning vectors containing inserts into competent E. coli JM 
109 cells treated with modified TB (calcium chloride) 
 
2.9.3.1 Materials 
Competent E. coli JM 109 cells (Section 2.8.3.2) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
X-gal [50 mg/ml] (Section 2.9.1.1) 
100 mM IPTG (Section 2.9.1.1) 
S.O.C medium (Section 2.8.3.1) 
DMSO (Section 2.2) 
 
2.9.3.2 Procedure 
 Ligation mix (2-4 µl) was added to competent cells (100 µl), DMSO (1 µl) added and the 
cells were incubated on ice for 30 min. The cells were placed in a water bath at 42°C for 90 s 
and incubated on ice for 2 min. S.O.C medium (400 ml) was added and the cells were 
incubated at 37°C with shaking for 45 min. Transformed cells (100 µl) were plated on pre-
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warmed S.O.C agar plates containing ampicillin (100 µg/ml), 50 g/ml X-gal and 100 M 
IPTG and incubated overnight at 37°C. 
2.9.4. Electroporation of electro-competent E. coli JM 109 cells  
 
2.9.4.1 Materials 
Electro-competent E. coli JM 109 cells (Section 2.8.4.2) 
2× YT medium (Section 2.8.1.1) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
X-gal [50 mg/ml] (Section 2.9.1.1) 
100 mM IPTG (Section 2.9.1.1) 
2× YT-ampicillin plates (Section 2.8.1.1) 
 
2.9.4.2 Procedure 
Cells (100 µl) were thawed on ice and ligation mix (2 µl) added to the cells. The cells were 
incubated on ice for 30 min, transferred into cold 0.2 cm electroporation cuvettes (BioRad) 
on ice, and were pulsed at 25 µF, 200 Ω and 2.5 kV for 4.5-4.8 ms. Sterile 2× YT medium 
(900 l) was added to the cells after the pulse and the cell suspension transferred into 15 ml 
conical centrifuge tubes. The cells were grown at 37°C with agitation for 1 h in a shaker at 
225 rpm and the transformed cells (200 µl) were spread on 2× YT agar plates containing 
ampicillin (100 µg/ml), 50 mg/ml X-gal (10 µl) and 100 mM IPTG (20 µl) and plates were 
incubated overnight at 37°C. 
2.9.5  Transformation of pGEM
®
-T Easy vector containing PCR products 
 
2.9.5.1 Materials  
Competent JM 109 E. coli  cells >10
8
 Cfu/ g (Table 2.1) 
2× YT media (Section 2.8.1.1) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
X-gal [50 mg/ml] (Section 2.9.1.1) 
100 mM IPTG (Section 2.9.1.1) 
2× YT-ampicillin agar plates (Section 2.8.1.1) 
 
2.9.5.2 Procedure  
Ligation mix (2 µl) was added to thawed competent cells (20 µl) in a 15 ml sterile conical 
centrifuge tube placed on ice and incubated for 20 min, followed firstly by incubation at 
42°C for 45 s and secondly on ice for 2 min. 2× YT media (200 ml) was added and the 
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sample incubated in a shaker at 37°C for 1 h. The transformed cells were plated on 2× YT 
agar plates containing 100 µg/ml ampicillin, 50 mg/ml X-gal (10 µl) and 100 mM IPTG (20 
µl). The plates were incubated overnight at 37°C. 
2.10  Screening of recombinant plasmids by colony PCR 
Colonies carrying the cloned fragments were identified by PCR using universal primers SP6 
and T7 (Section 2.7) 
2.10.1  Materials 
SP6 primer: TATTTAGGTGACACTATAG, Tm (50ºC)  
T7 primer: TAATACGACTCACTATAGGG, Tm (56 ºC) 
Sterile tooth pick 
PCR reagents (Table 2.4) 
2.10.2 Procedure 
A sterile tooth pick was used to transfer part of a white colony into 0.2 ml PCR tubes 
containing PCR master mix (25 µl). The PCR tubes were flicked at the bottom to mix the 
cells with PCR reagents and centrifuged briefly. The tubes were subjected to PCR cycling 
conditions: 94°C for 5 min (initial denaturation), denaturation at 94°C for 45 s, annealing at 
50°C for 45 s, polymerisation 72°C for 1-2 min for 25 cycles and final extension at 72°C for 
7 min.  
2.11  Purification of plasmid DNA (Minipreps) 
Plasmid DNA was obtained by minipreparation of plasmids (minipreps). Wizard
® 
Plus SV 
Miniprep DNA purification system exploits the alkaline/SDS-denaturation method for 
purifying plasmid DNA (Birnboim and Doly, 1979). The SDS-denaturation method is based 
on the differences in denaturation and renaturation characteristics between plasmid DNA and 
chromosomal DNA. Denaturation of both plasmid and chromosomal DNA occurs under 
alkaline conditions. Upon addition of neutralisation solution, the chromosomal DNA 
rehybridises in an intra-strand manner, hence forming an insoluble aggregate that 
precipitates, whereas plasmid DNA undergoes interstrand rehybridisation and remains in 
solution. Potassium forms an insoluble salt with SDS, which precipitates proteins and 
complexes together with chromosomal DNA, leaving the plasmid DNA in the clear lysate. 
The chromosomal and plasmid DNA are then separated by centrifugation; any RNA present 
is digested by RNases present in the resuspension solution. The clear lysate formed is then 
transferred onto a column containing silica where the DNA binds in the presence of a high 
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concentration of guanidine hydrochloride (Marko et al., 1982; Boom et al., 1990). Two 
ethanol washes remove the salts and the DNA is eluted in a low ionic strength solution such 
as TE buffer or nuclease free water. 
2.11.1  Materials  
2× YT media (Section 2.8.1.1) 
Ampicillin [50 mg/ml] (Section 2.8.1.1) 
Wizard
®
 Plus SV Minipreps DNA purification kit (Table 2.1) 
2.11.2  Procedure 
A single colony from a 2× YT agar plate was inoculated into the 2× YT medium (5 ml) 
containing ampicillin (100 µg/ml) and incubated overnight (12-16 h) at 37°C in a shaking 
incubator. The bacterial culture was centrifuged (5000×g, 5 min, RT) in a table top 
centrifuge, the supernatant was poured off and the pellet resuspend in resuspension solution 
(provided in the Wizard
®
 Plus SV Minipreps DNA purification kit) and transferred into 1.5 
ml microfuge tubes. The plasmid DNA was purified using Wizard
®
 Plus SV Minipreps DNA 
purification kit according to the manufacturer‟s instructions.  
2.12  DNA purification using Wizard
®
 DNA Clean-Up System 
Good quality DNA is required in all DNA manipulation steps. Wizard
®
 DNA Clean-Up 
System purifies DNA from salts, enzymes and also concentrates DNA. Purification using this 
kit relies on the same principle as the Wizard SV Gel and PCR clean-up system as described 
in Section 2.6. The chaotropic buffer contains silica (resin) to which DNA binds. A sequence 
of ethanol washes and centrifugation steps removes contaminants from the DNA and the 
DNA is then eluted from the silica mini-columns with a low salt concentration solution such 
as TE or nuclease free water. 
2.12.1  Materials 
Wizard
®
 DNA Clean-Up System (Table 2.1) 
Isopropanol [80% v/v ] (Section 2.6.1) 
2.12.2  Procedure 
The DNA was purified using Wizard
®
 DNA Clean-Up System according to the 
manufacturer‟s specifications. 
2.13  DNA sequencing 
DNA fragments are sequenced to determine the order of the nucleotides in a given fragment. 
There are two major methods of DNA sequencing, i.e. the chain termination method (Sanger 
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et al., 1977) and chemical sequencing (Maxam and Gilbert, 1977).  Chain termination 
sequencing also called Sanger sequencing, is the most widely used method and was used in 
the present study. This method is based on the replacement of the 3‟-OH group by hydrogen 
to result in a 2‟, 3‟-dideoxynucleotide that cannot form a phosphodiester bond with the next 
nucleotide and DNA chain elongation is thus terminated. Oligonucleotide primers are used to 
initiate sequencing, and like in normal PCR reactions the chain is elongated by DNA 
polymerase in the presence of dNTPs and a low concentration of four dideoxynucleotides 
(ddATP, ddGTP, ddCTP and ddTTP). DNA polymerase elongates the chain until a 
dideoxynucleotide is incorporated into the growing strand. The different-sized fragments are 
separated on a polyacrylamide gel. Originally, the sequencing process involved 4 
independent reactions, each with one terminating ddNTP. Currently dideoxynucleotides are 
labelled with different fluorescent dyes with different emission wavelengths that allow 
reading of the nucleotide sequence with a fluorescent scanner. All sequencing was carried out 
at the International Livestock Research Institute (ILRI), Nairobi, Kenya.  
2.14  Bioinformatics 
A variety of bioinformatics tools were used in the present study: sequence alignment, use of 
homology (BLAST) programmes for identification of sequence, nucleotide translation into 
protein and a study of the restriction pattern of congopain-like cysteine proteases. To design 
the primers used in the present study, alignment of sequences was done by Sequencher 4.5 
(Gene Codes Corporation) and ClustalW (www.ebi.ac.uk/ClustalW). These two programmes 
were also used to align sequences obtained from the study and establish their relatedness. 
Phylogenetic trees were also constructed using ClustalW. NCBI BLAST 
(www.ncbi.nlm.nih.gov/BLAST) (Thompson et al., 1994) was used to confirm that cloned 
DNA sequences were part of cysteine protease genes. GeneDb (www.genedb.org) was also 
used to blast sequences and compare cloned DNA sequences with existing sequences in this 
database. ExPAsy proteomics tools (www.expasy.org/tools) were used to translate nucleotide 
sequences into predicted amino acid sequences. NEBcutter V2.0 
(www.tools.neb.com/NEBcutter2) was used to determine restriction sites in congopain-like 




CONSTRUCTION OF A CONGOPAIN-LIKE CYSTEINE PROTEASE 
GENE UNITS LIBRARY 
3.1  Introduction 
Congopain is the major cysteine protease in T. congolense infected-cattle (Authié et al., 
1992) and has been shown to contribute to the pathology of trypanosomosis (Authié et al., 
1993, 2001; Authié, 1994). Cattle immunized with congopain develop high levels of anti-
congopain IgG which inhibit its activity (Authié et al., 2001). Cysteine protease inhibitors 
have been suggested as potential chemotherapeutic agents in parasitic diseases (Sajid and 
McKerrow, 2002). Development of an anti-disease vaccine and a chemotherapeutic agent 
based on congopain-like cysteine proteases requires an understanding of their genetic 
diversity. Therefore, the variability within these families of genes was studied using different 
approaches. In this chapter, one approach is reported, by constructing and screening a 
congopain 2 kbp gene unit library from cosmid clones containing various length of the 
congopain locus.  
In a previous study, a cosmid library of T. congolense IL 3000 genomic DNA was 
constructed, screened using the CP2 open reading frame as a probe and 15 positive clones 
were selected (Dr. Boulangé, manuscript in preparation). The clones were digested with PstI 
and the released 2 kb gene units cloned into a pGEM
®
-3Zf(+) vector. Approximately 120 
clones were selected and screened by sequencing (24 clones) and PCR (96 clones) to 
establish the variability within the congopain-like cysteine protease genes present in the 
locus.  
3.2  Materials and Methods  
3.2.1  Digestion of CP cosmid clones with PstI 
The location of PstI restriction site in the congopain gene is shown in Appendix A. 
 
3.2.1.1 Materials 
PstI (Table 2.2) 
10× buffer H (provided together with PstI, Table 2.2) 
Cosmid clones (Provided by Dr. Boulangé) 
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3.2.1.2 Procedure 
For each of the 15 CP cosmid clones, the digestion reaction consisted of CP cosmid DNA (11 
µl), 10× buffer (1.5 µl), PstI (0.5 µl) and made up to 15 µl with dH2O. The digest was carried 
out at 37°C for 2 h and the fragments separated on a 0.6% (w/v) agarose gel and stained with 
ethidium bromide (Section 2.3.2). For each of the 15 clones the 2 kb fragment was excised 
from the gel and purified as a pool using Wizard
®
 PCR Preps DNA Purification kit according 
to the manufacturer‟s protocol. 
3.2.2 Digestion of pGEM
®
-3Zf(+) cloning vector with PstI 
A map of the pGEM
®
-3Zf(+) cloning vector showing the multiple cloning sites is given in 
Figure 3.1. 
 
3.2.2.1 Materials  
pGEM
®
-3Zf(+) cloning vector (Promega) 
PstI (Table 2.2) 





-3Zf(+) cloning vector (1.2 µg) was digested with PstI (1 µl), in 1µl (10× buffer 
H) and made up to 10 µl with dH2O. The reaction was incubated at 37°C for 30 min. 
3.2.3  Dephosphorylation of digested pGEM
®




-3Zf(+) (Section 3.2.3) 
Shrimp Alkaline phosphatase (SAP) (Table 2.2) 





-3Zf(+) (1.0 µg) was dephosphorylated by adding 10× 
dephosphorylation buffer (1.3 µl), SAP (1.0 µl) and made up to 13 µl with dH2O. The 
reaction was done at 37°C for 1 h, the SAP was inactivated in a water bath at 65°C for 30 
min. Digested and dephosphorylated pGEM
®
-3Zf(+) was purified using Wizard
®
 DNA 























Figure 3.1 Map of pGEM
®
-3Zf(+) cloning vector (www.promega.com accession date 19
th
 November 2006). 
  
3.2.4  Cloning of the 2 kb CP cosmid PstI digested fragment into PstI digested and 
dephosphorylated pGEM
®
-3Zf(+) cloning vector 
 
3.2.4.1 Materials 
PstI-digested and dephosphorylated pGEM
®
-3Zf(+) (Section 3.2.4.2) 
2 kb fragment from CP cosmid library (Section 3.2.1.2) 
T4 DNA ligase (Table 2.2) 
10× ligation buffer (provided together with T4 DNA ligase, Table 2.2) 
 
3.2.4.2 Procedure 
To the PstI-digested and dephosphorylated pGEM
®
-3Zf(+) cloning vector (0.2µg), 2 kb CP 
cosmid fragment (0.7µg), 10× ligation buffer 1 µl and T4 DNA ligase 1.0 µl were added and 
ligation carried out overnight at 16°C. 
3.2.5  Transformation of ligated pGEM
®
-3Zf(+) cloning vector/2 kb CP cosmid 
fragment into competent E. coli JM 109 cells  
 
3.2.5.1 Materials 
Competent E. coli JM 109 cells (Table 2.1) 
2× YT medium (Section 2.8.1.1) 
2× YT-ampicillin agar plates (Section 2.8.1.1) 
 40 
PstI-digested and dephosphorylated pGEM
®
-3Zf(+) cloning vector and 2 kb ligation (Section 
3.2.4.2)  
X-gal [50 mg/ml] (Section 2.9.1.1) 
100mM IPTG (Section 2.9.1.1) 
 
3.2.5.2 Procedure 
Competent E. coli JM 109 cells (100 µl) were transformed by adding ligation mixture (3 µl) 
and the reaction conducted as per the manufacturer‟s protocol. The transformed cells were 
plated on 2× YT agar plates containing 100 µg/ml ampicillin, 50 g/ml X-gal and 100 M 
IPTG. The plates were incubated overnight at 37°C. The recombinant colonies from 2 × YT 
plates were inoculated in 2× YT medium (5 ml) containing ampicillin (100 µg/ml) and 
incubated overnight (12-16 h) at 37°C in a shaking incubator. The bacterial culture was 
centrifuged (6000×g, 5 min, RT) in a table top centrifuge, the supernatant poured off, the 
pellet resuspended in resuspension solution (provided in the Wizard
®
 Plus SV Minipreps 
DNA purification kit, Table 2.1) and transferred into 1.5 ml microfuge tubes. Plasmid DNA 
was isolated using Wizard
®
 Plus SV Minipreps DNA purification kit (Table 2.1) according to 
the manufacturer‟s protocol.  
3.2.6  PstI digestion of recombinant pGEM
®
-3Zf(+)/2 kb clones 
 
3.2.6.1 Materials  
Recombinant pGEM
®
-3Zf(+)/2 kb clones (Section 3.2.5.2) 
PstI (Table 2.2) 
10× buffer H (provided together with PstI, Table 2.2) 
 
3.2.6.2 Procedure  
Recombinant pGEM
®
-3Zf(+)/2 kb clones 1-30 were digested with PstI in a reaction 
consisting of recombinant plasmid DNA (5.0 µl), 10× buffer (1 µl), PstI (0.5µl) and made up 
to 10 µl with dH2O. The digestion was carried out for 1 h at 37°C and separated on a 0.8% 
(w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). 
3.2.7 Design of primers for screening the 2 kb CP cosmid library 
Preliminary results of sequencing showed that the genes clustered in three groups, named 
CP1, CP2 and CP3, as they respectively most closely resembled the 3 genes present in the 
database. In order to establish the proportions of CP1, CP2 and CP3 in the 2 kb CP cosmid 
library, six different pairs of primers were designed, two sets for each family. The first set, 
Cluster-C1, -C2, -C3 (Fw and Rev), amplify the same-sized product of 250 bp. The second 
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set has a single forward primer (Forward-all-CP) common to all CPs and 3 distinct reverse 
primers (Rev-C1,-C2,-C3), located at different position on congopain, generating different-
sized products. It was originally designed to be used as a mix of four primers in a single PCR 
reaction. 
 
The forward primers Cluster-C1, -C2, -C3, -Fw target the sequence coding for the amino 
acids around the active cysteine residue (or serine in the case of CP3, see the results section 
of this chapter), while Cluster-C1, -C2, -C3, -Rv target a sequence situated 250 bp 
downstream, in a region of less conservation at DNA level (Table 3.1). 
 
The other set of primers was composed of a common forward primer named Forward-all-CP 
targeting the sequence coding for amino acid residues EAFRF, a region in the propeptide that 
is conserved in cysteine proteases of the cathepsin L-like subfamily (Sajid and McKerrow, 
2002). Rev-C1 primer targeted the genes coding for a region around the histidine residue of 
the catalytic domain which is unique to CP1 (LDHDVLL), 700 bp downstream of Forward-
all-CP primer, Rev-C2 primer targeted an sequence unique to CP2 within the catalytic 
domain, 415 bp downstream, and Rev-C3 targeted a region at the end of the catalytic domain 
and unique to a group of CP3-like cysteine proteases, 840 bp downstream (Table 3.1).  
Table 3.1 CP cluster and other primers used for screening 2 kb CP cosmid clones  
















































3.2.8 Screening of 2 kb CP cosmid clones by PCR 
In addition to the 24 clones sequenced, the remaining 96 were screened by PCR using two 
separate sets of primers (Section 3.2.7) designed from congopain-like cysteine protease genes 
based on either CP1, CP2 or CP3 DNA sequences (Table 3.1). These primers were used to 
establish the proportions of CP1, CP2 and CP3 related clones from the 2 kbp gene unit 
library, and compared with results obtained by sequencing. 
 
3.2.8.1 Materials 
Glycerol stocks of pGEM
®
-3Zf(+)/2 kb clones (Section 3.2.5.2) 
Cluster primers-C1, -C2 and -C3 (Fw and Rev) (Table 3.1) 
Forward-all-CP and Rev-C1, Rev- C2 and Rev-C3 primers (Table 3.1) 
PCR reagents (Table 2.4) 
 
3.2.8.2 Procedure 
The clones were amplified by three pairs of cluster primers-C1, -C2 and -C3 (Fw and Rev) 
and another set of three primers: Forward-all-CP and Rev-C1, Rev-C2 and Rev-C3 (Table 
3.1). The PCR products were separated on a 1% (w/v) agarose gel (Section 2.3.2). The PCR 
reaction mixture was prepared as per Table 3.2, and subjected to PCR cycling conditions: 
denaturation at 94°C for 5 min and 94°C for 45 s, annealing at 60°C for 45 s, polymerisation 
at 72°C for 1-2 min (25 cycles) and final extension at 72°C for 7 min.   
 
Table 3.2 PCR reagents for amplification of CPs from cosmid library clones using cluster primers-C1, C2 
and C3 (Fw and Rev), Forward-all-CP and Rev-C1, Rev-C2 and Rev-C3 primer. 
 
PCR reagents Volumes 25 µl Final concentration 
DNA/glycerol stocks  
Cluster primers-C1, -C2 and -C3 (Fw) 
Cluster primers-C1, -C2 and -C3 (Rev) 
10 × PCR buffer II 
25 mM MgCl2 
10 mM dNTPs  
AmpliTaq
®




















3.3  Results 
3.3.1  Construction of a 2 kbp congopain gene unit library 
In a previous study (Boulangé, manuscript in preparation), a T. congolense cosmid library 
had been constructed, and 15 cosmid clones had been selected by screening with CP2 coding 
sequence used as a probe. The existence of a PstI site towards the 3‟ end of the three known 
congopain-like cysteine protease genes was exploited in the construction of a sub-cosmidic 
library. The 15 cosmid clones digested with PstI gave bands at approximately 2 kb (single 
gene unit), 2.3 kb and 4 kb (likely to consist of two gene copies, one missing the PstI site) 
(Figure 3.2). There were other bands on the gel but they did not show any given pattern.  
The bands at 2 kbp were excised and cloned into pGEM®-3Zf(+). About 120 recombinant 
clones were obtained. All the clones were digested with PstI and inserts of approximately 2 
kb could be observed confirming that they were recombinants (Figure 3.3). 
 
 
Figure 3.2 PstI restriction digest of cosmid library clones 1-15. The digested samples were separated on a 
0.6% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). Lane M, molecular weight markers; 















Figure 3.3 PstI restriction digest of recombinant pGEM
®
-3Zf(+)/2 kb clones. The digested samples were 
separated on a 1% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). Lane M, molecular 
weight markers; lanes 2, 4, 5, 6, 7, 8 and 9, corresponding 2 kb clones 2, 4, 5, 6, 7, 8 and 9 digested with PstI.  
 
3.3.2  Sequence analysis of 2 kb CP cosmid clones  
Sequencing was done for 2 kb cosmid clones 1-30, using SP6 and T7 primers (Section 
2.10.1) as well as internal primer Rev-new-830 (Table 3.1) to obtain the complete gene 
sequence. Eighteen clones were sequenced to full length, but 7 clones were only partial; the 
remaining 5 were either non recombinant or had more than one insert. The analysis was 
hence performed on 25 clones. The DNA sequences were compared with other CP genes in 
the database using the NCBI BLAST website (Section 2.14). All the clones matched 
significantly with all the three cysteine proteinase genes described in T. congolense; CP1 
(Fish et al., 1995, EMBL accession number Z25813), CP2 (Jaye et al., 1994, EMBL 
accession number L25130) and CP3 (Downey and Donelson, 1999, EMBL accession no. 
AF139913). The DNA sequences were translated into predicted amino acid sequences using 
ExPAsy tools and aligned by ClustalW (Figures 3.6-3.8), and showed high sequence identity 
(88-100%). 
 
The signal peptides (20 amino acid long) in all 25 clones had 100% sequence identity; the 
propeptide was highly homologous as well with only very few amino acid substitutions. The 
inhibitory peptide sequence YHNGA (Lalmanach et al., 1998) of the propeptide (Figure 3.4, 
text box 1) was present and conserved in all the clones.  


















































































Since part of the catalytic domain of some of the clones was not sequenced, the variability 
was examined mainly around the active site cysteine residue of the enzymes (Figure 3.4). 
Two distinct propeptide cleavage sites were found, APEA in 22 clones and APDA in three 
clones (Figure 3.4, text box 2). All the clones coding for the latter proenzyme cleavage site 
sequence carried a serine residue at the active site instead of a cysteine (Figure 3.4, text box 
4). All clones coding for APEA, on the other hand had a cysteine residue, apart from one 
clone coding for a serine (Figure 3.4, text box 4). An QGQ sequence at positions 19-21 
(papain numbering) was present in 19 clones coding for a cysteine residue at the active site, 
while it was replaced by ERL in all the clones coding for a serine at the active site (Figure 
3.4, text box 3). The exceptions were one clone coding for a serine residue that had a QGQ 
residue in place of ERL (Figure 3.4, text box 3), and only CP1 has QGA in this position. The 
histidine and asparagine residues forming the catalytic triad were conserved in all the clones 
(Figure 3.5, text boxes 1 and 2 respectively). The C-terminal extension sequences are joined 
to the catalytic domains by a 6-residue polyproline hinge (Figure 3.6, text box 1) and was 91-
100% identical. 
 
A phylogenetic tree based on the amino acid sequence alignment using ClustalW formed five 
clusters, four clones clustered together with CP2 and two more clusters of five and six clones 
were close to the CP2 cluster (Figure 3.7). The fourth cluster consisted of four clones with a 
serine residue at the active site and was very similar in sequence to CP3. The last cluster was 
composed of six clones closely related to CP1. Overall six clones were considered closely 
related to CP1, fifteen to CP2 and four clones to CP3. It should be noted however that if 
several clones exactly match the sequence of CP2 present in the database, none exactly 
match CP1 or CP3. 
 
A certain degree of variability seems to exist within these clones mainly in the catalytic 
domain, with fewer differences in the amino acid sequence at the maturation site and amino 
acid residues forming the catalytic triad. As shown in Figure 3.8 regions represented by text 
boxes 1 and 2 have a higher degree of variability. The amino acid residues at these positions 
show the difference in the cysteine protease isoforms, clones closely related to CP1 have a 
different sequence compared to those closely related to both CP2 and CP3. In some instances 
(Figure 3.8 text box 1) clones coding for negatively charged amino acid residues (glutamate) 
are substituted by positively charged amino acid residues (arginine) or the amide asparagine, 
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while hydrophilic amino acid residues (aspartate) are replaced by hydrophobic amino acid 
residues (phenylalanine). Further significant differences in sequences are shown in Figure 
3.8, text box 2 such as the substitution of aspartate in CP2-like clones by asparagine in CP1-
like clones. The part of the catalytic domain shown in Figure 3.8 has a higher degree of 
variability than the part illustrated in Figure 3.5. There is very little sequence polymorphism 
in the C-terminal extension (Figure 3.6), unlike at the cleavage site and around the active site 
(Figure 3.4) of these cysteine protease clones. 
 
CLUSTALW (1.83) multiple sequence alignment 
                          1                                                          2                                         3           4 
Clone22       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone24       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone30       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone17       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone16       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone15       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone14       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone13       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone11       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone10       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone09       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone08       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone07       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone06       MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
CP2           MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone05       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone23       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone27       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone19       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone20       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone25       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
Clone26       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD QGQC GS C W 60 
CP1           MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APPA VDWRKKGAVTPVKD QGAC GS C W 60 
CP3           MSPEEFRAT YHNGA EYYAAALKRPRKVVNVSTGK APPA IDWRKKGAVTPVKD QGQC HS S W 60 
Clone02       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APDA VDWRKKGAVTPVRD ERLC DS S W 60 
Clone04       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APDA VDWRKKGAVTPVRD ERLC DS S W 60 
Clone29       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APDA VDWRKKGAVTPVRD ERLC DS S W 60 
Clone21       MSPEEFRAT YHNGA EYYAAALKRPRKVVTVSTGK APEA VDWRKKGAVTPVKD ERLC DS S W 60 
                            ********* ***** **************.***** ** * :***********:* :  *  * . * 
 
Figure 3.4 ClustalW alignment of predicted amino acid sequences showing the N-terminus of mature CP 
and part of the catalytic domain of CP obtained from cosmid library clones. The clones were sequenced 
and the DNA sequences translated into amino acid sequence using ExPAsy software and aligned by ClustalW. 
CP1, CP2 and CP3 are predicted amino acid sequences of cysteine protease isoforms CP1, CP2 and CP3 
respectively. Text box 1, inhibitory peptide YHNGA of the propeptide; text box 2, the cleavage site between the 
propeptide and the central domain; text box 3, amino acid residues QGQ/QGA/ERL (positions 18-21 papain 
numbering) and text box 4, either cysteine or serine residues at the active site. 
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                                              1                                            2 
Clone24         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
CP2             SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone08         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone11         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone20         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone07         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone17         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone10         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone22         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone06         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone16         SEHLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone13         SEHLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone01         SEHLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone14         SEHLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone30         SEHLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
CP3             SEHLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG 60 
Clone05         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone23         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone26         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone15         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone19         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone27         SKQLD H GVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
CP1             SKGLD H DVLLVGYDDTSKPPYWIIK N SWSKGWGEEGYIRIEKGTNQCLMKNYARSAVVSG 60 
Clone25         SKQLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone29         SEQLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone02         SEQLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone04         SEQLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
Clone21         SEQLD H GVLLVGYDDTSKPPYWIIK N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG 60 
                *: ** * .****************** * **.********************** . ****** 
 
  
Figure 3.5 ClustalW alignment of predicted amino sequences showing part of the catalytic domain that 
includes the Histidine and Asparagine of the catalytic triad of CP obtained from cosmid library clones. 
The clones were sequenced and the DNA sequences translated into amino acid sequence using ExPAsy 
software and aligned by ClustalW. CP1, CP2 and CP3 are predicted amino acid sequences of cysteine protease 
isoforms CP1, CP2 and CP3 respectively. Text box 1, conserved histidine and Text box 2, conserved asparagine 
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Clone5          PVPPPPPPAS TFTQEFCEGAQCQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone26         PVPPPPPPAS TFTQEFCEGAQCQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone19         PVPPPPPPAS TFTQEFCEGAQCQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone27         PVPPPPPPAS TFTQEFCEGAQCQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone23         PVPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone21         PVPPPPPPAS TFTQEFCEGAEC-SGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 59 
Clone25         PVPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone29         PVPPPPPPPP TFTQEFCEGAQC-SGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 59 
Clone04         PVPPPPPPPP TFTQEFCEGAQC-SGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 59 
Clone02         PVPPPPPPPP TFTQEFCEGAQC-SGCTKATFPTGKCVQLSGAGSVIASCGPNNLTQIVYP 59 
Clone20         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
CP2             --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone24         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone08         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone07         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone10         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone22         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone06         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone16         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone17         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone11         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone13         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSAIASCGSNNLTQIVYP 58 
Clone30         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSAIASCGSNNLTQIVYP 58 
Clone14         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
CP3             --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone01         --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone15         PVPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
CP1             PPPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQFGGAGSVIASCGSNNLTQIVYP 60 
                  ******.. *****:****:* * *************:.****.*****.********* 
 
Figure 3.6 ClustalW alignment of predicted amino sequences showing the C-terminal extension of CP 
obtained from cosmid library clones. The clones were sequenced and the DNA sequences translated into 
predicted amino acid sequence using ExPAsy software and aligned by ClustalW.  CP1, CP2 and CP3 are 
predicted amino acid sequences of cysteine protease isoforms CP1, CP2 and CP3 respectively. Text box 1, the 


























Figure 3.7 Phylogenetic tree constructed by ClustalW on congopain-like cysteine protease genes (clones) 
obtained from the CP cosmid library. CP1, CP2 and CP3 are cysteine protease isoforms CP1, CP2 and CP3 
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Clone27         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEQSYPYA SKGGKMPPCNMSGK VVGAKIRDH 185 
Clone19         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEQSYPYA SKGGKMPPCNMSGK VVGANIRDH 240 
Clone26         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEQSYPYA SKGGKMPPCNMSGK VVGANIRDH 240 
Clone05         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEQSYPYA SKGGKMPPCNMSGK VVGANIRDH 240 
Clone25         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEESYPYA SKGGKMPPCNMSGK VVGANIRDH 240 
Clone23         CDTEDDGCGGG LMDNAFQWIVSSNKGNVFTEQSYPYA SKGGKMPPCNMSGK VVGAKIRDH 240 
CP1             CDTTDYGCRGG LMDKSLQWIVSSNKGNVFTAQSYPYA SGGGKMPPCNKSGK VVGAKISGH 240 
Clone15         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPACDKSGK VVGAKIRDH 203 
Clone09         CQTNDFGCEGG LMDDAFKWIVSSNKDNVFTEQSY--- -------------- --------- 127 
Clone07         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone08         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
CP2             CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone22         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone06         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone17         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone11         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone16         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone10         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone24         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone20         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
Clone13         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPACDKSGK VVGAKIRDH 240 
Clone30         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPACDKSGK VVGAKIRDH 240 
Clone14         CDTNDFGCEGG LMDDAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDH 240 
CP3             CDTNDFGCGGG FSDPAFKWIVSSNKGNVFTEQSYPYA SGGGNVPTCDKSGK VVGAKIRDR 240 
Clone02         CDTREDGCGGG LMDRAFQWIVSSNKGNVFTEQSYPYA S------------- --------- 187 
Clone04         CDTREDGCGGG LMDRAFQWIVSSNKGNVFTEQSYPYA S------------- --------- 148 
Clone29         CDTREDGCGGG LMDRAFQWIVSSNKGNVFTEQSYPYA S------------- --------- 166 
Clone21         CDTREDGCGGG LMDRAFKWIVSSNKGNVFTEQSYPYA S------------- --------- 162 
                *:* : ** ** : * :::*******.**** :**         :         ::   :    
 
Figure 3.8 ClustalW alignment of predicted amino acid sequences showing a variable region of 
congopain-like gene (clones) obtained from CP cosmid library 
 
3.3.3  Screening of 2 kb CP gene unit clones by PCR 
Cluster primers-C1, -C2 and -C3 (Fw) were used for screening 2 kb CP clones that were not 
sequenced. The three pairs of primers gave a band at approximately 250 bp, as shown in 
Figure 3.9, clones that gave a strong signal with either C1 or C2 or C3 were considered 
closely related to CP1, CP2 and CP3 respectively. Forward-all-CP and Rev-C1, Rev-C2 and 
Rev-C3 primers formed bands of different sizes (Figure 3.10). As shown with the cluster 
primers clones that gave a strong signal with the latter primers were designated as either CP1 
or CP2 or CP3. Some uncertainty obtained with a set of primers could generally be lifted 
with the other set, as illustrated by clone 5, uncertain with Cluster-C1/2/3 set, but definite 
with Fw-all-CP set. Overall, both sets of primers identified half the clones as closely related 
to CP2, a third related to CP1 and the rest were considered close to CP3. These ratios were 





































Figure 3.9 PCR on 2 kb CP cosmid library clones using cluster pairs of primers C1, C2 and C3. The 
digested samples were separated on a 1% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). 
Lanes M, molecular weight markers; lanes 1, 3, 5, 15, 19, 21, 28, 29, clones 1, 3, 5, 15, 19, 21, 28, 29 amplified 
by cluster primers-C1, (Panel A), -C2 (Panel B) and -C3 (Panel C). Lanes IL 3000, T. congolense IL 3000 
genomic DNA (positive control) amplified by cluster pairs of primers C1, C2 and C3 Fw and Rev in Panels A, 















































































































































































































Figure 3.10 PCR on 2 kb CP cosmid library clones using Forward-all-CP and Rev-C1, Rev-C2 and Rev-
C3 pairs of primers. The digested samples were separated on a 1% (w/v) agarose gel and stained with 
ethidium bromide (Section 2.3.2). Lanes M, molecular weight markers; lanes 3, 5, 19, 13, 15, 17, 21, 29, clones 
3, 5, 19, 13, 15, 17, 21, 29 amplified by Forward-all-CP and Rev-C1 primers (Panel A), Forward-all-CP and 
Rev-C2 primers (Panel B) and Forward-all-CP and Rev-C3 primers (Panel C). Lanes IL 3000, T. congolense IL 
3000 genomic DNA (positive control) amplified by C1, C2 and C3 Fw and C1 Rev, C2 Rev and C3 Rev pairs 






























































Mw         3          5          19        13         15        17       21        29   IL3000 
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3.4  Discussion 
Approximately 120 clones of congopain-like cysteine protease were obtained after cloning 
the 2 kb band obtained by PstI digestion of the cosmid library clones. Sequencing was done 
for 25 clones while the rest were screened by PCR to establish the proportions of CP1- CP2-
or CP3-like cysteine protease genes. Out of the 25 sequenced clones, fifteen clustered with 
CP2, six clones with CP1 and four clones that code for a serine residue at the active site 
clustered with CP3. This was in agreement with results obtained by PCR screening using 
cluster primers-C1, -C2 and -C3 (Fw and Rev) and Forward-all-CP and Rev-C1, Rev-C2 and 
Rev-C3 primers. PCR screening identified approximately half of the clones as being close to 
CP2, a third as CP1 and the remaining being close to CP3. The sequenced clones were also 
subjected to PCR using cluster primers-C1, -C2 and -C3 (Fw and Rev), and Forward-all-CP 
and Rev-C1, Rev-C2 and Rev-C3 primers, the results obtained agreed with the clustering 
based on the phylogenic tree. 
 
A significant degree of variability seems to exist within these clones mainly in the catalytic 
domain, with notable differences in the amino acid sequence at the maturation site and 
around the amino acid residues forming the catalytic triad. The amino acid residues at these 
positions show the difference in the cysteine protease isoforms. In some instances clones 
coding for negatively charged amino acid residues (glutamate) are substituted by positively 
charged amino acid residues (arginine) or the amide asparagine, while hydrophilic amino 
acid residues (aspartate) are replaced by hydrophobic amino acid residues (phenylalanine). 
Further significant differences in sequences are the substitution of aspartate in CP2-like 
clones by asparagine in CP1-like clones. This difference affecting the vicinity of the active 
site, or the overall pI of the enzyme, may affect the enzyme‟s activity and properties, as 
shown for CP1 and CP2 (Boulangé et al., 2001). Half of the amino acid residues substitution 
between C1 (CP1) and C2 (CP2), led to the former having a negative charge unlike CP2 and 
consequently both enzymes had different pI values and elution profiles on ion-exchange 
chromatography. Moreover CP2 exhibited activity over a wide range of pH unlike CP1 
which was active only at acidic conditions but inactivated at neutral or alkaline pH. Lima et 
al. (2001) reported that two cysteine protease isoforms (cruzain and cruzipain 2) from T. 
cruzi with very few amino acid substitutions in the catalytic domain led to enzymes with 
different pH stability, substrate sensitivity and sensitivity to inhibition by inhibitors of 
cysteine proteases.  
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Of particular concern was that sequence exactly matching the CP1 or CP3 of the database 
where not found among these clones, while they were selected from a cDNA library. This 
can mean that either they are specific of the T. congolense strains used for their cloning, a 
possibility addressed in Chapter 4, or they are located outside of the cloned locus, addressed 
in Chapter 5. 
 
Although there is a degree of variability in the congopain-like cysteine protease (clones), 
predicted amino acid sequences are 88-100% identical. Therefore it is likely that congopain 
based vaccine will inhibit all congopain-like cysteine protease. Due to the degree of 
variability among congopain-like cysteine protease clones from a single T. congolense IL 
3000 strain, it was necessary to establish and compare their diversity in other strains of T. 
congolense as well as in other trypanosomes species as described in the next Chapter. 
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CHAPTER 4 
VARIABILITY OF CONGOPAIN-LIKE CYSTEINE PROTEASE 
GENES IN TRYPANOSOMES 
4.1  Introduction  
Analysis of a congopain-like cysteine protease gene unit library was undertaken to study the 
variability of CP genes (Chapter 3). It was shown that the signal peptide and propeptide were 
highly conserved with very few amino acid differences. Furthermore it was shown that the 
catalytic domain showed variability, especially at and around the active site of the enzyme, 
while the C-terminal domain was more conserved.  The highest degree of variability was 
seen in the sequences corresponding to residues cysteine to serine at the active site of the 
enzyme. Although the different clones obtained in the present study of T. congolense IL3000 
strain showed at least 88% amino acid sequence identity, it was deemed necessary to the 
study the diversity of congopain-like cysteine protease genes in different strains of T. 
congolense to determine the extent of diversity across T. congolense strains. Secondly, an 
attempt was made to determine how different other congopain-like cysteine protease genes in 
T. b. brucei and T. vivax are from congopain, i.e. the interspecies variability. 
 
To determine the variability of congopain-like cysteine protease genes in three major 
trypanosome species (T. congolense, T. vivax and T. brucei), PCR, cloning and sequencing 
methodology was used. Six degenerate primers were designed based on congopain-like 
cysteine protease genes of T. congolense, T. vivax and T. b. brucei. (Figure 4.1). Three 
degenerate species-specific primer pairs were designed based on the nucleotide sequences of 
the cloned congopain-like cysteine protease gene fragments. The primers were used to 
amplify part of the catalytic domain, but also the intergenic region. The intergenic region 
though not translated into protein, and hence not necessary for vaccine design, was 
investigated to gain insight into diversity and polymorphism. 
 
All the PCR products were cloned into pGEM
®
-T Easy cloning vector, transformed into 
competent E. coli JM 109 cells and recombinant plasmid purified and sequenced. The 
nucleotide sequences were analysed by NCBI BLAST (www.ncbi.nlm.nih.gov/BLAST), 
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translated into amino acid sequences by ExPAsy proteomics tools (www.expasy.org/tools) 
and aligned by ClustalW (www.ebi.ac.uk/ClustalW). 
 
4.4.1 Design of degenerate and species-specific primers 
At the time of designing this study, the T. congolense genome had not been unveiled, the 
only available information on the cysteine proteases of T. congolense was CP1 [Fish et al., 
1995, EMBL accession number Z25813), CP2 (Jaye et al., 1994, EMBL accession number 
L25130 Boulangé et al., 2001] and CP3 (Downey and Donelson, 1999 EMBL accession no. 
AF139913). This necessitated the use of the cysteine protease present in the database for T. 
congolense, T. b. brucei, and T. cruzi to design degenerate primers, targeting the catalytic 
domain and intergenic region of cysteine protease genes. 
 
Six degenerate primers (Figure 4.1) were designed to amplify cysteine proteases in 
trypanosome species (T. congolense, T. vivax and T. b. brucei), based on an alignment of 
cysteine protease genes from T. congolense (CP1 and CP2), T. b. brucei and T. cruzi 
(Appendix B). Two pairs of primers CP2/CP3 and CP2/CP5 targeted the gene coding for the 
catalytic domain, CP2/CP3 primer pair (Table 4.1) was designed to amplify part of the 
propeptide and part of the catalytic domain around the active site cysteine of the enzyme. 
CP2/CP5 primer pair (Table 4.1) was designed to amplify part of the propeptide and almost 
the entire catalytic domain. The CP1/CP4 primer pair (Table 4.1) was designed to amplify a 
portion of the catalytic domain, the entire C-terminal extension, the intergenic region, the 
signal peptide and part of the propeptide (Figure 4.1). The CP1/CP6 primer pair (Table 4.1) 
targeted part of the C-terminal extension, the intergenic region, the signal peptide and part of 
the propeptide region.  
 
After obtaining a few clones with the degenerate primers, the clones were sequenced and 
aligned to design species-specific primers. Clones obtained from T. congolense strains 
genomic DNA using CP2/CP3 primers were aligned (Appendix C) and new primers Tc/Tv 
CP2/CP3 designed. Tc CP1/CP4 primer pair was designed from alignment of DNA 
sequences of clones obtained using the degenerate CP1/CP4 primer pair (Appendix D). 
Lastly DNA sequences obtained from T. vivax clones amplified by the CP1/CP6 primer pair 
were aligned to design species-specific primers Tv CP1/CP6 (Table 4.1).  
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Figure 4.1 Location of degenerate primers on cysteine protease genes. Numbering 1-6, positions of primers 
CP1, CP2, CP3, CP4, CP5 and CP6 respectively. 2/3 part of the coding region amplified by CP2/CP3 primer 
pair, 2/5 part of the coding region amplified by primers CP2/CP5. 1/4 and 1/6 coding and intergenic regions 
amplified by CP1/CP4 and CP1/CP6 respectively.  In Red: pre-peptide; in blue: propeptide; in yellow: catalytic 
domain; in purple: C-terminal domain; in orange: intergenic region. 
 
4.2 Materials 
87 samples of genomic DNA from T. congolense, T. vivax, T. b. brucei, T. simiae, T. 
equiperdum and T. lewisi (Table 2.3) 
PCR reagents (Table 2.4) 
Primers (Tables 4.1) 
 
Table 4.1 Primers used for the amplification of Trypanosoma spp CPs. Degenerate primers, Y=C/T, R=A/G, 
M=A/C, S=C/G, H=A/C/T, V=A/C/G and N=A/C/G/T. 
 






































4.3  Methods 
Cysteine protease gene fragments were amplified by PCR as per Section 2.4.2. The PCR 
products were excised from the gels and purified using the Wizard
®
 SV Gel and PCR clean-
up system (Table 2.1) as described by the manufacturer, cloned into pGEM
®
-T Easy cloning 
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vector (Section 2.7.2) and transformed into competent E. coli JM 109 cells as per the 
manufacturer‟s instructions. The recombinant clones were screened by colony PCR using 
SP6 and T7 primers (Section 2.10.2) and plasmids carrying the inserts purified using 
Wizard
® 
Plus SV Minipreps DNA purification according to the protocol supplied and 
sequenced at ILRI, Nairobi, Kenya. 
4.4  Results 
4.4.1  Amplification of cysteine protease-like genes from T. congolense IL 3000 
PCR reactions were optimised using T. congolense IL 3000 genomic DNA before using other 
trypanosome species and strains (Figure 4.2). Primers CP1/CP4 amplified a fragment of 
approximately 1200 bp in size and an unexpected band could also be seen at approximately 
600 bp. The second primer pair (CP1/CP6) amplified the intergenic region, resulting in a 
PCR product of approximately 1 kb. Primers CP2/CP3 amplified a ~ 400 bp fragment, while 

















Figure 4.2 Amplification of cysteine protease genes from T. congolense IL3000 genomic DNA using 
degenerate primers. Lane M, molecular weight markers; lane CP1/4, T. congolense IL 3000 genomic DNA 
amplified by primers CP1/CP4; lane CP1/6, T. congolense IL3000 genomic DNA amplified by CP1/CP6 
primers; lane CP2/3, PCR product from T. congolense IL3000 genomic DNA amplified by CP2/CP3 primers; 
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4.4.2  Amplification of cysteine protease genes in other trypanosomal species 
The four pairs of primers were used with genomic DNA from T. simiae, T. vivax, T. b. brucei 
and T. congolense as shown in Figure 4.3. The CP1/CP4 primer pair (panel A) amplified a 
fragment of approximately 1 kb in T. vivax and T. b. brucei (lanes 2 and 3) which was 
smaller than that in T. congolense IL 3000 (lane 4). Unlike in T. congolense the 600 bp was 
noticeably missing from T. vivax and T. b. brucei DNA. This primer pair showed no 
amplification of CPs from T. simiae. The primer set CP1/CP6 (panel B) amplified CP genes 
of T. congolense, T. b. brucei and T. vivax and the resulting PCR product was less intense 
compared to that obtained with CP1/CP4, similarly this primer set showed no amplification 
of T. simiae CPs. As observed earlier the PCR product obtained with this primer pair was 
smaller in size (approx. 800 bp) in T. b. brucei and T. vivax as compared to T. congolense (~1 
kb), suggesting that the intergenic region of T. congolense is longer than that of T. b. brucei 
and T. vivax.  Genomic DNA from all the species formed a strong band (~380 bp) upon 
amplification using CP2/CP3 primer pair (panel C). CP2/CP5 primer pair (panel D) 
amplified part of the CP genes forming a PCR product of ~ 800 bp with genomic DNA from 






























                                                
                                                                                              
 
 
                                                 
                                                 







                                                                       
Figure 4.3 Amplification of cysteine protease genes in T. simiae, T. vivax, T. b. brucei and T. congolense 
using degenerate primers. The PCR products were separated on a 1% (w/v) agarose gel and stained with 
ethidium bromide (Section 2.3.2). Lanes 1, 2, 3 and 4, T. simiae, T. vivax, T. b. brucei and T. congolense 
IL3000 genomic DNA respectively and lane M, molecular weight markers. Panels A-D, amplification with 
primer pairs CP1/4, CP1/6, CP2/3 and CP2/5 respectively.    
 
4.4.3  Amplification of cysteine protease genes in trypanosomes using species-specific 
primers 
Nucleotide sequence of the gene coding for the congopain catalytic domain and the 
intergenic region sequence of the cloned fragments obtained using degenerate primers were 
aligned to design species-specific primers. The nucleotide sequences of T. congolense were 
CP1/4 CP1/6 























































































































































aligned by Sequencher 4.5 software (Gene Codes Corporation) to design species-specific 
primers for the catalytic domain. The new primers Tc/Tv CP2 and Tc/Tv CP3 (Table 4.1) 
were used to amplify and clone the gene coding for the catalytic domain of CPs from other 
strains of T. congolense and T. vivax. The nucleotide sequences of the intergenic region of 
cysteine protease of T. congolense strains were also aligned by Sequencher 4.5 software and 
new T. congolense specific primers were designed (Appendix C and D). Primers Tc CP1 and 
Tc CP4 (Table 4.1) amplified a shorter fragment of approximately 500 bp encompassing part 










Figure 4.4 PCR on genomic DNA from T. congolense strains using Tc CP1 and Tc CP4.  The PCR 
products were separated on a 1% (w/v) agarose gel and stained with ethidium bromide. (Section 2.3.2). Each 
PCR product was loaded into three wells and one well was skipped before loading the next PCR product. Lane 
1, molecular weight markers; lanes 1-3, Tcs37; lanes 4-6, Tcs45; lanes 7-9, Tcs48; lanes 10-12,  Tcs56 and 
lanes 13 – 15, T. congolense IL 3000, (see Table 2.3 for full names of T. congolense strains).    
 
 
Nucleotide sequences of cloned intergenic regions of CPs in T. vivax were also aligned using 
the Sequencher 4.5 programme to design primers Tv CP1 and Tv CP6 (Table 4.1) and used 
to amplify a 800 bp fragment for all T. vivax strains (Tv08, Tv10, Tv13, Tv14, Tv17, Tv18, 
Tv21, Tv25, Tv26, Tv29, Tv30 and Tv33) as shown in Figures 4.5 A and B. Another band at 
approximately 400 bp was observed when T. vivax strains (Tv16, Tv23, Tv31) were 
amplified by Tv CP1 and Tv CP6 intergenic region primers (Figures 4.5 A and B) suggesting 
the existence of more than one locus, of differing intergenic region size, also mispriming 
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Figure 4.5 PCR on genomic DNA from T. vivax strains using T. vivax intergenic primers Tv CP1 and Tv 
CP6.  The PCR products were separated on a 1% (w/v) agarose gel and stained with ethidium bromide (Section 
2.3.2). (A) Lane M, molecular weight markers; lanes 08-27, PCR on Tv08, Tv09, Tv10, Tv11, Tv12, Tv13, 
Tv14, Tv15, Tv16, Tv17, Tv18, Tv19, Tv20, Tv21 Tv23, Tv24, Tv25, Tv26 and Tv27 genomic DNA 
respectively amplified by Tv CP1 and Tv CP6 primers. (B) Lane M, molecular weight markers; lanes 28-34, 
PCR on Tv28, Tv29, Tv30, Tv31, Tv32, Tv33 and Tv34 genomic DNA respectively; lane 35, negative control 
(PCR master mix without DNA); lane 36, T. congolense IL 3000 genomic DNA (see Table 2.3 for full names of 
T. vivax strains).  
 
4.4.4  Screening for recombinants by colony PCR using SP6 and T7 primers 
After successful PCR on genomic DNA of the trypanosomes strains, the PCR products were 
cloned into a pGEM
®
-T Easy vector and white colonies screened by colony PCR using SP6 
and T7 primers as shown in Figure 4.6 A and B. In the example shown on figure 4.6, four out 
of the 34 white colonies screened did not amplify (lane 7, 12, 27 and 34) and were 
considered non-recombinant, and 2 amplified a product of the wrong size (lanes 13 and 20) 
and were not selected (Figure 4.6 B) (for full names of T. vivax strains see Table 2.3). All the 
other colonies amplified bands of the expected sizes and were considered recombinant. 
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Figure 4.6 Colony PCR on T. vivax strains amplified by Tv CP1 and Tv CP6 and on T. congolense strains 
amplified by Tc/Tv CP2 and Tc/Tv CP3 and cloned into pGEM
®
-T Easy cloning vector. The PCR products 
were separated on a 1% (w/v) agarose gel stained with ethidium bromide (Section 2.3.2). (A) Lane M, 
molecular weight makers; colonies from lanes 1-2, Tv09; lanes 3-5, Tv12; lanes 6-8, Tv16; lanes 9-11, Tv19; 
lanes 12-14, Tv20; lanes 15-17, Tv28 and lanes 18-19,  Tv34. (B) Lane M, molecular weight markers; lane 20, 
Tv34; lanes 21-23, 400 bp Tv16; lanes 24-26, Tcs37; lanes 27-29, Tcs45; lanes 30-31, Tcs48; lane 32, (positive 
control) Tcs57; lane 33, (positive control) recombinant plasmid DNA from Tcs57 and lane 34, a blue colony 
(negative control), (see Table 2.3 for full names of T. vivax and T. congolense strains). 
 
4.4.5  Sequence analysis 
All the nucleotide sequences were translated and aligned (Section 2.14). The cysteine 
protease genes amplified by both CP2/CP3 (degenerate) and Tc/Tv CP2 and Tc/Tv CP3 
(species-specific) primers (Table 4.1) from T. congolense strain genomic DNA, showed a 
high degree of identity at amino acid level ranging between 79-100 %, possibly because the 
amplified fragment included the gene coding for part of the conserved propeptide region and 
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coding for the 70 amino acid residue-long propeptide amplified by the two pairs of primers 
was 92-100% identical among T. congolense strains, while the part of the catalytic domain 
cloned was between 81-100% identical. The peptide sequence YHNGA in the propeptide 
responsible for inhibition of congopain (Lalmanach et al., 1998) was present in all the T. 
congolense strains (Figure 4.7, text box 1), while a similar peptide (YRNGA) was also 
present in all T. b. brucei strains cloned (Figure 4.8, text box 1).  
 
The cleavage site between the propeptide and the catalytic domain varied with 11 out of the 
18 T. congolense clones coding for an APEA N-terminal sequence, 4 clones coding for 
APPA, a single clone for APDA and 2 clones for PPMT N-terminus sequence (Figure 4.7, 
text box 2). The sequences APPA and APEA at the proenzyme cleavage site of cysteine 
protease have been reported in CP1 and CP2 respectively (Boulangé et al., 2001). The 
cysteine residue at the active site of the catalytic domain was conserved in 14 clones, 3 
clones from T. congolense strains had a serine residue instead and included Tcf2, Tcs41 and 
Tcs50 (for full names of T. congolense strains see Table 2.3). Apart from the serine residue, 
one clone (Tcs65) coded for a phenylalanine residue instead of cysteine at the active site 
(Figure 4.7, text box 3). The only T. simiae strain analysed in the present study was 100% 
identical to T. congolense CP1 (Figure 4.9). The T. simiae clone had the peptide YHNGA in 
the propeptide, APPA N-terminal sequence for the mature form of the protease and a 
conserved cysteine residue in the catalytic triad.  
 
The entire sequence coding for the 97 residue long C-terminal domain of the cysteine 
proteases in T. congolense was amplified by CP1/CP4, except for one strain, T. congolense 
Savannah (Tcs36) that had a 98 amino acid long C-terminal region. The C-terminal regions 
of these clones were 83-97% identical and are linked to the catalytic domain by six proline 
residues. The same clone of T. congolense (Tcs36) had an unusual polyproline hinge, 
composed of 14 proline residues linking the catalytic domain to the C-terminal region 
(results not shown). A complement of the 22 nucleotide polypyrimidine tract 
(TTTCCTTTTCTTTCTTCTTTTC) that precedes the start codon of cysteine proteases was 
found in all intergenic region sequences from T. congolense strains (Figure 4.10, text box 1).  
 
Six clones showing sequences coding for the catalytic domain were obtained from seven 
strains of T. b. brucei, one did not amplify, and these exhibited a higher identity (97-100%) 
than was the case for T. congolense (Figure 4.8). The 71 amino acid-long propeptide was 97-
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100% identical with only two amino acid differences, while the part of the catalytic domain 
cloned (54 amino acid long) was 98-100% identical with only one amino acid residue 
difference. The cleavage site (APAA) between the propeptide and the catalytic domain in T. 
b. brucei strains was conserved in all six clones (Figure 4.8, text box 2), as was the cysteine 
residue in the active site of the catalytic domain (Figure 4.8, text box 3). The CP amino acid 
sequence of a T. equiperdum strain was aligned with six clones of T. b. brucei and found to 
be 98-99% identical, as was the amino acid sequence from a T. lewisi clone (Figure 4.9). The 
two T. equiperdum and T. lewisi clones had the same inhibitory propeptide peptide sequence, 
proenzyme cleavage site and a conserved cysteine residue at the active site as was the case 
for T. b. brucei strains (results not shown).   
 
The CP C-terminal regions in T. b. brucei clones were 93-100% identical and are linked to 
the catalytic domain by eight proline residues in four clones while clones T. b. brucei ILTat 
1.1 and T. equiperdum had nine proline residues (results not shown). The intergenic region 
was 98-100% identical, which is higher than that in T. congolense (96-98%). The identity of 
the intergenic region in T. vivax was also in the same range (93-98% identity) as shown in 
Figure 4.13.  
 
Cysteine protease genes from T. vivax were amplified using the CP2/CP3 primer pair in a 
few strains and gave very faint bands that necessitated to be reamplified in order to obtain 
sufficient material for cloning. Such fragments were cloned and sequenced. However, 
analysis showed that these sequences were not for T. vivax, but T. congolense. It is likely that 
the degenerate primers did not amplify from T. vivax genomic DNA, but rather picked up T. 
congolense contamination present in the laboratory. Consequently, such sequences were not 
included in the analysis. Time and resources being scarce, a new T. vivax  analysis with new 
primers was not launched, given that the primary target of the study is T. congolense. 
 
A neighbouring joining tree was generated using the predicted amino acid sequences of 27 
clones (propeptide and catalytic domain, 111 amino acids long) from T. congolense (18), T. 
b. brucei (6), one clone from each of T. lewisi, T. equiperdum and T. simiae, two sequences 
from the gene database T. vivax and T. cruzi, CP1, CP2/CP3, was done. These clones were 
found to be 56-100% identical (not shown). Seven clusters were formed, the first consisted of 
two clones Tcs49 and Tcs59 strains (Figure 4.9, cluster 1), the second cluster comprised of 
CP1-like cysteine proteases which included the T. simiae clone, and two other clones from 
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Tcs36 and Tcs57 strains (Figure 4.9, cluster 2). The third cluster comprised CP3-like cysteine 
proteases and consisted of clones Tcf02, Tcs50, Tcs41 and Tcs65 (Figure 4.9, cluster 3). 
These clones had a serine residue instead of a cysteine at the active site apart from Tcs65 
which had a unique phenylalanine residue. A fourth cluster consisted of Tcs37, Tcs45, 
Tcs62, Tcs66 and Tcs58 strains (Figure 4.9, cluster 4). The fifth cluster comprised of CP2-
like cysteine proteases and consisted of clones from Tcs43, Tcs47, Tcs48, Tcs60, Tcs54 
strains (Figure 4.9, cluster 5). The sixth cluster was comprised of clones from T. equiperdum, 
Tb05, Tb03, Tb06, Tb07, TbILtat, T. lewisi and TbCP23 strains (Figure 4.9, cluster 6). The 
seventh cluster had two sequences coming from the database, for T. vivax and T. cruzi 
(Figure 4.9, cluster 7) which were used as the outlaying group in this alignment. In summary, 
cluster one to five consisted of clones from T. congolense strains apart from the T. simiae 
clone which had a high identity with CP1. Whereas all the T. congolense clones, except 
Tcf02 belonged to the Savannah subgroup, it would have been interesting if several Forest 
and Kilifi subgroups strains of T. congolense were included in the present study. The sixth 
cluster had all the T. brucei ssp clones including T. equiperdum and T. lewisi. 
 
The DNA sequences for the intergenic region of CP genes obtained from T. brucei, T. 
congolense and T. vivax strains showed an unexpected high conservation rate at 93-98% 
identity (data not shown). In comparison, the intergenic region of the cysteine proteases 
genes was found to be more conserved than the gene coding region, which goes against the 
admitted paradigm. The region was 93-98% identical in T. vivax, 96-98% identical in T. 
congolense and 98-100% identical for T. b. brucei, while the catalytic domain was 81-100% 
identical in T. congolense and 98-100% identical in T. b. brucei. It appear generally that 




CLUSTALW (1.83) multiple sequence alignment 
                                                                 1  
Tcs37           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs45           --------------REGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs43           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs47           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs60           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs48           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs54           AEEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 60 
Tcs62           AEEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMPPEEFRAT YHNGA EYYAAALKR 60 
Tcs49           AEEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDVSPEEFRAT YHNGA EYYAAALKR 60 
Tcs59           AAEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDVSPEEFRAT YHNGA EYYAAALKR 60 
Tcs58           AAEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 60 
Tcs66           AAEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 60 
Tcs57           -AEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 59 
Tcs36           AEEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 60 
Tcs50           --------------MEGAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 46 
Tcs65           --EEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 58 
Tcs41           AEEEAFRFRFFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 60 
Tcf2            -EEEAFRFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKR 59 
                               * ********************:.******* ***** ********* 
                             2                        3 
Tcs37           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGRCGS C WAFSAIGNIEGQWKIAGHELTSLS 106 
Tcs45           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGRCGS C WAFSAIGNIEGQWKIAGHELTSLS 106 
Tcs43           PRKVVTVSTGK APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVAGHELTSLS 106 
Tcs47           PRKVVTVSTGK APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVAGHELTSLS 106 
Tcs60           PRKVVTVSTGK APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVAGHELTSLS 106 
Tcs48           PRKVVNVSTGK APPA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVTDHNLTSLS 106 
Tcs54           PRKVVTVSTGK APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVTGHNLTSLS 120 
Tcs62           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGRCGS C WAFSAIGNIEGQWKIAGHELTSLS 120 
Tcs49           PRKVVTVSTGK APDA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKIAGHELTSLS 120 
Tcs59           PRKVVNVSTGK APPA IDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKIAGHEPTSLS 120 
Tcs58           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKIAGYELTSLS 120 
Tcs66           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGRCGS C WAFSATGNIEGQWKIAGHELTSLS 120 
Tcs57           PRKVVTVSTGK APPA VDWRKKGAVTPVKDQGSCGS C WAFAATGNIEGQWKIAGHELTSLS 119 
Tcs36           PRKVVNVSTGK APPA VDWRKKGAVTPVKDQGKCGS C WAFSATGNIEGQWKVAGHELTSLS 120 
Tcs50           PRKVVNVSTGR PPMT VDWRKKGAVTPVKDQGKCDS S WAFSATGNIEGQWKIAGHELTSLS 106 
Tcs65           PRKVVNVSTGE APPA IDWRKKGAVTPVKDEGKCDS F WAFSAIGNIEGQWKIAGHELTSLS 118 
Tcs41           PRKVVNVSTGK APEA VDWRKKGAVTPVKDQGKCDS S WAFTVIGNIEGQWKIAGHELTSLS 120 
Tcf2            PRKVVNVSTGR PPMT VDWRKKGAVTPVKDQGKCDS S WAFSATGNIEG------------- 106 
                *****.****. .* : :*************:* *.*   ***:. *****              
 
Tcs37           EQMLVS 112 
Tcs45           EQMLVS 112 
Tcs43           EQMLVS 112 
Tcs47           EQMLVS 112 
Tcs60           EQMLVS 112 
Tcs48           EQMLVS 112 
Tcs54           EQMLV- 125 
Tcs62           EQMLV- 125 
Tcs49           EQMLV- 125 
Tcs59           EQMLV- 125 
Tcs58           EQMLV- 125 
Tcs66           EQMLV- 125 
Tcs57           EQMLV- 124 
Tcs36           EQMLV- 125 
Tcs50           EQMLVS 112 
Tcs65           EQMLVS 124 
Tcs41           EQMLV- 125 
Tcf2            ------ 
                       
  
Figure 4.7 ClustalW alignment of predicted amino acid sequences of the propeptide and part of catalytic 
domain of congopain-like cysteine protease genes in T. congolense amplified by CP2/CP3 primers.  Tcf2, 
Tcs36, Tcs37, Tcs41, Tcs43, Tcs45, Tcs47, Tcs48, Tcs49, Tcs50, Tcs54, Tcs57, Tcs58, Tcs59, Tcs60, Tcs62, 
Tcs65 and Tcs66 (see Table 2.3 for full names of strains). Text box 1, the inhibitory peptide of the propeptide in 
T. congolense; text box 2, the proenzyme cleavage site of CPs in T. congolense; text box 3, cysteine or serine or 












CLUSTALW (1.83) multiple sequence alignment 
 
                                                                 1 
Tb6             AEEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
Tb7             AEEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
Tb3             AEEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
Tb5             AEEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
TbCP23          AKEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
TbILtat         AKEEAFRFRAFEENMEQAKIQAAANPYATFGVTPFSDMTREEFRAR YRNGA SYFAAAQKR 60 
                *:******************************************** ***** ********* 
                              2                       3 
Tb6             LRKTVNVTTGR APAA VDWREKGAVTPVKDQGQCGS C WAFSTIGNIEGQWQVAGNPLVSLS 120 
Tb7             LRKTVNVTTGR APAA VDWREKGAVTPVKDQGQCGS C WAFSTIGNIEGQWQVAGNPLVSLS 120 
Tb3             LRKTVNVTTGR APAA VDWREKGAVTPVKDQGQCGS C WAFSTIGNIEGQWQVAGNPLVSLS 120 
Tb5             LRKTVNVTTGR APAA VDWREKGAVTPVKDQGQCGS C WALSTIGNIEGQWQVAGNPLVSLS 120 
TbCP23          LRKTVNVTTGS APAA VDWREKGAVTPVKDQGQCGS C WAFSTIGNIEGQWQVAGNPLVSLS 120 
TbILtat         LRKTVNVTTGR APAA VDWREKGAVTPVKDQGQCGS C WAFSTIGNIEGQWQVAGNPLVSLS 120 
                **********  **** ******************** * **:********************* 
 
Tb6             EQMLV 125 
Tb7             EQMLV 125 
Tb3             EQMLV 125 
Tb5             EQMLV 125 
TbCP23          EQMLV 125 
TbILtat         EQMLV 125 
                ***** 
 
 
Figure 4.8 ClustalW alignment of predicted amino acid sequences of the propeptide and part of catalytic 
domain of congopain-like cysteine protease genes in T. b. brucei amplified by CP2/CP3 primers.  Tb3, 
Tb5, Tb6 and Tb7 (see Table 2.3 for full name of strains), TbCP23 (T. b. brucei) and TbILTat (T. b. brucei IL 
Tat 1.1). Text box 1, the inhibitory peptide in the propeptide in T .b. brucei; text box 2, the amino acid residues 




























Figure 4.9 Neighbouring Joining tree generated by ClustalW alignment of 111 amino acid-long fragments 
of the cysteine protease genes in trypanosomes amplified by CP2/CP3 and Tc/Tv CP2 and Tc/Tv CP3 
primers. Cluster 1, clones from Tcs49 and Tcs59 strains; cluster 2, clones from Tcs36 and Tcs57 strains, T. 
simiae and CP1; cluster 3, clones from Tcf02, Tcs50, Tcs41, Tcs65 strains and CP3; cluster 4, clones from 
Tcs37, Tcs45, Tcs62, Tcs66 and Tcs58 strains; cluster 5, clones from Tcs43, Tcs47, Tcs48, Tcs60, Tcs54 
strains and CP2; cluster 7, clones from T. vivax and T. cruzi. T. equip (T. equiperdum), sequences obtained by 
amplifying and cloning genomic DNA provided by Dr. Majiwa of ILRI, Nairobi, Kenya, T. vivax, sequence 
obtained from http://www.genedb.org/genedb/tvivax/blast.jsp accession number tviv521g07.p1k_2,  T. cruzi 
sequence obtained from http://www.ncbi.nlm.nih.gov/blast/Blast, accession number AAC00067.1. (for full 










4.5 Discussion  
Cysteine protease genes from T. congolense, T. brucei, T. vivax, T. simiae and T. equiperdum 
were amplified by PCR using degenerate and species-specific primers, cloned and 
sequenced.  The PCR targeted both the gene coding and the intergenic regions of congopain-
like cysteine protease genes. Out of the two pairs of primers (CP2/CP3 and CP2/CP5) for 
amplifying the coding region of cysteine proteases gene, the former was preferred because it 
amplified part of the propeptide (which is relatively conserved among T. congolense), and 
part of the catalytic domain especially around the active site cysteine residue. The primer pair 
(CP2/CP5) amplified a region spanning part of the propeptide till the end of the central 
domain, a region most interesting for our analysis. The two pairs of primers designed to 
amplify the intergenic region, CP1/CP4 primer pair was best suited for T. congolense and T. 
b. brucei strains and hence used throughout the study, whereas CP1/CP6 primer pair worked 
best for T. vivax strains. In comparison, it was more difficult to amplify CP genes from T. 
vivax, than their T. congolense and T. b. brucei counterparts, consequently there was 
contamination of the T. vivax PCR product with T. congolense IL 3000 genomic DNA during 
reamplification, and hence clones obtained from these PCR products were found to be 
identical to those from T. congolense strains. The cysteine proteases from T. vivax were 
found later to be distantly related to those from T. congolense and T. b. brucei and this 
probably explains why it was difficult to amplify the T. vivax CP genes using degenerate 
primers. 
 
All the primers gave PCR products of the expected size, with the exception of the CP1/CP4 
primer pair which formed an extra band at approximately 600 bp in addition to the expected 
1.2 kb band. This particular band was only seen in T. congolense strains. Upon cloning the 
600 bp PCR product, it was found not to be related to a cysteine proteases gene, and assumed 
to be some sequence that may share some sequence identity with the cysteine proteases in the 
region where these primers were designed. Two major features were shown by amplification 
of the intergenic region of cysteine proteases, i.e. firstly the region was found to be 
polymorphic in size as it was shorter in T. b. brucei and T. vivax than in T. congolense 
strains. Secondly, amplification of this region in T. vivax strains resulted in two bands 
suggesting the existences of two loci of cysteine protease genes in the T. vivax genome. 
 
Species-specific primers were preferred to the original degenerate primers and were used 
thereafter in the present study. The switch from CP2/CP3 to Tc/Tv CP2 and Tc/Tv CP3 
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proofed very useful because these primers were better suited to amplify the target region. The 
intergenic region primers were also changed from CP1/CP4 to Tc CP1 and Tc CP4, which 
amplified a shorter fragment (approximately 550 bp) from T. congolense strains, unlike the 
previous 1.2 kb region. The C-terminal extension is a characteristic feature of trypanosomal 
cysteine proteases (Mottram et al., 1989; Pamer et al., 1990; Souza et al., 1992; Traub-Cseko 
et al., 1993; Stoka et al., 2000). The polypyrimidine tract previously described by Matthews 
et al. (1994); Fish et al. (1995) was found in the intergenic region just before the start codon 
of cysteine proteases from all T. congolense strains analysed. The CP1/CP6 primer pair was 
also replaced with T. vivax specific primers Tv CP1 and Tv CP6 which amplified an 
approximately 800 bp region encompassing the intergenic part of cysteine protease gene in T. 
vivax strains. 
 
In the previous Chapter it was shown that the majority of the clones have a cysteine residue 
in the active site, likewise the majority of the clones obtained from the different strains 
cloned had cysteine residues. Interestingly a few clones had a serine residue instead of a 
cysteine, apart from one clone from Tcs65 which had a phenylalanine residue, a feature 
common to a group of cysteine proteases from Plasmodium called the Serine Repeat Antigen 
(SERA) which possess a central domain that show homology to the papain family of cysteine 
proteases, but exhibit an unusual cysteine to serine substitution at the active site (Bzik et al., 
1988; Kiefer et al., 1996; Gor et al., 1998; Hodder et al., 2003). A unique proenzyme 
cleavage site (PPMT) between the propeptide and the catalytic domain was found in two 
clones Tcf02 and Tcs50, both of which possess a serine residue instead of a cysteine in the 
active site.  
 
The alignment of the clones consisting of 111 amino acid-long fragment (encompassing part 
of the propeptide and the catalytic domain, and generated using CP2/CP3 primer pair) 
showed that there was a high degree of identity among clones. Only clones from T. vivax and 
T. cruzi were quite distantly related to the other clones, with T. cruzi and Tcf02 clones giving 
the least identity (56%). Although clone Tcf02 carried an active site serine residue, the fact 
that a smaller fragment (92 amino acids long) was analysed might explain why it gave the 
least identity with various clones (72%). All the other clones showed a high identity (74-
100%); this feature is an indication that congopain is not very different from other cysteine 
proteases of trypanosomes and therefore an immunogen that would induce antibodies that 
inhibit congopain activity would most likely also act on these cysteine proteases. The 
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biological significance of the mutants with a replacement of their active site cysteine by a 
serine is puzzling, in the sense that it is far too common, and far too widespread amongst 
strains, to be fortuitous. As was done with SERA genes of P. falciparum (Miller et al., 2002), 
it would be necessary to establish the expression these mutants, and also disrupt their genes 
through RNA interference to determine their role in host-parasite interactions. In P. 
falciparum SERA-4 and SERA-5 (with a serine residue at the active site) and SERA-6 (with 
a cysteine residue at the active site) were found to be highly expressed, and the fact they 
could not be disrupted by gene knock-out is an indication of the important role they play in 
maintenance of the erythrocytic cycle (Miller et al., 2002). These aspects are being addressed 
in our laboratory but fall outside the scope of the present study.  
 
Another interesting feature is that Neighbouring Joining trees formed upon alignment of 
either the gene coding region or the intergenic region sequences, placed some strains in 
different positions for example T. congolense strains Tcs57 and Tcs58 were shown to be very 
close when their intergenic regions are compared, but were further apart when their gene 
coding regions were compared. It can be suggested that since many copies of cysteine 
protease genes exist in the genome, it is possible that different cysteine protease genes were 
amplified by the two pairs of primers used, therefore it might not be ideal to compare the two 
regions phylogenetically. The main conclusion to draw from this chapter is that in T. 
congolense, the level of variability that we had met in one strain, IL 3000, is basically the 
same as one meets across T. congolense strains from various origins, at least from the 
Savannah group. Therefore, conclusions drawn from this IL 3000 strain as per gene 
organisation and variability of congopain-like CP genes would be valid for all strains. 
 
As discussed in Chapter 3, where a 2 kb gene unit library of CP genes construction from 
cosmid clones was described, it has emerged that some of the cysteine protease genes are 
scattered outside of the main locus, and therefore restriction endonucleases which restrict 
within the gene omit genes outside the locus. A restriction endonuclease which restricts the 
gene in the intergenic region was used to construct a subgenomic library which would 
include the scattered copies of cysteine protease genes. This is reported in Chapter 5.  
 
The results presented so far showed that several clones of congopain-like cysteine proteases 
were found to contain an unusual substitution of the cysteine residue of the catalytic triad of 
cysteine proteases with a serine residue. It was not clear whether the cysteine proteases 
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containing the serine residue are expressed and their role in pathogenesis is unknown. As 
mentioned above, investigating the significance of these mutations in host-parasite 
relationships will require reverse genetics. The study of the expression of these cysteine 
proteases at the mRNA level however is an easier task that was undertaken using reverse 




CONSTRUCTION AND SCREENING OF A 2 KBP SUBGENOMIC 
LIBRARY. INSIGHT INTO THE EXPRESSION OF MUTANT GENES. 
5.1  Introduction 
A gene library is a collection of cloned fragments which together represent an entire genome 
of a particular organism (Dale and von Schantz, 2002), while a subgenomic library generally 
represents an entire chromosome or gene locus, or, as in the present study, a size-restricted 
portion of the genome. The genomic DNA is fragmented into smaller fragments that are 
easily cloned into a suitable vector. Fragments to be cloned are generated using restriction 
enzymes for complete or partial digest of genomic DNA or by exposing the genomic DNA to 
mechanical shearing. A DNA probe is the most common method used to identify clones 
harbouring the gene of interest in a library. In certain cases PCR can also be used, because it 
is less tedious, time saving and has a high stringency as compared to the use of probes 
(Israel, 1993). 
 
The genomic organisation of congopain was studied by southern blotting using a congopain 
coding sequence as a probe. Congopain was found to exist at a single locus consisting of 12-
14 copies of cysteine protease genes in a tandem array. It was also observed that longer 
exposure time of the blots resulted in additional bands to that of the congopain gene locus, 
leading to the hypothesis that other congopain-like genes could be scattered in the genome 
outside of the main locus (Boulangé manuscript in preparation). It is this hypothesis that led 
to the construction of a subgenomic library of 2 kb fragment using a restriction endonuclease 
that cuts the gene in the intergenic region so that other genes outside of the main locus of 
congopain would be included in the library. Restriction sites however are scarce in the 
intergenic region, partly because of its small size, about 500 bp, and partly because it is AT-
rich. Actually, only one enzyme, MluI, was adequate, in the sense that it had a conventional 
recognition site, i.e. 6-cutter and palindromic, and cuts in the recognition sequence, and 
generates cohesive ends. Recognition sites for MluI are usually not available in the 
polycloning site of commonly used plasmids. A cloning vector was therefore modified by 
introducing a MluI site.  
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The catalytic triad of the papain-like cysteine proteases consists of cysteine, histidine and 
asparagine. (Storer and Ménard, 1994). However the existence of congopain-like cysteine 
protease genes having a serine residue in the place of the cysteine residue (that defines the 
CP3 family) reported before (Downey and Donelson, 1999, EMBL accession no. AF139913) 
raised concerns whether these are true genes or pseudogenes. Apart from the serine residue at 
the active site, CP3s also differ in their proenzyme cleavage sites resulting in N-terminal 
sequences varying among APEA, APPA, APDA, and PPMT. It is not clear whether the 
corresponding proteases are expressed in trypanosomes and what their role in host-parasite 
interactions might be. Boulangé et al. (2001) reported two cysteine protease isoforms (CP1 
and CP2) from T. congolense with a small number of amino acid differences in their catalytic 
domains, yet having different enzymatic characteristics that could lead to different roles in 
the parasite. It was therefore of interest to determine whether these congopain-like cysteine 
protease genes (coding for serine instead of cysteine at the active site) are expressed in 
trypanosomes. Given the high level of identity of the different congopain-like gene product 
deduced from the cloned sequences, it would have been very difficult to study the expression 
of these variants at protein level. This would have necessitated highly specific anti-peptide 
antibodies, or the use of Mass-Spectrometry and 2-Dimensional separation. For this reason, 
we studied the expression at messenger level by RT-PCR on mRNA isolated from T. 
congolense IL 3000 parasites.  
 
The RT-PCR was performed using primers Forward-all-CP and Rev-C1, Rev-C2, Rev-C3 
(Table 3.1) used in Section 3.2.7. In addition, we designed Rev-C4 (Section 5.8.1), which is 
similar to Rev-C3, which is specific of the CP3 family, but based on the sequence of the 
CP3-like protease sequence present in the database (Downey and Donelson, 1999 EMBL 
accession no. AF139913), while Rev-C3 is based on the sequence of the CP3s cloned from 
the 2 kbp gene-units library generated from cosmids (Chapter 3). We used also in this study 
cluster primers-C1, -C2 and -C3 (Fw and Rev) (Table 3.1) used in Section 3.2.7, that 
generate different-sized fragment according to the targeted CP gene family. 
5.2  Construction of the pMluI cloning plasmid 
A mentioned above, MluI is the only adequate enzyme whose restriction site is present in the 
intergenic region of congopain gene. A cloning vector with an MluI restriction site was thus 
required. A few cloning vectors have an MluI restriction site, but they are rare, hard to 
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procure, and very expensive. This led to the construction of a vector containing this 
restriction site. Two methods of constructing the vector with an MluI restriction site were 
used, i.e. site-directed mutagenesis of the multiple cloning sites (MCS) of pGEM
®
-11Zf(+) 
cloning vector and cloning of annealed primers with the MluI restriction site into the 
pGEM
®
-11Zf(+) MCS.  
 
Site-directed mutagenesis involves annealing of selection oligonucleotide and mutagenic 
oligonucleotide to denatured pGEM
®
-11Zf(+) cloning vector, followed by synthesis of the 
mutant strand by T4 DNA polymerase and ligation of the two oligonucleotides by T4 DNA 
ligase. The ligated oligonucleotides are transformed into E. coli strain BMH 71-18 mutS and 
cells are grown in the presence of GeneEditor
™ 
Antibiotic selection to select clones 
containing the mutant plasmid. These are isolated by minipreps and transformed into 
competent E. coli JM 109 cells. Mutant plasmids can then be screened using IPTG and X-gal 
indicator plates or by targeting restriction sites within mutagenic primers with the appropriate 
endonucleases. 
 
For the second method used, two complimentary oligonucleotides were designed, bearing a 
MluI site in their midst, and showing once annealed protruding ends such as those generated 
by EcoRI on one side, and XbaI on the other, so that the two oligonucleotides correspond to a 
small double-stranded DNA fragment that can be directionally cloned in a vector such as 
pGEM
®
-11Zf(+) cut with EcoRI and XbaI. 
5.2.1  Alkaline denaturation of pGEM
®
-11Zf(+) 
Alkaline denaturation refers to breaking down of the hydrogen bonds in a double stranded 
molecule (DNA template) to make it single stranded, by use of an alkaline solution such as 
NaOH. As selection oligonucleotide is an oligonucleotide provided in the Gene editor in vitro 
site-directed mutagenesis system, and encodes the mutations which alter the ampicillin 
resistance and hence create a new additional resistance to GeneEditor
™ 
Antibiotic selection 
mix. Mutagenic primer is an oligonucleotide that incorporates the desired mutation; it is 
complimentary to the target template except the area of mismatch. Both primers have to 
hybridize at the same strand but in the opposite directions. The pGEM
®
-11Zf(+) vector was 
denatured in the presence of NaOH, to make it single stranded for hybridisation with 






-11Zf(+). (Provided in Gene editor in vitro site-directed mutagenesis system, Table 
2.1) 
10 M NaOH. NaOH pellets (4 g) were dissolved in dH2O (10 ml) 
0.5 mM EDTA. EDTA (1.861 g) was dissolved in dH2O (8 ml), adjusted to pH 8.0 using 1 M 
NaOH, made up to 10 ml with dH2O and autoclaved (121°C, 30 min, RT) 
2 M NaOH, 2 mM EDTA. NaOH (10 M) (2 ml), 0.5 mM EDTA (40 µl) were mixed with 





-11Zf(+) (1 µg) was denatured by addition of 2 M NaOH/2 mM (2 µl) EDTA and the 
reaction made up to 20 µl with dH2O, and the reaction carried out according to the 
manufacturer‟s instructions. 
5.2.2  Hybridization of denatured pGEM
®
-11Zf(+) and selection of mutagenic 
oligonucleotides 
Hybridisation involves the annealing of the selection and mutagenic oligonucleotides to the 
target after denaturation; it occurs at specific temperatures depending on the composition of 
the mutagenic primer. Generally the annealing step is done at 75°C and the reaction is allowed 






Mutagenic primer (F3): GCCGAGCTCGAACGCGTCGACCTCGAGG, Tm (70.2°C) 
Selection oligonucleotides (bottom and top strand). (Provided in Gene editor in vitro site-
directed mutagenesis system, Table 2.1) 




Half of the denatured pGEM
®
-11Zf(+) vector (0.5 µg) was used in the hybridisation reaction 
consisting of: mutagenic oligonucleotide (1 µl), selection oligonucleotide (1 µl), 10× 
annealing buffer (1 µl) and made up to 20 µl with dH2O, the reaction was carried out as per 
the manufacturer‟s instructions. 
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5.2.3  Mutant strand synthesis and ligation. 
The synthesis of the mutant strand takes place in the presence of T4 DNA polymerase, which 
minimises the risk of secondary undesired mutations and of T4 DNA ligase which ligates the 
two oligonucleotides with the newly synthesised strand.  
 
5.2.3.1 Materials 
10× synthesis buffer. (Provided in Gene editor in vitro site-directed mutagenesis system, 
Table 2.1) 
T4 DNA polymerase. (Provided in Gene editor in vitro site-directed mutagenesis system, 
Table 2.1) 




To the hybridisation mixture, 10× synthesis buffer (3 µl), T4 DNA polymerase (1 µl) and T4 
DNA ligase were added and the reaction made up to 30 µl with dH2O. The reaction was 
carried out at 37°C for 90 min. 
5.2.4  Transformation of BMH 71-18 mutS and competent E. coli JM 109 cells 
Transformation is carried out using two different strains of E. coli i.e. BMH71-18 muts and 
JM 109. The former strain enhances the efficiency of mutagenesis at the initial 
transformation. Transformation in the JM 109 strain ensures separation of the mutant and the 
non-mutants, consequently giving a high proportion of the mutants. 
 
5.2.4.1 Materials 
BMH 71-18 mutS and competent E. coli JM 109 cells. (Provided in Gene editor in vitro site-
directed mutagenesis system, Table 2.1) 
2 × YT- ampicillin medium. (Section 2.8.1.1) 
2 × YT- ampicillin agar plates. (Section 2.8.1.1) 
GeneEditor
™ 
Antibiotic selection mix. (Provided in Gene editor in vitro site-directed 
mutagenesis system, Table 2.1) 
 
5.2.4.2 Procedure 
Mutant synthesis mixture (2 µl) was used to transform 100 µl of BMH 71-68 mutS cells as 
described by the manufacturer. The plasmid was purified using Wizard
®
 Plus SV Minipreps 
DNA purification protocol and transformed into competent E. coli JM 109 cells as per the 
manufacturer‟s protocol. 
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5.2.5  Cutting of pGEM
®
-11Zf(+) with XbaI and EcoRI 
The pGEM
®
-11Zf(+) cloning vector was cut with restriction endonucleases XbaI and EcoRI, 
so that the fragment constituted by the two annealed primers containing the MluI restriction 
site can be inserted by directional cloning. The map of pGEM
®
-11Zf(+) cloning vector is 
shown in Figure 5.1 
 
5.2.5.1 Materials 
 XbaI (Table 2.2) 
EcoRI (Table 2.2) 
10× buffer H. (Provided together with EcoRI, Table 2.2) 
pGEM
®
-11Zf(+). (Provided in Gene editor in vitro site-directed mutagenesis system, Table 
2.1). 
 
5.2.5.2 Procedure  
pGEM
®
-11Zf(+) (2 µg) was cut by XbaI (2 µl) in a reaction containing 10× buffer D (5µl), 
100 mM BSA (0.5 µl) and made up to 50 µl with dH2O. The digest was carried out overnight 
at 37°C. EcoRI (3 µl) was added to the digest mixture and incubated overnight at 37°C. The 















Figure 5.1 Map of pGEM
®
-11Zf(+) cloning vector www.Promega.com accessed on 12
th
 September 2006.  
  
5.2.6  Dephosporylation of pGEM
®
-11Zf(+) cut by XbaI and EcoRI 
Dephosphorylation is the process of removing phosphate groups from an organic compound 
by hydrolysis. Shrimp alkaline phosphatase (SAP) catalyzes the dephosphorylation of 5‟ 
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phosphates from DNA and RNA. SAP can be inactivated by heat treatment for 15 min at 




Shrimp alkaline phosphatase [1 unit/µl], Table 2.2) 
10× dephosphorylation buffer. (Provided with SAP, Table 2.2) 
 XbaI and EcoRI cut pGEM 11Z f (+) (Section 5.2.5.2) 
 
5.2.6.2 Procedure  
The digestion mix (90 µl) was dephosphorylated in a reaction containing 10× 
dephosphorylation buffer (20 µl), SAP (3 µl) and made up to 200 µl with dH2O. The reaction 
was performed at 37°C for 1 h and the SAP was inactivated in a water bath at 65°C for 30 
min. Cut and dephosphorylated pGEM
®
-11Zf(+) was purified using the Wizard
®
 DNA 
Clean-Up System as described by the manufacturer. 
5.2.7 Design of primers containing an MluI restriction site   
For the synthesis of an artificial double stranded DNA fragment containing a MluI site, two 
complimentary oligonucleotides were designed, generating once annealed protruding ends 
corresponding to those produced by restriction with EcoRI and XbaI. In addition, the primers 
introduced a NotI site, an eight-cutter that has become very common in cloning, and a second 
EcoRI site on the other side of the MluI site. In the new pMlu vector, the MluI site is hence 
flanked by two EcoRI sites. We added this feature to our pMlu vector so that any insert 
cloned on the MluI site can be excised using EcoRI. The rationale behind that is the high cost 
of MluI enzyme as compared to EcoRI.  The first primer sequence was 5‟-AATTC 
GCGGCCGC ACGCGT GAATTC T-3‟ introduced partial EcoRI, NotI, MluI, EcoRI and 
partial XbaI restriction sites (only a T for the latter) (Figure 5.3) while the second primer was 
a reverse complement of the first primer with sequence 5‟-CTAGA GAATTC ACGCGT 
GCGGCCGC G-3 that introduced partial XbaI, EcoRI, MluI, NotI and partial EcoRI (only a 
G for the latter) (Figure 5.3). Cutting of the MCS of pGEM
®
-11Zf(+) with both enzymes 
removed SalI, XhoI, Bam HI and ApaI sites (Figure 5.2).  
 
The mutagenic primer for site-directed mutagenesis (5‟-GCC GAG CTC GAA CGC GTC 




encompass restriction sites SacI, EcoRI, SalI and XhoI, mutating the EcoRI site into a MluI 













Figure 5.2  The multiple cloning sites of pGEM
®
-11Zf(+) cloning vector www.Promega.com accessed 
on 12
th




Figure 5.3 Multiple cloning site of pMluI vector. EcoRI and XbaI, restriction sites used to clone a double 
stranded fragment incorporating an MluI restriction site. 
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5.2.8  Phosphorylation of primers containing an MluI restriction site  
Phosphorylation is the addition of a phosphate group into a protein or a small molecule. T4 
polynucleotide kinase (T4 PNK) is a polynucleotide 5'-hydroxyl kinase that catalyzes the 
transfer of the γ-phosphate from ATP to the 5'-OH group of single- and double-stranded 
DNA and RNA, oligonucleotides or nucleoside 3'-monophosphates (Richardson, 1965). In 
the presence of ADP, T4 PNK exhibits 5'-phosphatase activity and catalyzes the exchange of 
terminal 5'-phosphate groups. 
 
5.2.8.1 Materials 
T4 Polynucleotide Kinase [30 U/µl] (Table 2.2) 
10× polynucleotide kinase buffer. (Provided with T4 Polynucleotide Kinase, Table 2.2) 
F1 primer:  AATTCGCGGCCGCACGCGTGAATTC, Tm (67.1°C) 
F2 primer: CTAGAGAATTCACGCGTGCGGCCGCG, Tm (67.1°C) 
F3 mutagenic primer (Section 5.2.2.1) 
100 mM ATP. (Section 2.2) 
 
5.2.8.2 Procedure 
The mutagenic primer and both forward and reverse primers (section 5.2.7) were 
phosphorylated at 37°C for 1 h. The reaction components were: 10× polynucleotide kinase 
buffer (2.5 µl), T4 DNA polynucleotide kinase (15 units) (0.5 µl), 100 mM ATP (2.5 µl) 
made up to 25 µl with dH2O. The T4 DNA polynucleotide kinase was inactivated by heating 
at 70°C in a water bath for 15 min.  






Phosphorylation mix (Section 5.2.8) 
Cut and dephosphorylated pGEM
®
-11Zf(+) (Section 5.6) 
5× Rapid ligation buffer (Table 2.1) 
T4 DNA ligase (Provided with 5× Rapid ligation buffer, Table 2.1) 
 
5.2.9.2 Procedure 
The primers still in the phosphorylation mix were mixed 1:1 with one another and allowed to 
anneal by cooling the reaction mixture slowly in water bath to obtain a double stranded 
fragment that can be cloned into pGEM
®
-11Zf(+). Phosphorylation mix (5 µl) was used in a 
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ligation reaction consisting of 100 ng (2 µl) of the cut and dephosphorylated pGEM
®
-
11Zf(+), 5× Rapid ligation buffer (4 µl) and T4 DNA ligase (1 µl) made up to 20 µl with 
dH2O. The ligation was done overnight at room temperature. The ligated vector was 
transformed into competent E. coli JM 109 cells, plasmids containing the MluI restriction site 
insert were purified and linearised by MluI to confirm recombinants, and named pMluI. 
5.3 Preparation of pMluI vector for ligation with 2 kb fragments 
5.3.1 Materials 
pMluI (Section 5.9) 
MluI (Table 2.2) 
10 × buffer R (Provided with MluI, Table 2.2) 
100 mM BSA (Section 2.2) 
5.3.2 Procedure 
pMluI (5 µg) vector was cut with MluI (20 units) in a 150 µl reaction containing 10 × buffer 
R (15 µl), 100 mM BSA (1.5 µl) and dH2O (31.5 µl), overnight at 37°C. The vector was 
purified as described in Wizard
®
 DNA Clean-Up protocol and dephosphorylated by SAP and 
separated on a 1% agarose gel stained with ethidium bromide. Cut and dephosphorylated 
pMluI was excised from the gel and purified as per Wizard
®
 SV Gel and PCR clean-up 
protocol. 
5.4  Isolation of genomic DNA from trypanosomes 
Genomic DNA was isolated from T. congolense IL 3000 frozen cells using two methods of 
DNA extraction i.e. phenol/chloroform extraction and the second using the Fermentas 
genomic DNA purification kit. 
5.4.1  Phenol: chloroform genomic DNA extraction 
Isolation of DNA by this method is based on digestion of proteins by Proteinase K and RNA 
by RNase. After digestion of RNA, RNase and cellular proteins are extracted into the organic 
phase of buffer saturated phenol:chloroform while the DNA remains in the aqueous phase. 
Two more phenol:chloroform extractions are done to remove traces of proteins from the 
DNA. The genomic DNA is precipitated by two volumes of cold ethanol 100% (v/v), washed 




Phenol : chloroform : isoamylalcohol (25:24:1). Phenol (100 g) was dissolved in 50 mM 
Tris-HCl, pH 8 (100 ml) with gentle shaking. The supernatant was removed with a pipette, 
another 50 mM Tris-HCl, pH 8 (100 ml), added, stirred, and left to stand and form phases. 
This step was repeated five times to ensure the pH range was between 7 and 8. Chloroform 
(96 ml) was mixed with isoamylalcohol (4 ml), this mixture was added to the phenol and 
overlaid with 50 mM Tris-HCl, pH (100 ml) and kept at -20°C (prepared in a fume hood). 
500 mM Tris-HCl, pH 8. Tris-base (60.5 g) was dissolved in dH2O (900 ml), the pH was 
adjusted to 8 with HCl, made up to 1000 ml with dH2O and autoclaved (121°C, 30 min, RT) 
50 mM Tris-HCl, pH 8. Tris-HCl (500 mM) pH 8 (100 ml) was made up to 1000 ml with 
sterile dH2O and stored at RT. 
Proteinase K (Table 2.2) 10 mg/ml 
RNases A (Table 2.2) 10 mg/ml 
T congolense IL 3000 trypanosomes (5 x 10
8
) (Provided by ILRI, Nairobi, Kenya) 
Ethanol 100% (v/v) (Section 2.2) 
Ethanol 70% (v/v). Ethanol (70 ml) was made up to 100 ml with sterile dH2O and stored at 
RT. 
3 M Sodium acetate buffer pH 5.2. Glacial acetic acid (18.015/1.05) ml was mixed with 




Trypanosomes were resuspended in dH2O (200 µl), RNase A (5 µl) was added before 
incubation at 37°C for 10 min. Proteinase K was added to a final concentration of 100 µg/ml 
and incubated at 50°C for 3 h. The DNA was extracted by adding phenol:chloroform:isoamyl 
alcohol (25:24:1) (400 µl) and gently mixing until an emulsion was formed. The two phases 
were separated by centrifugation (10,000×g, 15 min, RT). The upper aqueous phase 
containing the genomic DNA was removed and transferred into a new microfuge tube. The 
DNA was again extracted by adding saturated phenol:chloroform:isoamyl alcohol solution 
(400 µl) to the aqueous phase, mixing gently and the DNA recovered by centrifugation 
(10,000×g, 15 min, RT). The aqueous phase was removed and transferred into a new 
microfuge tube. The DNA solution (300 µl) was precipitated by adding 3 M sodium acetate 
buffer (pH 5.2) (30 µl) and cold 100% (v/v) ethanol (660 µl). The mixture was swirled until a 
DNA pellet formed, which was removed from the ethanol phase with a very thin glass rod 
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made from stretching a Pasteur pipette over a gas burner and sealing the end. The pellet stuck 
to the glass rod was washed in cold 70% (v/v) ethanol and dried at RT. The pellet was then 
dissolved in dH2O (200 µl) and stored at -20°C.  
5.4.2  Fermentas genomic DNA purification method 
Genomic DNA is obtained after the trypanosomes are lysed by high salt concentration (that 
also denatures cellular proteins) present in the lysis solution, while RNA is degraded by 
RNases. The DNA is then precipitated by ethanol and dissolved in sterile water.  
5.4.2.1 Materials  
Lysis solution (Provided in the Fermentas Genomic DNA purification kit, Table 2.1) 
10 × Precipitation solution (Provided in the Fermentas Genomic DNA purification kit, Table 
2.1) 
1.2 M Sodium chloride solution (Provided in the Fermentas Genomic DNA purification kit, 
Table 2.1)   
T. congolense IL 3000 trypanosomes (5 x 10
8
) (Provided by ILRI, Nairobi, Kenya) 
Chloroform (Section 2.2) 
Ethanol 100% (v/v) (Section 2.2) 
Ethanol 70% (v/v) (Section 5.4.1.1) 
RNases (Table 2.2) 
 
5.4.2.2 Procedure 
Trypanosome cells were resuspended in dH2O (200 µl), 400 µl of lysis solution was added 
and incubated at 65°C for 5 min, genomic DNA was isolated as described by the 
manufacturer‟s protocol. 
5.5  Preparation and cloning of 2 kb inserts from T.  congolense IL 3000 genomic 
DNA into pMluI  
5.5.1  Cutting of T. congolense IL 3000 genomic DNA with MluI 
When constructing a genomic library, the DNA is fragmented into smaller fragments that can 
easily be cloned.  As congopain-like genes have a MluI restriction site in the intergenic 
region, cutting the gene with this enzyme gives complete genes units (2 kb).  
 
5.5.1.1 Materials 
 T. congolense IL 3000 genomic DNA [400 µg/ml] (Provided by ILRI, Nairobi, Kenya) 
MluI [10 units/µl] (Table 2.2) 
10× buffer R (Provided with MluI, Table 2.2) 
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5.5.1.2 Procedure  
T. congolense IL 3000 (30 µg) was cut in a reaction composed of 10 × buffer R (20 µl), MluI 
enzyme (3 µl) and dH2O (67 µl). The digestion was done overnight at 37°C, separated on a 
0.8% (w/v) agarose gel and DNA with a size of approximately 2 kb (actually probably 1.7 to 
2.3 kbp) as estimated using the position of the molecular weight markers on the gel was 
excised as it corresponds to the size of the cysteine protease genes. The 2 kb fragment was 
purified from agarose gel slice using DNA purification Wizard
®
 SV Gel and PCR clean-up 
system according to the manufacturer‟s protocol. 
5.5.2  Cloning of the 2 kb fragment into MluI cut pMluI 
Cut and dephosphorylated pMluI (1 µl) was ligated with purified 2 kb fragments (16 µl) in 
20 µl reaction mixtures consisting of 10 × ligation buffer (2 µl) and T4 DNA ligase (1 µl). 
The ligation was done overnight at room temperature. 





 Top 10 competent cells (Table 2.1) 
S.O.C medium (Provided together with One shot
®
 Top 10 competent cells, Table 2.1)   
X-gal [50 mg/ml] (Section 2.9.1.1) 
S.O.C-ampicillin agar plates (Section 2.8.3.1) 
Ampicillin [100 µg/ml] (Section 2.8.1.1) 
 
5.5.3.2 Procedure 
The ligation mix was centrifuged briefly and kept on ice; the vial of competent cells was 
thawed on ice. The ligation mix (5 µl) was transformed into One shot
®
 Top10 competent 
cells as described by the manufacturers of the kit. The transformed cells (100 µl) were plated 
on S.O.C agar plates containing ampicillin (100 µg/ml) and 50 mg/ml X-gal (10 µl). Plates 
were incubated overnight at 37°C. 
5.6  Screening for 2 kb CP clones using SP6/T7 and CP-specific primers 
White colonies were screened by PCR using SP6/T7 primers to confirm the presence of an 
insert. To differentiate congopain-like cysteine proteases in the subgenomic library from non 
cysteine proteases, further screening was done by PCR using primers Tc/Tv CP2 and Tc/Tv 
CP3 (Table 4.1) designed from the central domain of the T. congolense as radioactive 
probing was not an option in our laboratory.  
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5.6.1  Materials 
SP6 and T7 primers (Section 2.10.1) 
PCR reagents (Table 2.4) 
Tc/Tv CP2 and Tc/Tv CP3 primers (Table 4.1) 
Cp seq Fw primer TSTTCAAGCAGARCATGGAGC, Tm (52°C) 
Cp seq Rev primer TTATTGGRSCCGCACGAGGC, Tm (62°C)  
5.6.2  Procedure 
PCR was carried out as described in Section 2.10.2. The PCR products were separated on a 
1% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). 
5.7  Restriction digest of the CP clones from the subgenomic library with PstI 
As shown on figure 3.2 and discussed in Chapter 3, the presence of a band a 4 kbp in cosmid 
DNA cut with PstI means that a limited number of gene copies do not have a PstI site; such 
copies would have been missed from the cosmid gene units library described in Chapter 3. 
To establish whether gene copies lacking PstI site are present in the selected MluI 2 kbp gene 
units, clones were restricted with PstI. The multiple cloning site of pMluI does not have a 
PstI restriction site. To make results more visual, the 2 kb inserts were amplified by PCR 
using SP6 and T7 primers and digested with PstI.  
5.7.1  Materials  
8 CP clones from the library (Section 5.6)  
PstI (Table 2.2) 
10× buffer H (Provided together with PstI, Table 2.2) 
SalI (Table 2.2) 
10× buffer D (Provided together with SalI, Table 2.2) 
5.7.2  Procedure 
PCR product (20 µl) was digested in a reaction consisting of PstI (2 µl), 10× buffer H (4 µl), 
made up to 40 µl with dH2O and incubated overnight at 37°C. Digestion products (20 µl) were 
separated on a 1.2% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). 
5.8  Purification of mRNA from T. congolense IL 3000 and amplification of cysteine 
protease isoforms by RT-PCR 
5.8.1 Materials 
T. congolense IL 3000 parasites (Provided by ILRI, Nairobi, Kenya) 
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Primers: Forward-all-CP and Rev-C1, Rev-C2 and Rev-C3 primers, cluster primers-C1, -C2 
and -C3 (Fw and Rev) (Table 3.1) 
Primer Rev-C4 5‟-CGAGAGAATGCCCACGAAGAGTG-3‟, Tm (60°C)  
SV Total RNA isolation kit (Table 2.1) 
Access RT-PCR kit (Table 2.1) 
RNAid Kit (Table 2.1) 
5.8.2  Procedure  
Total RNA was isolated from T. congolense clone IL 3000 parasites using SV Total RNA 
isolation kit as described by the manufacturer and the mRNA subfraction gel purified 
according to RNAid Kit protocol. Cysteine protease genes were amplified by RT-PCR 
(Section 2.5.2) using the primers detailed in Table 3.1 as well as Rev-C4   (Section 5.8.1) and 
separated on an agarose gel and stained with ethidium bromide (Section 2.3.2). 
5.9  Results of construction and screening of subgenomic library 
5.9.1 Construction of the pMluI cloning plasmid 
Of the two methods used in construction of the pMluI cloning vector, only cloning of 
annealed primers with the MluI restriction site was successful and was confirmed by cutting 
the vector with MluI. The plasmids which were linearised by MluI were considered 
recombinant as they contained the MluI restriction site (results not shown). The site-directed 
mutagenesis of the pGEM
®
-11Zf(+) MCS failed as no recombinants with the desired 
mutations were found.  
 
5.9.1.1 Cutting of pGEM
®
-11Zf(+) with XbaI and EcoRI 
The pGEM
®
-11Zf(+) plasmid was linearised by digestion with either XbaI or EcoRI in the 
same buffer H, and digestion products (10 l) separated on a 1% (w/v) agarose gel (fig. 5.5). 
This was to make sure that both enzymes are able to cut the plasmid in this buffer. Given that 
the two restriction sites are close to each other, it would not have been possible to tell 
whether both enzymes had cut by electrophoretic analysis. The analysis with each enzyme 
was followed by a double digest in buffer H (not shown). The vector appeared to have been 
cut by the two enzymes, as a unique band at 3.2 kbp is visible. In the uncut vector lanes, two 
bands are present, at 2 kbp and 4 kbp. They correspond to supercoiled plasmid DNA 
(covalently closed circular form), monomer and dimer that migrate faster than linear plasmid 
















Figure 5.5 Restriction digests of pGEM
®
-11Zf(+) with XbaI and EcoRI. The samples were separated on a 
1% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2), Lane M, molecular weight makers; 
lanes 1 and 3, pGEM
®
-11Zf(+) cut by XbaI and EcoRI; lanes 2 and 4, uncut pGEM®-11Zf(+). 
 
5.9.2  Preparation of pMluI for ligation with 2 kb fragments. 
The pMlu plasmid was restricted with MluI enzyme and dephosphorylated to prevent 
recircularisation of the plasmid. The cloning vector appeared linear as shown in Figure 5.6; 
as explained above, the linearised plasmid migrated slower than uncut plasmid, though no 
multimeric forms were visible. Cut and dephosphorylated pMluI was gel purified in order to 
eliminate any traces of uncut plasmid that could be remaining, and could be a source of 
background (Figure 5.7). This separation of the cut pMluI from the uncut was done in one 
long well as a large quantity of concentrated cut pMluI was required for subsequent cloning. 
 























































































































































Figure 5.6 Restriction digest of pMluI plasmid with MluI. Samples were separated on a 1% (w/v) agarose 
gel and stained with ethidium bromide (Section 2.3.2). Lane M, molecular weight markers; lane 1, pMluI vector 




Figure 5.7 pMluI plasmid cut with MluI and dephosphorylated by SAP. Sample was separated on a 1% 
(w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). Lane M, molecular weight markers; lane 
1, (three teeth of the comb were sealed to make one long well on the gel), pMluI plasmid cut by MluI and 
dephosphorylated by SAP.  
5.9.3  Isolation of genomic DNA from trypanosomes 
Purified T. congolense IL 3000 genomic DNA (5 µl) was separated on a 0.8% (w/v) agarose 
gel to confirm successful isolation from trypanosomes. All the lanes gave two high molecular 
mass bands showing genomic DNA of good quality that is not degraded. The two bands are 
likely to correspond to nuclear DNA and to kinetoplast DNA (see section 1.6). The DNA 
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purified using the kit appears of better quality than the one purified using phenol:chloroform 
technique. 
 
Figure 5.8 Analysis of T. congolense IL 3000 genomic DNA isolated from trypanosomes. The T. congolense 
IL 3000 genomic DNA samples (5 µl) were separated on a 0.8% (w/v) agarose gel and stained with ethidium 
bromide (Section 2.3.2).  Lanes 1-6, DNA extraction from frozen trypanosomes using Fermentas Genomic 
DNA purification method; lane 7, DNA isolated by phenol: chloroform technique.  
5.9.4  Cutting of T. congolense genomic DNA IL 3000 with MluI 
The genomic DNA was digested by MluI and separated on a 0.8% (w/v) agarose gel (Figure 
5.9). The genomic DNA appeared completely digested by MluI, a few distinct bands were 
visualised and the DNA around 2 kb (in the fact, 1.7 to 2.3 kbp) as shown by the arrow 
Figure 5.9) representing the size of the cysteine protease genes, was excised from the gel.  
 
Figure 5.9 Restriction digest of T. congolense IL 3000 genomic DNA using MluI. The DNA samples were 
separated on a 0.8% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2), lane M, molecular 
weight markers; lanes 1 and 2, T. congolense IL 3000 genomic DNA completely digested by MluI. The arrow 
indicates the region on the gel containing the digested genomic DNA of 2 kb that was excised from the gel for 
further studies.   
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5.9.5 Cloning of 2 kb fragment into pMluI cut with MluI 
Purified genomic DNA in the 1.7-2.3 kbp range was ligated into pMlu at the MluI site and 
the ligation mix used to transformation one shot
®
 Top10 competent cells. Many white 
colonies were visible on Xgal-containing S.O.C-ampicillin agar plates, with a 10 to 15 % 
background of blue colonies. White colonies were considered as recombinant and further 
screened by PCR to establish the clones carrying the 2 kb fragment.  
5.9.6  Screening for CP clones using CP-specific primers 
White colonies of pMluI/2 kb clones were screened by PCR using SP6/T7 primers to confirm 
the presence of a 2 kb insert and representative analyses are shown in Figure 5.10 A and B 
(lanes 1, 9, 16, 18, 20, 21, 22, 23, 27, 30 and 30). A total of 206 recombinants were obtained 
and only 8 clones (2, 3, 4, 6, 30, 31, 50 and 203) were identified as containing congopain-like 
cysteine protease by PCR using CP-specific primers, prior to sequencing (Figure 5.11 A, B 
and C, lanes 11, 30, 31 and 50). The rest of clones were considered non cysteine protease 





Figure 5.10 PCR on colonies of each clone of the 2 kb library using SP6 and T7 primers. The samples were 
separated on a 1 % (w/v) agarose gel and stained with ethidium bromide. (Section 2.3.2), (A) lane M, molecular 
weight makers; lanes 1-19, PCR on colonies 1-19 (B) lane M, molecular weight makers; lanes 20-32, PCR on 




Figure 5.11 PCR on recombinant colonies amplified by CP-specific primers.  The samples were separated 
on a 1.2% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). Lanes M, molecular weight 
markers. (A) Lanes 1-19, recombinant colonies 1-19 amplified by CP-specific primers. (B) Lanes 20-35, PCR 
on recombinant colonies 20-35. (C)  lanes 36-51, recombinant colonies 36-51 amplified by CP-specific primers, 
lane 52, a negative control (PCR on a blue colony) and lane 53, a positive control (PCR on clones 3).
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5.9.7  Restriction mapping of the CP clones from the subgenomic library 
The insert of the 8 positive clones were amplified by PCR using primers flanking the MCS 
(so-called T7 and SP6), and the PCR product cut with PstI. The digests were separated on a 
1.2% (w/v) agarose gel containing ethidium bromide. All eight CP positive clones were cut 
by PstI resulting in two bands at 500 bp and 2 kb (Figure 5.12). Hence the copies that do not 
have a PstI site that we hoped would be present in the library were not selected. 
The NEBcutter V2.0 (www.tools.neb.com/NEBcutter2) was used to establish the restriction 
map of the clones. All the clones had PstI, BamHI, and AatII among other restriction sites 
common to all trypanosomal cysteine protease. Interestingly, it was previously thought that 
the SalI restriction site was confined to CP1 isoforms, while the NcoI restriction site was 
associated with CP2 and CP3 isoforms, however clones 4, 6 and 50 which had both SalI and 
NcoI restriction sites. HindIII and XbaI restriction sites were also thought not to exist within 
the CP genes however, clone 30 had an XbaI restriction site while clone 203 had a unique 
HindIII restriction site. Clones 30, 31 and 203 were the only clones without an NcoI 
restriction site.  
 
Figure 5.12 PstI and SalI restriction digest of CP clones amplified with SP6 and T7 primers. The samples 
were separated on a 1.2% (w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). (A). Lane M, 
molecular weight markers; numbers correspond to the clone numbers digested by PstI. (B). Lanes M, molecular 
weight markers; numbers correspond to the clone numbers digested using SalI. 
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5.9.8  Sequence analysis 
The eight CP clones were sequenced with SP6 and T7 primers (Section 2.10.1) from both 
ends and internally by CP-seq Fw and Rev primers to get the full sequence. There was a 
problem in sequencing clone 2 and its sequence was excluded from the analysis. The DNA 
sequences were compared with other congopain-like cysteine protease genes in available at 
NCBI BLAST (www.ncbi.nlm.nih.gov/BLAST, accessed on 15.11.2006). At the amino acid 
level the seven clones showed significant identity (86-94%) with CP1 (Fish et al., 1995, 
EMBL accession number Z25813), CP2 (Jaye et al., 1994, EMBL accession number 
L25130) and CP3 (Downey and Donelson, 1999 EMBL accession no. AF139913). The DNA 
sequences were translated into protein sequences by ExPAsy software and aligned with CP1, 
CP2 and CP3 by ClustalW, and showed high identity (86-100%).  
The signal peptide (20 amino acids long) was 100% identical (Figure 5.13, text box 1); while 
the propeptide was 95-100% identical and 105 amino acids long (Figure 5.13). The inhibitory 
peptide YHNGA sequence (Figure 5.13, text box 2) in the propeptide (Lalmanach et al., 
1998) was present in all the clones. All the clones had the 22 nucleotide polypyrimidine tract 
(CTTTTCTTCTTTCTTTTCCTTT) that precedes the start codon of cysteine proteases in T. 
congolense (results not shown). The catalytic domains of the clones were 216 amino acid 
residues long and showed some degree of variability (79-96 % identity). Clones 6 and 50 had 
identical catalytic domains (Figure 5.14). Clones 4, 6, 30 and 50 had the APEA sequence at 
the maturation site (N-terminus of mature protease), while clone 203 had APPA, clone 3 had 
APDA and clone 31 had the PPMT (Figure 5.14, text box 1). The N-terminus sequences 
APPA and APEA have previously been described in CP1 and CP2 respectively (Boulangé et 
al., 2001).  Among the seven clones only clone 4 had a conserved cysteine residue in the 
catalytic triad, the other clones had a serine residue (Figure 5.14, text box 2). The histidine 
residue of the catalytic triad was conserved in clones 3, 4, 6, 50 and 203, while in clones 30 
and 31 it was substituted by a serine residue (Figure 5.14, text box 3), first reported in CP3 
(Downey and Donelson, 1999 EMBL accession no. AF139913). The asparagine residue of 
the catalytic triad was present in all the clones (Figure 5.14, text box 4).  
The length of the C-terminal extension varied among the clones; it was 97 amino acids long 
in clones 6, 30, 31, 50 and 203, 95 amino acids long in clone 3 and 98 amino acids long in 
clone 4 (Figure 5.15). The clones had a C-terminal extension linked to the central domain by 
polyproline residues and were 90 – 92 % identical. Clones 4, 6, 50, 30, 31, 50 and 203 had 
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six proline residues while clone 3 had 8 proline residues as was the case for CP1 (Figure 
5.15, text box 1).   
 
A Neighbouring Joining tree performed on translated amino acid sequences of the seven 
clones together with cysteine protease isoforms CP1, CP2 and CP3, formed six clusters 
(Figure 5.16). The first cluster consisted of clones 6 and 50, these clones had a serine residue 
instead of cysteine at the active site but the other residues forming the catalytic triad were 
conserved. Clone 3 fell into the second cluster and like clones 6 and 50 had a serine residue 
at the active site and the histidine and asparagine residues of the catalytic triad were 
conserved. However in contrast to clones 6 and 50 which had an N-terminal APEA sequence, 
clone 3 had N-terminal APDA sequence. The third cluster comprised of clone 4 and CP1 
both of which had the three amino acid residues of the catalytic triad (CHN) conserved, but 
differed in their N-terminal sequences: clone 4 (APEA) and CP1 (APPA). Surprisingly, the 
fourth cluster comprised CP2 and CP3, which differ in their amino acid residues at the active 
site of the mature enzyme, CP2 (cysteine) and CP3 (serine). CP2 and CP3 also differed in 
their N-terminal sequences (APEA for CP2 and APPA for CP3). The fifth cluster comprised 
of clone 203 occurring between CP3 and clones 30 and 31; this clone had a serine residue 
instead of a cysteine residue but histidine and asparagine residues conserved. The last cluster 
(sixth) comprised of clones 30 and 31, bearing a serine residue at the active site, a serine 
residue instead of histidine and a conserved asparagine residue. Clone 30 had the APEA N-
terminus while clone 31 had the unique PPMT sequence. The seven clones appeared closely 




CLUSTAL 2.0.3 multiple sequence alignment 
                           1 
                          
Clone3          MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone4          MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone6          MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone31         MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone50         MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
CP2             MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
CP3             MPRSEMTRTLGFSVGLHAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
CP1             MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone203        MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAKQSLQQQFAAFKQKYSRSYKDATEEAF 60 
Clone30         MPRSEMTRTLRFSVGLLAVA  ACFVPVALGVLHAEQSLQQQFAAFKQKYSRSYRDATEEAF 60 
                ********** ***** ***  *************:******************:******* 
                                                           2 
Clone3          RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVT 120 
Clone4          RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVT 120 
Clone6          RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVT 120 
Clone31         RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVN 120 
Clone50         RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVT 120 
CP2             RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVN 120 
CP3             RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVN 120 
CP1             RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVN 120 
Clone203        RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEEFRAT YHNGA EYYAAALKRPRKVVN 120 
Clone30         RFRVFKQNMERAKEEAAANPYATFGVTRFSDMSPEVRKAT YHNGA EYYAAALKRPRKVVN 120 
                ***********************************  :** ***** **************. 
 
Clone3          VSTGK-- 125 
Clone4          VSTGK-- 125 
Clone6          VSTGK-- 125 
Clone31         VSTGR-- 125 
Clone50         VSTGK-- 125 
CP2             VSTGK-- 125 
CP3             VSTGK-- 125 
CP1             VSTGK-- 125 
Clone203        VSTGK-- 125 
Clone30         VSTGK-- 125 
                ****:   
 
 
Figure 5.13 ClustalW alignment of translated amino sequences of subgenomic library clones showing the 
signal and propeptide regions of congopain-like cysteine proteases. Clones 3, 4, 6, 30, 31, 50 and 203, 
translated amino acid sequences of clones 3, 4, 6, 30, 31, 50 and 203 respectively; CP1, CP2 and CP3 are 
translated amino acid sequences of cysteine protease isoforms CP1, CP2 and CP3 respectively. Text box 1, the 
signal peptide of congopain-like cysteine proteases; text box 2, the YHNGA peptide in the propeptide. The 
remainder of the amino acid residues after text box 1, represent the 105 amino acid long propeptide region of 











CLUSTAL 2.0.3 multiple sequence alignment 
 
                 1                                                      2   
Clone6          APEA VDWRKKGAVTPVKDERLCDS S WAFSAIGNIEGQWKVAGHELTSLSEQMLLSCDTRE 60 
Clone50         APEA VDWRKKGAVTPVKDERLCDS S WAFSAIGNIEGQWKVAGHELTSLSEQMLLSCDTRE 60 
Clone3          APDA VDWRKKGAVTPVRDERLCDS S WAFSAIGNIEGQWKVAGHELTSLSEQMLLSCDTRE 60 
Clone4          APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVAGHELTSLSEQMLVSCDTED 60 
CP1             APPA VDWRKKGAVTPVKDQGACGS C WAFSAIGNIEGQWKVAGHELTSLSEQMLVSCDTTD 60 
CP2             APEA VDWRKKGAVTPVKDQGQCGS C WAFSAIGNIEGQWKVAGHELTSLSEQMLVSCDTND 60 
CP3             APPA IDWRKKGAVTPVKDQGQCHS S WAFSAIGNIEGQWKIAGHELTSLSEQMLVSCDTND 60 
Clone203        APPA IDWRKKGAVTPVKDQGQCGS S WAFSAIGSIEGQWKVAGHELTSLSEQMLVSCDTND 60 
Clone31         PPMT VDWRKKGAVTPVKDQGQCDS S WAFSAIGNIEGQWKIAGHELTSLSEQMLVSCDTND 60 
Clone30         APEA VDWRNLGAVTPVKDQGKCDS S WAFTVIGNIEGQWKIAGHELTSLSEQMLVSCDTND 60 
                .* : :***: ******:*:  * * . ***:.**.******:*************:**** : 
 
Clone6          DGCGGGLMDRAFKWIVSSNKGNVFTEQSYPYASTDGDVPRCNKSGKVVGAKIRDHVDLPQ 120 
Clone50         DGCGGGLMDRAFKWIVSSNKGNVFTEQSYPYASTDGDVPRCNKSGKVVGAKIRDHVDLPQ 120 
Clone3          DGCGGGLMDRAFQWIVSSNKGNVFTEQSYPYASTDGDVPRCNKSGKVVGAKISDYVDLPQ 120 
Clone4          DGCGGGLMDNAFQWIVSSNKGNVFTEQSYPYASKGGKMPPCNMSGKVVGANIRDHVDLPK 120 
CP1             YGCRGGLMDKSLQWIVSSNKGNVFTAQSYPYASGGGKMPPCNKSGKVVGAKISGHINLPK 120 
CP2             FGCEGGLMDDAFKWIVSSNKGNVFTEQSYPYASGGGNVPTCDKSGKVVGAKIRDHVDLPE 120 
CP3             FGCGGGFSDPAFKWIVSSNKGNVFTEQSYPYASGGGNVPTCDKSGKVVGAKIRDRVDLPR 120 
Clone203        LGCKLGLMDFAFKWILWSNKGNVFTEQSYPYASGGGKVPTCNKSGKVVGAKISDWIHFPR 120 
Clone31         FGCGGGFSDPAFQWILSSNKGNVFTEQSYPYASGGGNVPACNMSGKVVGAKISNRLYLPR 120 
Clone30         FGCRAGFMDTAFKWIVSPNDGNVFTEQSYPYASGGGNVPACNKSGKVVGANIRDHVHILD 120 
                 **  *: * :::**: .*.***** ******* .*.:* *: *******:* . : :   
                                                          3 
Clone6          DENAIAEWLAKNGPVAIAVDATSLQRYTDGVLTSCISEQLD H GVLLVGYDDTSKPPYWII 180 
Clone50         DENAIAEWLAKNGPVAIAVDATSLQRYTDGVLTSCISEQLD H GVLLVGYDDTSKPPYWII 180 
Clone3          DENAIAEWLAKNGPVAIAVEATSLQRYTGGVLTSCISEQLD H GVLLVGYDDTSKPPYWII 180 
Clone4          DENAIAEWLAKNGPVAIAVDATSFLDYTGGVLTSCISKQLD H GVLLVGYDDTSKPPYWII 180 
CP1             DENAIAEWLAKNGPVAIAVDATSFLGYKGGVLTSCISKGLD H DVLLVGYDDTSKPPYWII 180 
CP2             DENAIAEWLAKNGPVAIAVDATSFQSYTGGVLTSCISEHLD H GVLLVGYDDTSKPPYWII 180 
CP3             DENAIAEWLAKKGPVAIAVDATSFQSYTGGVLTSCISEHLD H GVLLVGYDDTSKPPYWII 180 
Clone203        DEDIIAEWLAKNGPVAIAVDSTSFQSYTGGVLTSCISEYLD H AVLLVGYDDTSKPPYWII 180 
Clone31         DEDMIAEWLAKKGPVAIAVDATSFQSYTGGVLTSCISKEVN S AALLVGYDDTSKPPYWII 180 
Clone30         NENAIAEWLAKNGPVAIAVDATSFQRYTGGVLTSCISKEVN S AALLVGYDDTSKPPYWII 180 
                :*: *******:*******::**:  *..********: ::    .**************** 
                  4 
Clone6          K N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG-- 216 
Clone50         K N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG-- 216 
Clone3          K N SWGKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG-- 216 
Clone4          K N SWSKGWGEEGYIRIEKGTNQCLMKNYASSAVVSG-- 216 
CP1             K N SWSKGWGEEGYIRIEKGTNQCLMKNYARSAVVSG-- 216 
CP2             K N SWSKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG-- 216 
CP3             K N SWGKGWGEEGYIRIEKGTNQCLMKNLPSSAVVSG-- 216 
Clone203        K N SWSKGWGEEGYIRIEKGTNQCLVQEYASSAVVIG-- 216 
Clone31         K N SWSKGWGEEGYIRIEKGTNQCLVQEYASSAVVSG-- 216 
Clone30         K N SWGKGWGEEGYIRIEKGTNQCRMKDYVSSAVVSG-- 216 
                * * **.****************** :::   **** *   
 
 
Figure 5.14 ClustalW alignment of translated amino sequences of subgenomic library clones showing the 
catalytic domain of congopain-like cysteine proteases. Clones 3, 4, 6, 30, 31, 50 and 203, translated amino 
acid sequences of clones 3, 4, 6, 30, 31, 50 and 203 respectively; CP1, CP2 and CP3 are translated amino acid 
sequence of cysteine protease isoforms CP1, CP2 and CP3 respectively. Text box 1, cleavage site between the 
propeptide and the catalytic domain of congopain-like cysteine proteases; text box 2,  cysteine or serine residues 
at the active site; text box 3, histidine or serine residues of the catalytic triad; text box 4, asparagine residue of 












CLUSTAL 2.0.3 multiple sequence alignment 
 
                    1  
Clone6          PVPPPPPPAS TFTQEFCEGAEC-SGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 59 
Clone50         PVPPPPPPAS TFTQEFCEGAEC-SGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 59 
Clone4          PVPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 60 
Clone3          PVPPPPPPPP TFTQEFCEGAQC-SGCTKATFPTGKCVQLSGAGSVIASCGPNNLTQIVYP 59 
CP2             --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
CP3             --PPPPPPTP TFTQELCEGAECQSKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 58 
Clone31         --PPPPPPTP TFTQELCEGAEC-SKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 57 
Clone30         --PPPPPPTP TFTQELCEGAEC-SKCTKATFPTGKCVQLSGAGSAIASCGSNNLTQIVYP 57 
Clone203        --PPPPPPTP TSTQELCEGAEC-SKCTKATFPTGKCVQLSGAGSVIASCGSNNLTQIVYP 57 
CP1             PPPPPPPPAS TFTQEFCEGAECQSGCTKATFPTGKCVQFGGAGSVIASCGSNNLTQIVYP 60 
                  ******.. * ***:****:* * *************:.****.*****.********* 
 
Clone6          LSSSCSGYSVPLTVPLDKCLPIVIGSVMYECSGKAPTESARLVRHE--- 105 
Clone50         LSSSCSGYSVPLTVPLDKCLPIVIGSVMYECSGKAPTESARLVRHE--- 105 
Clone4          LSSSCSGYSVPLTVPLDKCLPIVIGSVMYECSGKAPTESARLVRHE--- 106 
Clone3          LSSSCSGYSVPLTVPLDKCLPIVIGSVMYECSGKAPTESARLVRHE--- 105 
CP2             LSSSCSGFSVPLTVPLDKCLPIVIGSVMYECSDKAPTESARLVRHE--- 104 
CP3             LSSSCSGFSVPLTVPLDKCLPIVIGSVMYECSDKAPTDPPG-------- 99 
Clone31         LSSSCSGFSVPLTVPLDKCLPIVIGSVMYECSDKAPTESSRLVRHE--- 103 
Clone30         LSSSCSGFSVPLTVPLDKCLPIVIGSVMYKCSDKAPTASARLVRHE--- 103 
Clone203        LSSSCSGFSIPLTVPLDKCLPIVIGSVMYECSDRAPTESARLVRHE--- 103 
CP1             LSSSCSGFSIPLTVPLDKCLPIVVGSVMYECSGKAPTESARLVRHE--- 106 
                *******:*:*************:*****:**.:*** ..          
 
Figure 5.15 ClustalW alignment of translated amino sequences of subgenomic library clones showing the 
polyproline hinge and the C-terminal extension of congopain-like cysteine proteases. Clones 3, 4, 6, 30, 31, 
50 and 203, translated amino acid sequences of clones 3, 4, 6, 30, 31, 50 and 203 respectively; CP1, CP2 and 
CP3 are translated amino acid sequence of cysteine protease isoforms CP1, CP2 and CP3 respectively. Text box 


















Figure 5.16 Neighbouring Joining tree performed by ClustalW alignment on translated amino acid 
sequence of entire congopain-like cysteine protease genes (clones) obtained from the subgenomic library. 
CP1, CP2 and CP3 are cysteine protease isoforms CP1, CP2 and CP3 respectively. Clones 3, 4, 6, 30, 31, 50, 
and 203, predicted amino acid sequences of the corresponding clones used in the construction of the 










5.10  Results of detection of cysteine protease isoform transcript by RT-PCR   
5.10.1  Isolation of total T. congolense IL3000 RNA  
Total RNA was successfully isolated from T. congolense IL 3000 trypanosomes as shown in 
Figure 5.17. Since the open reading frames of CP1 and CP2 are 1334 bp and 1335 bp 
respectively and also considering the length of the poly (A)
+
 tail, the RNA around 1.5-1.7 kb 
was excised and purified to increase RT-PCR efficiency. The eukaryotic (5S, 5.8S, 18S and 
28S) and prokaryotic (5S, 16S and 23S) rRNA subunits, were visible on the gel (Figure 
5.17). Prokaryotic rRNA originates from the kinetoplast (a large mitochondrion). 
 
 
Figure 5.17 Total RNA isolated from T. congolense IL 3000 parasites.  Total RNA was separated on a 1% 
(w/v) agarose gel and stained with ethidium bromide (Section 2.3.2). Bands represent the subunits of eukaryotic 
and prokaryotic rRNA. 
5.10.2  RT-PCR of cysteine protease isoforms mRNA 
The mRNA transcript of the different cysteine protease isoforms were targeted by RT-PCR 
using cluster-C1, -C2, -C3 (Fw and Rev) and another set of three primers with a common 
forward primer (Forward-all-CP) and reverse primers (Rev-C1,-C2,-C3, -C4; Table 3.1). All 
the primer sets gave a PCR product of the expected sizes (Figure 5.18). Cluster primers-C1, -
C2 and -C3 (Fw and Rev) amplified as expected a fragment of approximately 250 bp (lanes 
5-7). The common forward primer (Forward-all-CP) and the reverse primers gave a band at ~ 
700 bp (C1-Rev), ~ 400 bp for C2-Rev, ~ 850 bp for C3-Rev and ~ 300 bp for C4-Rev as 
shown in lanes 1-4 (Figure 5.18). These results suggested that all the CP families (CP1, CP2 



















Figure 5.18 RT-PCR on T. congolense IL 3000 congopain-like cysteine protease genes.  The samples were 
separated on a 1% (w/v) agarose gel stained with ethidium bromide (Section 2.3.2). Lane M, molecular weight 
markers; lane 1, mRNA amplified by primers Forward-all-CP and Rev-C1 (CP1); lane 2, RT-PCR using 
Forward-all-CP and Rev-C2 (CP2); lane 3, RT-PCR by Forward-all-CP  and Rev-C3 ; lane 4, mRNA amplified 
by Forward-all-CP and Rev-C4; lane 5, RT-PCR using cluster primers-C1 (Fw and Rev); lane 6, RT-PCR using 
cluster primers-C2 (Fw and Rev) and lane 7, RT-PCR by cluster primers-C3 Fw and Rev. 
 
5.10.3  Control experiment using Taq DNA polymerase  
RNA molecules are much more fragile than DNA, hence RNA preparation are often 
contaminated by traces of genomic DNA. If for most applications this is not a problem, for 
RT-PCR, it could generate false positive. It is therefore important to check, by PCR, that no 
DNA is present in RNA samples that could be amplified by a thermostable polymerase. A 
negative control experiment in which Taq DNA polymerase was used for RT-PCR instead of 
Tfl DNA polymerase failed to show a PCR product (Figure 5.19). This confirmed that there 
was no contaminating DNA in the mRNA preparation used to conduct the reverse 
transcription. A positive control, T. congolense IL3000 genomic DNA was amplified by Taq 
DNA polymerase using primers Forward-all-CP and Rev-C2 (CP2) and Rev-C1 (CP1) 
resulting in bands of the expected size of ~ 400 bp and ~ 700 bp respectively (Figure 5.19), 




































































































Figure 5.19 RT-PCR on T. congolense IL 3000 congopain-like cysteine protease using Taq polymerase 
DNA. Samples were separated on a 1% (w/v) agarose gel stained with ethidium bromide (Section 2.3.2). Lane 
M, molecular weight markers; lane 1, mRNA amplified by primers Forward-all-CP and Rev-C1 (CP1); lane 2, 
RT-PCR using Forward-all-CP and Rev-C2 (CP2); lane 3, RT-PCR by Forward-all-CP and Rev-C3 ; lane 4, 
mRNA amplified by Forward-all-CP and Rev-C4  ; lane 5, RT-PCR using cluster primers-C1 (Fw and Rv); lane 
6, RT-PCR using cluster primers-C2 (Fw and Rev); lane 7, RT-PCR by cluster-C3 (Fw and Rev) primers; lane 
8, PCR on T. congolense IL 3000 genomic DNA using Forward-all-CP and Rev-C2 (CP2) and lane 9, PCR on 
T. congolense IL 3000 genomic DNA using Forward-all-CP and Rev-C1. 
 
 
5.11  Discussion  
In a previous study, cysteine protease genes were found to exist at a single locus of 
approximately 25 kb and in a tandem repeat of 12-14 copies in T. congolense strain IL3000 
(Boulangé et al., manuscript in preparation). Similarly, a multi-gene family of cysteine 
protease genes has been reported having 20 copies in T. brucei (Mottram et al., 1989), 19 
copies in L. mexicana (Souza et al., 1992), 6 copies in T. cruzi (Eakin et al., 1992), eight 
SERA-like genes in P. falciparum (Gardner et al., 2002), five SERA-like genes in P. vivax 
(Kiefer et al., 1996) and three SERA homologues in P. vinckei (Gor et al., 1998). However, 
other cysteine protease genes such as cathepsin L-like cpa exists as single copy in L. 
mexicana (Mottram et al., 1998), L. pifanoi (Traub-Cseko et al., 1993) and in L. donovani 
chagasi (Omara-Opyene and Gedamu, 1997). Cathepsin B-like cpc also exists as a single 
copy in L. mexicana (Bart et al., 1995) and in L.  major (Sakanari et al., 1997). In T. 
congolense 13 genes coding for cathepsin B-like cysteine proteases have been reported, 
where they do not occur in a tandem repeat, but are located on different chromosomes 
(Palomares et al., 2008), while only 1 copy exists in T. brucei and 2 in T. vivax..  
 

















































































































































































































































The existence of an MluI restriction site in the intergenic region of cysteine proteases of T. 
congolense made it possible to make a subgenomic library of complete gene units, unlike in 
previous experiments where restriction endonucleases such as PstI and BamHI were used, 
that cut within the coding sequence (leaving part of the C-terminal coding sequence). The 
latter restriction endonucleases both cut within the gene and therefore, generated partial 
cysteine protease gene libraries. It was not evident whether cysteine proteases that occur 
outside of the main locus were cloned through this approach, as all the clones obtained are 
closely related to those obtained earlier. All the clones from the subgenomic library had more 
than 86% identity with CP1, CP2 and CP3. 
 
During the construction and screening of the 2 kb subgenomic library of congopain-like 
cysteine proteases a number of challenges were faced. 1/ For successful cloning, a 
completely cut and dephosphorylated vector is required. Purification by ethanol-precipitation 
without size fractionation on an agarose gel was found to generate high background upon 
transformation, because the cut vector was mixed with small amount of uncut vector. Uncut 
vector, under covalently closed circular conformation, is preferentially taken up by 
competent cells. Purification of the cut and dephosphorylated pMluI was found effective by 
separating the cut and uncut vector on an agarose gel and then excising and purifying the cut 
vector band. 2/ The introduction of a MluI site into the MCS of the pGEM
®
-11Zf(+) cloning 
vector by site-directed mutagenesis failed. The pMluI plasmid was constructed by an 
alternative method, involving cloning of annealed primers with the MluI restricted site into 
the pGEM
®
-11Zf(+) MCS. 3/ A high quantity of T. congolense IL 3000 genomic DNA was 
required for digestion with MluI restriction endonuclease to give sufficient insert. Hence 
large quantities of parasites were required for DNA extraction. 4/ It was difficult to establish 
the right vector to insert ratios.  5/ Lastly, very few congopain-like cysteine proteases coding 
clones were obtained from the library (8 out of 204, or about 4 %), the majority of the clones 
coding for non cysteine proteases. 
 
It was noted that out of the seven clones obtained from the subgenomic library of 2 kbp 
fragments, only one clone had a cysteine residue at the active site while the rest had a serine 
residue. This observation was also made in a related study conducted in our laboratory, 
whereby a congopain gene-units library was constructed from the same cosmid clones but 
using the MluI restriction site (Pillay et al., manuscript in preparation): most clones obtained 
were found to be of the CP3 type, with a serine instead of a cysteine in the active site. This is 
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in contrast with the results reported in the Chapters 3 and 4, where the majority of the clones 
obtained had the expected cysteine residue as opposed to a serine residue in the active site. 
The main difference between the MluI clones and the others, either partial (PCR fragment) or 
cut in the coding sequence (like in the case of the PstI library), is that these are complete 
gene units. There is a possibility that clones carrying congopain genes with a cysteine residue 
at the active site have the active enzyme produced in the bacteria, where it can prove lethal. 
Clones with a serine in the active site are likely to generate an inactive enzyme, hence are 
preferentially taken up by bacteria as not lethal. 
 
The essential amino acid residues in the active site of cysteine protease are cysteine, histidine 
and asparagine as they form the catalytic triad (Storer and Ménard, 1994). Occasionally the 
substitution of a cysteine residue by a serine residue has been noted, as well as the 
substitution of other amino acid residues forming the catalytic triad (Kiefer et al., 1996; Gor 
et al., 1998). In a group of cysteine proteases called SERA in Plasmodium, the majority of 
genes carry a serine repeat and a serine residue instead of cysteine residue at the active site 
(Bzik et al., 1988; Kiefer et al., 1996; Gor et al., 1998; Hodder et al., 2003). The variability 
of cysteine protease genes has also been reported in plants where a protease named SPE31 
isolated from the seeds of the legume Pachyrhizus erosus was found to have a glycine 
instead of the cysteine in the active site (Zhang et al., 2006). It showed 78% sequence 
identity with protein P34 from soy beans that also has a glycine instead of a cysteine residue, 
but has no activity. Two clones from the subgenomic library constructed here had the 
histidine residue of the catalytic triad substituted by a serine residue. In P. vivax a similar 
observation was reported in SERA where the histidine residue was substituted by leucine 
(Kiefer et al., 1996) and by methionine in P. vinckei (Gor et al., 1998). These substitutions 
are believed to affect the proteolytic activities of these cysteine proteases and thus it has been 
suggested that some of these cysteine proteases could be the product of pseudogenes. 
Expression of some of the variants will be necessary to establish their activity. Miller et al. 
(2002) found that SERA-4 and 5 which contain a serine residue, is highly expressed in P. 
falciparum. A gene knock-out experiment would be necessary to determine their role in host-
parasite interactions. SERA-4, 5 and 6 (with a cysteine residue at the active site) in P. 
falciparum were found to be necessary for the parasite‟s erythrocytic cycle, because these 
genes could not be disrupted by RNAi (Miller et al., 2002). Also in P. falciparum cysteine 
proteases falcipain-1 and -2 activities was silenced by RNAi (Malhotra et al., 2002).  
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RT-PCR confirmed the presence of cysteine protease mRNA in bloodstream forms of T. 
congolense IL 3000 for all these different isoforms, including the ones having a serine at the 
active site, suggesting that the different isoforms of congopain-like cysteine protease genes 
are expressed. The significance of the expression of these mutants remains unclear. The 
expression of some of these cysteine protease variants is underway in our laboratory and it 
will be interesting to characterise these enzymes, and to determine their role in parasite-host 
interactions by RNA interference.  
 
Although there was a marked substitution of essential amino acid residues in clones obtained 
from the subgenomic library, it is important to note that these clones showed a high degree of 
identity (86-100%), which suggests that an immunogen based on congopain can serve as a 





Trypanosomosis is the most important constraint to livestock production in sub-Saharan 
Africa (Kristjanson et al., 1999). Control of trypanosomosis has largely depended on vector 
management (insecticides, tsetse traps) and trypanocidal drugs (Schofield and Maudlin, 
2001) because they are considered relatively effective measures. Due to prolonged use of 
trypanocides, resistance to one or more of the trypanocidal drugs has been observed in 
African trypanosome-affected countries (Geerts et al., 2001). Development of a conventional 
vaccine has been hampered by the ability of the parasite to evade host immune responses by 
both antigen variation and immunosuppression (Donelson, 2003). Use of trypanotolerant 
cattle in the tsetse infested areas has been successful (d‟Ieteren et al., 1998), but these cattle 
are smaller than their trypanosusceptible counterparts meaning that they have low pulling 
(tractor) power. Their milk and meat production is also lower compared to that of 
trypanosusceptible breeds. 
 
Cysteine proteases are proteolytic enzymes present in almost all organisms, ranging from 
viruses to vertebrates (Sajid and McKerrow, 2002). Cysteine proteases of the papain-
superfamily belong to the C1 family within clan CA (Barrett and Rawlings, 2001). They are 
located within the lysosomes and synthesised as zymogen precursors that are activated by 
cleavage of the pro-domain to generate mature enzymes. Cysteine protease inhibitors have 
been cited as potential chemotherapeutic agents in parasitic diseases (Sajid and McKerrow, 
2002). In Schistosoma species cysteine protease based inhibitor peptidomimetic vinyl sulfone 
(K11777) exhibited at least 88% success in the elimination of parasite eggs and decrease in 
worm load (Abdulla et al., 2007, Caffrey, 2007). Rosenthal et al., (2004) observed that 
cysteine protease inhibitors block parasite haemoglobin degradation which is necessary for P. 
falciparum erythrocytic trophozoites, a role performed by falcipain-2.  
 
Pathogenic factors of trypanosomes are increasingly becoming drug and vaccine targets, such 
as trypanopain-Tc from T. congolense (Mbawa et al., 1992), congopain from T. congolense 
(Authié et al., 2001; Lalmanach et al., 2002), trypanopain-Tb from T. b. brucei (Troeberg et 
al., 1999; Caffrey et al., 2000) and cruzain of T. cruzi (Caffrey et al., 2000). In T. 
congolense, a chimeric reversible inhibitor Pcp27 derived from the YHNGA inhibitory 
peptide of the pro-region was found to inhibit congopain (Godat, et al., 2005). Tetramer 
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pseudopeptide reversible inhibitors were found to inhibit both cruzain and congopain 
(Lecaille et al., 2001). In T. cruzi and T. brucei, peptidyl and peptidomimetic inhibitors of 
brucipain and cruzipain have been found to limit parasite survival both in vivo and in vitro 
(Caffrey et al., 2000; Steverding et al., 2006). 
 
Congopain, the major cysteine protease in T. congolense has been shown to contribute to the 
pathology of trypanosomosis (Authié et al., 1993, 2001; Authié, 1994). Cattle immunized 
with congopain develop high levels of anti-congopain IgG which inhibit its activity (Authié 
et al., 2001). Upon infection, immunised animals remained more productive than controls. 
Three cysteine proteinases of the papain family have been described in T. congolense, 
namely, CP1 (Fish et al., 1995, EMBL accession number Z25813), CP2 (Jaye et al., 1994, 
EMBL accession number L25130) and CP3 (Downey and Donelson, 1999 EMBL accession 
no. AF139913). The proteases predicted by the gene sequence of CP1 and CP2 are identical 
in their pre and pro-peptides, differing from CP3 by only two amino acid residues in the 
signal peptide, while their C-terminal extensions show 86-95% identity, and their catalytic 
domains are 88-95% identical. However they differ in their N-terminal sequences APPA for 
CP1 and CP3 and APEA for CP2 (Boulangé et al., 2001). CP3 differs from CP1 and CP2 due 
to a replacement of a cysteine residue at position Cys
25
 (papain numbering) by a serine 
residue. Development of an anti-disease vaccine or a chemotherapeutic agent based on 
congopain-like cysteine protease requires an understanding of the diversity of the genes 
coding for these proteases. Therefore the variability within these families of genes was 
studied firstly by constructing and screening a congopain-like-cysteine protease gene units 
library from some existing cosmid clones, secondly by amplification by PCR and cloning of 
cysteine proteases genes from T. congolense, T. vivax and T. b. brucei genomic DNA. 
Thirdly, by constructing and screening a subgenomic library. Finally the pattern of 
expression of these isoforms was investigated by RT-PCR.  
 
Variability of congopain-like cysteine proteases was studied by constructing and screening a 
congopain-like-cysteine protease gene unit library from pre-existing congopain locus cosmid 
clones. The experiment was successful and 120 clones of congopain-like cysteine protease 
were obtained. It was shown that more than half of the clones were close to that of CP2, 
approximately a third to CP1 and the rest to CP3. The major amino acid sequence differences 
seem to occur in the catalytic domain and the proenzyme cleavage site sequences, APEA and 
APDA, with the former being predominant. Most of the clones coding for the APEA 
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sequence had a cysteine residue at the active site, while the clone coding for APDA had a 
serine instead. The other amino acid residues of the catalytic triad were conserved in all the 
clones. The C-terminal extension of congopain is joined to the catalytic domain by 
polyproline (Fish et al., 1995; Boulangé et al., 2001) as was the case in all the clones 
obtained showing six proline residues.  
 
The second objective of the present study was to study the variability of cysteine proteases 
across strain and species. This was done through amplification of CP gene fragments from T. 
congolense, T. vivax and T. brucei genomic DNA, cloning into pGEM
™
-T Easy and analyses 
of the sequences to establish intra- and inter-species variability within congopain-like 
cysteine protease genes.  A total of 87 genomic DNA samples from strains of the three 
species were obtained from various sources. Although degenerate primers were used initially 
for amplification, species-specific primers were found to be the most ideal for PCR. Across 
species, it was established that the intergenic region of T. b. brucei and T. vivax was shorter 
than that of T. congolense; in addition, T. vivax boasts two different sized intergenic regions, 
advocating for the presence of two loci for congopain-like genes (“vivapain”), a fact already 
reported elsewhere (Prof. T. Baltz, personal communication). The two bands were sequenced 
and found indeed to be part of cysteine protease genes. Amplification and cloning of part of 
the coding region was done successfully for T. congolense and T. brucei spp. However for T. 
vivax PCR reactions gave faint bands, and thus necessitated reamplification. The PCR 
products obtained after reamplification were not T. vivax cysteine proteases but those of T. 
congolense probably due to contamination from the original DNA. Therefore no coding 
sequence of T. vivax cysteine protease genes was obtained.  
 
The region amplified from T. congolense and T. b. brucei coding regions was constituted by 
a part of the propeptide and the catalytic region. The proenzyme cleavage site varied from 
APEA to APPA, APDA or PPMT. The most common N-terminal sequence was APEA and 
found mostly in CPs with a cysteine residue at the active site. The PPMT sequence was rare 
and only found in some CPs with a serine instead of cysteine at the active site. The 
proportion of CP genes coding for a cysteine residue at the active site was higher than those 
coding for enzyme with a serine residue; one clone was found to have a phenylalanine in 
place of a cysteine. Cys/Ser mutants were not found in T. brucei. The C-terminal regions of 
T. congolense strains were linked to the catalytic domain by six proline residues; one clone 
had a unique hinge consisting of 14 proline residues. The peptide sequence in the propeptide 
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of cysteine protease responsible for inhibition of cysteine proteases (Lalmanach et al., 1998) 
was conserved in all clones, being YHNGA for T. congolense and YRNGA for T. b. brucei.  
 
The variability of congopain-like cysteine protease genes was further studied through 
construction and screening of a 2 kbp size-restricted subgenomic library from T. congolense 
IL 3000 genomic DNA. The subgenomic library was successfully constructed and yielded a 
total of 206 clones, amongst which eight were identified as coding for congopain-like 
cysteine proteases. Six clones were found coding for a serine residue at the active site instead 
of a cysteine and one clone coding for a cysteine which fell in the same cluster as CP1. The 
variability among the clones at the maturation site had a similar pattern as described above, 
with the APEA N-terminal sequence being dominant, APPA and APDA sequences were 
found in one clone each while the PPMT sequence was found in two clones. The asparagine 
residue of the catalytic triad was conserved in all the clones and substitution of histidine by 
serine was noted in two clones. Size polymorphism of the C-terminal extension was noticed 
among the clones, and difference in the number of amino acid residues forming the 
polyproline hinge emerged. Minor amino acid sequence differences among the clones were 
observed, Gly-19 (papain numbering) was substituted by arginine in three clones while it was 
conserved in the rest.  
 
Although there are many restriction sites in the genes coding for cysteine proteases of T. 
congolense, not all have been used in our research, because of either their respective 
positions in the gene or their availability in the market, or both. Restriction sites in DNA 
sequences are frequently exploited in molecular biology, for genomic organisation studies, 
for library construction, or for polymorphism analyses. The restriction sites PstI, SalI, 
BamHI, PvuI and MluI that we used in cysteine protease genes have been used widely in 
genomic organisation studies in other organisms. These include T. cruzi (Eakin et al., 1992), 
L. major (Sakanari et al., 1997), L. donovani chagasi (Omara-Opyene and Gedamu, 1997), L. 
donovani complex (Mundodi et al., 2002) and also in western flowers thrips cysteine 
protease (Kuipers and Jongsma, 2004). The genomic organisation of congopain was studied 
using PstI, BamHI and MluI restriction sites in the present study, the first two occur within 
the gene while the latter exist in the intergenic region of congopain. XbaI and HindIII sites 
were found in one clone each, previously both restriction were not thought to exist within the 
congopain-like cysteine protease genes (Dr. Boulangé personal communication), although 
this observation was based on sequence analysis of a very small number of congopain-like 
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cysteine protease genes. Both SalI and NcoI sites were also found in the same clone; initially 
it was thought that SalI was a marker of CP1-like CPs while NcoI was believed to be a 
marker of CP2 and related genes (Dr. Boulangé personal communication). The identification 
of these restriction sites might be useful in further studies on the cysteine protease isoforms 
of T. congolense.  
 
Following the recurring identification of CP3-like sequences (where the active site Cys is 
replaced by Ser) in the present study, it was deemed necessary to determine whether CP3 –
type of mutants were expressed in T. congolense parasites. We achieve that through RT-PCR. 
The results confirmed the presence of all types of cysteine protease mRNA in bloodstream 
forms of T. congolense IL 3000, suggesting that different isoforms of congopain-like cysteine 
proteases are indeed expressed. In P. falciparum microarray analysis, antigenicity studies and 
gene knockout were used in addition to RT-PCR to detect the expression of the nine SERA 
genes (Miller et al., 2002). 
 
It was shown in the present study that the variability within congopain-like cysteine protease 
genes occurs mainly in the sequences coding for the catalytic domain, while those coding for 
the signal peptide and the propeptide are strictly conserved. The translated C-terminal 
extension and the intergenic region sequences showed higher sequence identity than that of 
the catalytic domain. Variability was found at the proenzyme cleavage site coding sequences 
translating into several N-terminal sequences, i.e. APPA, APEA, APDA and PPMT in T. 
congolense, and only APAA in T. b. brucei. APEA was the most common N-terminal 
sequence found, while PPMT coding sequence was only found in a group of cysteine 
protease genes that also code for a serine residue at the active site. Variability at the active 
site was more common; more clones were obtained coding for a cysteine residue than those 
coding for serine and one clone was found that codes for phenylalanine. However, the 
different approaches used in the present study gave different proportions of genes coding for 
cysteine and serine at the active site. It was observed that more congopain-like cysteine 
protease genes coding for a serine than a cysteine residue were obtained from the size-
restricted subgenomic library; contrary to results from the cosmid library and cloning of PCR 
products where congopain-like cysteine protease genes coding for cysteine were in the 
majority. In another study (outside the scope of the present study) where the cosmid clones 
(mentioned in Chapter five) were digested with MluI to generate a library, there was only one 
clone with a cysteine residue at the active site as opposed to many with serine residues. 
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These observations led to the hypothesis that when the entire gene unit encompassing 
regulatory sequences and open reading frame is cloned, some active enzyme is produced in 
the bacteria that have a deleterious effect on growth. This is thought not to happen when the 
gene is incomplete, as is the case in our other cloning (PstI library, Chapter 3, or PCR 
fragments, Chapter 4), or when the enzyme is inactive, such as when the cysteine or histidine 
is substituted with an other amino acid. 
 
Cysteine, histidine and asparagine, are the amino acid residues forming the catalytic triad of 
papain-like cysteine proteases (Storer and Ménard, 1994). In the present study, there was a 
marked cysteine to serine substitution at the active site of the catalytic domain, as well as 
substitution of other essential amino acid residues of the catalytic triad. The substitution of 
these essential amino acid residues was observed in congopain-like cysteine protease 
sequences obtained from http://www.genedb.org/genedb/tcongolense/blast.jsp. Other than the 
substitution of cysteine by a serine residue, histidine was substituted by either serine or 
tyrosine residues. Similarly, cysteine to serine substitutions were observed in cathepsin B-
like cysteine proteases in T. congolense (Palomares et al., 2008); in this case six genes coded 
for cysteine while seven genes coded for a serine residue. The substitution of serine for 
cysteine has been observed in other protozoans. A group of papain-family cysteine proteases 
in Plasmodium called the serine-repeat antigens (SERA), has a serine residue instead of a 
cysteine at the active site (Bzik et al., 1988; Knapp et al., 1991; Kiefer et al., 1996; Gor et 
al., 1998; Hodder et al., 2003). Additionally, the substitution of other amino acid residues of 
the catalytic domain was also observed, in P. vivax where the histidine residue was 
substituted by leucine (Kiefer et al., 1996) and by methionine in P. vinckei (Gor et al., 1998). 
The variability of cysteine protease genes has also been reported in other organisms such as 
Trichobilharzia regenti (Dvořák et al., 2005) and also in plants. A protein named SPE31 
isolated from the seeds of the legume Pachyrhizus erosus was found to have a glycine 
instead of the cysteine in the active site (Zhang et al., 2006) and showed 78% sequence 
identity with protein P34 from soy beans. These substitutions are believed to affect the 
proteolytic activities of these cysteine proteases. The substitution of very few amino acid 
residues in the catalytic domain of two cysteine protease isoforms (cruzain and cruzipain 2) 
from T. cruzi led to enzymes with different pH stability, substrate sensitivity and sensitivity 
to inhibition by cysteine protease inhibitors (Lima et al., 2001). 
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Expression of cysteine protease genes harbouring a serine residue at the catalytic site would 
be necessary to establish whether they are active. Likewise, gene knock-out studies would be 
necessary to determine the role of these groups of cysteine proteases in the pathogenesis of 
trypanosomosis. Miller et al. (2002) found that SERA-4 and 5 which contain a serine residue 
were highly expressed in P. falciparum, a similar observation was made for SERA-5 which 
was found predominantly expressed in the trophozoite and schizont stages (Aoki et al., 
2002). SERA-4, 5 and 6 (with a cysteine residue at the active site) of P. falciparum were 
found to be necessary for the erythrocytic cycle, because they could not be disrupted by 
RNAi (Miller et al., 2002). RNA interference was successful in targeting the papain-like 
falcipain-1 or falcipain-2 activity in P. falciparum, thereby inhibiting the development of 
erythrocytic parasites and a marked accumulation of undegraded haemoglobin was observed 
(Malhotra et al., 2002). SERA-5 was found to have serine protease (chymotrypsin-like) 
activity (Hodder et al., 2003). Although SERA-6 has a conserved catalytic cysteine it does 
not have cysteine protease activity. However, due to localisation of the two SERA proteins to 
the parasitophorous vacuole of mature schizonts, they might be involved in proteolytic 
activities together with other SERA proteins (Rosenthal, 2004). Also, it has been suggested 
that some of these cysteine protease could be the products of pseudogenes.  
 
The existence of serine to cysteine substitution at the active site of cysteine proteases has led 
to the suggestion that the enzymes might be encoded by pseudogenes (Pils and Schultz , 
2004). In T. congolense two cathepsin B-like cysteine proteases were identified as being 
coded by pseudogenes (Palomares et al., 2008). Pyrococcus furiosus1-like genes coding for a 
cysteine peptidase were found to be expressed in L. major but not in other Leishmania 
species and was also absent in T. brucei and T. cruzi suggesting that they might exist as 
pseudogenes in other Leishmania species (Eschenlauer et al., 2006). Calpains are a group of 
Ca
2+
-dependent cytosolic cysteine proteases, which belong to the family C2 within the clan 
C2 of cysteine proteases. Substitution of catalytic cysteine to serine residue of the maize 
DEKI protein (calpain) made it inactive (Wang et al., 2003), the same observation was made 
for other human calpain-like cysteine proteases (Masumoto et al., 1998; Hitomi et al., 1998). 
However, not all amino acid residue substitutions would render proteases inactive or be the 
products of pseudogene expression, especially residues outside the catalytic triad.   
 
The catalytic domains coded by the congopain-like cysteine protease genes showed only few 
amino acid substitutions; some of the substitutions however are likely to affect the  catalytic 
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characteristics of the enzyme, or its stability. Negatively charged amino acid residues 
(glutamate) were substituted by positively charged amino acid residues (arginine) or the 
amide asparagine; the hydrophilic amino acid residue aspartate was occasionally substituted 
by a hydrophobic phenylalanine. The differences in these genes may translate into different 
enzymes with different roles within the parasite, or in host-parasite interactions. In T. 
congolense, half of the amino acid substitutions encountered between C1 (CP1) and C2 
(CP2) are a change from a basic residue towards an acid one, leading to the enzymes having 
very different pI values and elution profiles on ion-exchange chromatography (Boulangé et 
al., 2001). Moreover CP2 exhibited activity over a wide pH range while CP1 was active only 
under acidic conditions, being inactivated at neutral or alkaline pH. Lima et al. (2001) 
reported that two cysteine protease isoforms (cruzain and cruzipain 2) from T. cruzi with 
very few amino acid substitutions in the catalytic domain led to enzymes with different pH 
stability, substrate sensitivity and sensitivity to inhibition by cysteine protease inhibitors. 
Indeed, cysteine proteases have a very specific substrates preference (Lecaille et al., 1999, 
2001; Juliano et al., 2004, Judice et al., 2005).  
 
Cysteine proteases are expressed at high level in L. mexicana (McKerrow et al., 2006). Three 
cysteine proteases of the papain family have been identified, namely CPA and CPC which 
are cathepsin L-like and CPB which is cathepsin B-like (Mottram et al., 1998). The role of 
CPA in L. mexicana remains unclear as deletion of cpa genes had no effect in the 
development of lesions in mice as well as macrophage infection (Souza et al., 1994). CPC on 
the other hand, plays a major role in macrophage infections; mutants for the cpc genes in L. 
mexicana showed impaired macrophage infection and affected lesion development in vivo 
(Bart et al., 1997). The role of CPB in pathogenesis in L. mexicana is more profound than 
that of either CPA or CPC (McKerrow et al., 2006). CPB has been shown to facilitate 
macrophage infections as CPB-1 and CPB-2 are highly expressed in infectious metacyclic 
promastigotes stages of L. mexicana (Mottram et al., 1997). Lastly CPB has been shown to 
inhibit Th1 responses and also plays a key role in suppressing protective immune responses 
in L. mexicana (Buxbaum et al., 2003). 
 
Cysteine proteases are important virulence factors in E. histolytica as they are required for 
parasite survival during acute amoebic liver abscesses in hamsters (Olivos-Garcia et al., 
2004). A total of 20 cysteine proteases have been predicted to exist in E. histolytica 
(Bruchhaus et al., 2003), but only three of these cysteine proteases have been found to have 
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activity, namely EhCP1, EhCP2 and EhCP5 (Bruchhaus et al., 1996). EhCP2 and EhCP5 are 
important for enteric cytopathology because they contribute to host layer disruption and 
EhCP2 also facilitates pathologic host inflammatory responses (Hellberg et al., 2001; Zhang 
et al., 2000). 
 
Falcipains are a group of cysteine proteases of the papain-family encoded by P. falciparum 
(Sijwali et al., 2006). Falcipain-1 was isolated and characterised (Rosenthal and Nelson, 
1992), and thought to be involved in host cell invasion (Greenbaum et al., 2002), although 
gene disruption studies have shown that this protease is not necessary for erythrocytic stage 
parasites (Eksi et al., 2004; Sijwali et al., 2004, 2006). Falcipain-2 has been linked with 
degradation of haemoglobin (Shenai et al., 2000; Sijwali et al., 2000; Dahl and Rosenthal, 
2005). Indeed gene knockout studies indicate the role of falcipain-2 in haemoglobin 
degradation, as parasites showed reduced haemoglobin hydrolysis in trophozoites (Sijwali 
and Rosenthal, 2004). Sijwali et al. (2006) observed that falcipain-1 and falcipain-2' do not 
play an important role in haemoglobin hydrolysis (the role of falcipain-2) and in erythrocytic 
parasites (the role of falcipain-3).  
 
The understanding of the roles of congopain, congopain-like cysteine proteases, and other 
virulence factors in pathogenesis will be a big step towards development of new drugs or 
vaccines against African trypanosomosis. The present study was important as it highlighted 
the diversity of the congopain-like gene family. Sequence alignments led to the identification 
of amino acid residues that may play a major role in the substrate specificity of the enzymes, 
a fact that may prove crucial in the design of chemotherapeutic inhibitors. Although there is a 
degree of variability in congopain-like cysteine proteases, predicted amino acid sequences 
are 88-100% identical. It is highly likely that a congopain-based vaccine will inhibit all 
congopain-like cysteine proteases that may be circulating in the infected host. This study 
highlighted also the ubiquitous substitution of a cysteine by a serine in the active site of 
several of these gene products. Further studies on the activity of such enzymes, and their 
potential role in host-parasite interactions will have to be tackled using recombinant 
technologies and reverse genetics.  
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APPENDIX B: Design of degenerate primers 
 
The primer CP1 targeted the region coding for FKQKYS in the propeptide, while CP2 targeted (AEEEAFRFR) 
a conserved region in the pro-region of cysteine proteases in trypanosomatids.  CP3 targeted (SEQMLV) a 
conserved region in catalytic domain of cysteine proteases among trypanosomes species. The region targeted by 
CP4 primer (WGEEGYIRI) occurs between the asparagine residue of the catalytic triad and the polyproline 
hinge. The region targeted by CP6 primer codes for SSSCSG in the C-terminal extension. 
 
 
                                                 (CP1)                                                                                (CP2)                                                                                                                
T.congoCP1      TTCGCCGCA TTCAAGCAAAAGTACAGCA GGTCGTACAAGGAC GCCACGGAGGAGGCATTC 180 
T.congoCP2      TTCGCCGCA TTCAAGCAAAAGTACAGCA GGTCGTACAAGGAC GCCACGGAGGAGGCATTC 180 
T.bruceiCP      TTTGCTGCG TTCAAGAAGAAGTACGGCA AGGTGTACAAGGAT GCTAAGGAGGAAGCATTC 180 
T.cruziCP1      TTCGCAGAA TTCAAGCAGAAGCATGGCA GGGTGTACGAGAGC GCCGCGGAGGAGGCGTTC 171 
T.cruziCP2      TTCGCAGAA TTCAAGCAGAAGCATGGCA GGGTGTACGGGAGC GCCGCGGAGGAGGCGTTC 171 
                ** ** *   ****** * *** *  ***  *  ****  *    **   ****** ** *** 
                                 
T.congoCP1      CGTTTCCG CGTCTTCAAGCAGAACATGGAGCGTGCAAAGGAGGAGGCCGCTGCGAACCCC 240 
T.congoCP2      CGTTTCCG TGTCTTCAAGCAGAACATGGAGCGTGCAAAGGAGGAGGCCGCTGCGAACCCC 240 
T.bruceiCP      CGCTTCCG TGCCTTTGAGGAAAATATGGAGCAGGCGAAGATTCAAGCTGCGGCGAACCCA 240 
T.cruziCP1      CGCCTGAG CGTGTTCAGGGAGAACCTGTTTCTTGCGAGGCTGCACGCCGCGGCAAACCCA 231 
T.cruziCP2      CGCCTGAG CGTGTTCCGGGCGAACCTGTTTCTTGCGAGGCTGCACGCCGCGGCAAACCCA 231 
                **  *  *  *  **   *   **  **   *  ** * *    * ** ** ** *****  
       
                                                         (CP3)                                                   
(CP3) 
T.congoCP1      GGCCAGTGGAAGGTTGCGGGCCATGAGCTGACGTCTCTG TCGGAGCAAATGCTCGTGTC A 540 
T.congoCP2      GGCCAGTGGAAGGTTGCAGGCCATGAGCTGACGTCTTTG TCGGAGCAGATGCTCGTGTC A 540 
T.bruceiCP      GGGCAGTGGCAGGTGGCAGGAAATCCTCTCGTATCCCTC TCGGAGCAGATGCTAGTGTC A 540 
T.cruziCP1      TGCCAGTGGTTTCTTGCCGGCCACCCGCTGACGAACCTG TCGGAGCAGATGCTCGTGTC G 531 
T.cruziCP2      TGCCAGTGGTTTCTCGCCGGCCACCCGCTGACGAACCTG TCGGAGCAGATGCTCGTGTC G 531 
                 * ******    * ** **  *    **        *  ******** ***** *****  
          S  E  Q  M  L  V  S  
 
         (CP4) 
T.congoCP1      CCATATTGGATTATCAAGAACTCATGGAGCAAGGGA TGGGGCGAGGAGGGTTACATCCGC 960 
T.congoCP2      CCATACTGGATTATCAAGAACTCATGGAGCAAGGGA TGGGGCGAGGAGGGTTAC-TCCGC 959 
T.bruceiCP      CCCTACTGGATCATCAAAAACTCGTGGAGCAACATG TGGGGCGAGGACGGCTACATCCGC 960 
T.cruziCP1      CCGTACTGGATCATCAAGAACTCGTGGACCACGCAG TGGGGCGAGGAAGGCTACATCCGC 951 
T.cruziCP2      CCGTACTGGGTCATCAAGAACTCGTGGACCACGCAG TGGGGTGAGGATGGCTACATCCGC 951 
                ** ** *** * ***** ***** **** **      ***** ***** ** *** ***** 
                                                                                 
T.congoCP1      AT TGAGAAGGGCACAAACCAATGTCTCATGAAAAATTACGCGAGGTCAGCCGTTGTCAGC 1020 
T.congoCP2      AT TGAGAAGG-CACAA-CCAATGTCTTATGAAAAATCTCCCAAGCTCCGCCGTTGTCAGC 1017 
T.bruceiCP      AT CGAGAAGGGCACAAACCAATGTCTCATGAATCAGGCCGTATCCTCCGCAGTTGTTGGA 1020 
T.cruziCP1      AT TGCAAAGGGCTCGAACCAGTGCCTTGTCAAGGAGGAGGCGAGCTCCGCGGTGGTCGGT 1011 
T.cruziCP2      AT TGCAAAGGGCTCGAACCAGTGCCTTGTGAAGGAGGAGGCGAGCTCCGCTGCCAAGCAT 1011 
                **  *  **** * * * *** ** **  * **  *          ** ** *         
     I 
 (CP6) 
T.congoCP1      TGCGGCTCCAATAACCTCACACAGATCGTCTACCCGTTG AGCAGCTCCTGCAGCGG CTTC 1227 
T.congoCP2      TGCGGCTCCAATAACCTCACGCAGATCGTCTACCCGTTG AGCAGCTCCTGCAGCGG CTTC 1218 
T.bruceiCP      TGTGGCGCAAGCAACCTTACACAAATAATCTACCCACTA AGCAGGAGCTGCAGCGG TCCC 1236 
T.cruziCP1      TGCGGTGCTGAGACTCTCACAGAAGAAGTCTTCCTTACG AGTACGCACTGCAGCGG CCCA 1251 
T.cruziCP2      --------------------------------------- ----------------- ---- 







APPENDIX C: Design of T. congolense specific primer Tc/Tv CP2/CP3 
 
The primer Tc/Tv CP2 targeted MEGAKEE a conserved region in the propeptide, Tc/Tv CP3 targeted 
SEQMLVS a conserved region at the catalytic domain 
 
 
CLUSTAL W (1.83) multiple sequence alignment 
 
         (Tc/Tv CP2) 
Tcs62           GGAGGAGGCGTTCCGTTTCCGCGTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
Tcs66           GGAGGAGGCGTTCCGTTTCCGTGTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
Tcs58           GGAGGAGGCGTTCCGTTTCCGCGTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
Tcs41           GGAGGAGGCGTTCCGTTTCCGCTTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
Tcs59           GGAGGAGGCGTTCCGTTTCCGCGTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
Tcs65           GGAGGAGGCGTTCCGTTTCCGCGTCTTCAAGCAGAA CATGGAGCGTGCAAAGGAGGAGG C 60 
                *********************  ************* *********************** * 
                                                                                        
Tcs62           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATATGCCACCCGAGGA 120 
Tcs66           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATATGTCACCCGAGGA 120 
Tcs58           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATATGTCACCCGAGGA 120 
Tcs41           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATATGTCACCCGAGGA 120 
Tcs59           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATGTGTCACCCGAGGA 120 
Tcs65           CGCTGCGAACCCCTATGCGACGTTTGGTGTGACGCGGTTCTCCGATATGTCACCCGAGGA 120 
                ********************************************** ** ********** 
 
Tcs62           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
Tcs66           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
Tcs58           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
Tcs41           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
Tcs59           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
Tcs65           GTTCAGGGCGACCTACCACAACGGGGCGGAGTACTACGCTGCGGCGCTGAAGCGACCACG 180 
                ************************************************************ 
 
Tcs62           CAAGGTGGTGAATGTGTCCACTGGGAAGGCACCTGAGGCAGTTGACTGGCGCAAGAAGGG 240 
Tcs66           CAAGGTGGTGAATGTGTCCACTGGGAAGGCACCTGAAGCAGTTGACTGGCGCAAGAAGGG 240 
Tcs58           CAAGGTGGTGAATGTGTCCACTGGGAAGGCACCTGAGGCAGTTGACTGGCGCAAGAAGGG 240 
Tcs41           CAAGGTGGTGAATGTGTCCACTGGGAAGGCACCTGAGGCAGTTGACTGGCGCAAGAAGGG 240 
Tcs59           CAAGGTGGTGAATGTGTCCACTGGGAAGGCACCGCCGGCAATTGACTGGCGCAAGAAGGG 240 
Tcs65           CAAGGTGGTGAATGTGTCCACTGGGGAGGCACCGCCGGCAATTGACTGGCGCAAGAAGGG 240 
                ************************* *******    *** ******************* 
 
Tcs62           CGCGGTGACACCCGTGAAGGACCAGGGG-CGATGCGGCTCTTGCTGGGCATTCTCTGCCA 299 
Tcs66           CGCGGTGACACCCGTGAAGGACCAGGGG-CGATGCGGCTCTTGCTGGGCATTCTCTGCCA 299 
Tcs58           CGCGGTGACACCCGTGAAGGACCAGGGA-CAATGCGGTTCTTGCTGGGCATTCTCTGCCA 299 
Tcs41           CGCGGTGACACCCGTAAAGGACCAGGGG-AAATGCGACTCTTCGTGGGCATTCACTGTCA 299 
Tcs59           CGCGGTGACACCCGTGAAGGACCAGGGG-CAATGCGGCTCTTGCTGGGCATTCTCTGCCA 299 
Tcs65           CGCGGTGACACCCGTGAAGGACGAGGGGGAAATGCGACTCTTTTTGGGCATTCTCTGCC- 299 
                *************** ****** ****    *****  ****  ********* *** *  
 
Tcs62           TAGGGAACATAGA-GGGCCAGTGGAAGATTGCGGGCCATGAGCTGACGTCTCTG TCGGAG 358 
Tcs66           CAGGGAACATAGA-GGGCCAGTGGAAGATTGCGGGCCATGAGCTGACGTCTCTG TCGGAG 358 
Tcs58           TAGGGAACATAGA-GGGCCAGTGGAAGATTGCGGGCTATGAGCTGACGTCTCTG TCGGAG 358 
Tcs41           TAGGGAACATAGA-GGGTCAGTGGAAGATTGCGGGCCATGAGCTGACGTCTCTG TCGGAG 358 
Tcs59           TAGGGAACATAGA-GGGCCAGTGGAAGATTGCGGGCCATGAGCCGACGTCTTTG TCGGAG 358 
Tcs65           TAGGGAACATAGAAGGGTCAGTGGAAGATTGCGGGCCATGAGCTGACGTCTCTG TCGGAG 359 
                 ************ *** ****************** ****** ******* ** ****** 
                                (Tc/Tv CP3)                                                   
Tcs62           CAAATGCTAGTGTC AAT 375 
Tcs66           CAAATGCTAGTGTC AAT 375 
Tcs58           CAGATGCTAGTGTC AAT 375 
Tcs41           CAAATGCTAGTGTC AAT 375 
Tcs59           CAAATGCTAGTGTC AAT 375 
Tcs65           CAGATGCTAGTGTC AAT 376 
                ** *********** *** 
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APPENDIX D: Design of T. congolense specific primers Tc CP1/CP4 
 
The primer Tc CP1 targeted VIASCGS in the C-terminal extension; while Tc CP4 targeted 
CAAAAATAAAAAGACAAGGCCAACGGG of intergenic region. 
 
 
CLUSTAL W (1.83) multiple sequence alignment 
 
 
Tcs57           AGTAAGTGCACCAAAGCCACATTCCCAACGGGCAAGTGCGTGCAGCTCAGCGGCGCCGGT 60 
Tcs58           AGTAAGTGCACCAAAGCCACATTCCCAACGGGCAAGTGCGTGCAGCTCAGCGGCGCCGGT 60 
Tcs66           AGTAAGTGCACCAAAGCCACATTCCCAACGGGCAAGTGCGTGCAGCTCAGCGGCGCCGGT 60 
Tcs49           AGTAAGTGCACCAAAGCCACATTCCCAACGGGCAAGTGCGTGCAGCTCAGCGACACCGGC 60 
                **************************************************** * ****  
                          (Tc CP1) 
Tcs57           TCT GTCATCGCCTCGTGCGGCTCC AATAACCTCACACAGATCGTCTACCCGTTGAGCAGC 120 
Tcs58           TCT GTCATCGCCTCGTGCGGCTCC AATAACCTCACACAGATCGTCTACCCGTTGAGCAGC 120 
Tcs66           TCT GTCATCGCCTCGTGCGGCTCC AATAACCTCACGCAGATCGTCTACCCGTTGAGCAGC 120 
Tcs49           TCC GCCATCGCCTCGTGCGGCTCC AATAACCTCACACAGATCGTCTACCCGTTGAGCAGC 120 
                **  * ******************* *********** ************************ 
                                                                                                                                             
Tcs57           TCCTGCAGCGGCTTCTCCGTTCCGTTGACTGTGCCACTGGACAAGTGCCTGCCCATCGTG 180 
Tcs58           TCCTGCAGCGGCTTCTCCGTTCCGTTGACTGTGCCACTGGACAAGTGCCTGCCCATCGTG 180 
Tcs66           TCCTGCAGCGGCTTCTCCGTTCCGTTGACTGTGCCACTGGACAAGTGCCTGCCCATCGTG 180 
Tcs49           TCCTGCAGCGGCTTCTCCGTTCCGTTGACTGTGCCACTGGACAAGTGCCTGCCCATCGTG 180 
                ************************************************************ 
 
Tcs57           ATTGGATCCGTGATGTATGAGTGCTCTGACAGGGTTCCTACGGAATCCGCCCGGCTCGTG 240 
Tcs58           ATTGGATCCGTGATGTATGAGTGCTCTGACAAGGCTCCTACGGAATCCGCCCGGCTCGTG 240 
Tcs66           ATTGGATCCATGATGTACAAGTGCTCTGACAAGGCTCCTACGGAATCCGCCCGGCTCGTG 240 
Tcs49           ATTGGATCCATGATGTATGAGTGCTCTGACAAGGCTCCTACGGAATCCGCCCGGCTCGTG 240 
                ********* *******  ************ ** ************************* 
 
CLUSTAL W (1.83) multiple sequence alignment 
 
     (Tc CP4) 
Tcs49           GTATTGGGAGCAAGTGTGGGTG CAAAAATAAAAAGACAAGGCCAACGGG GTGCGACGCTC 60 
Tcs57           GTATTGGGAGCAAGTGTGGGTG CAAAAATAAAAAGACAAGGCCAACGGG GTGCGACGCTC 60 
Tcs66           GTATTGGGAGCAAGTGTGGGTG CAAAAATAAAAAGACAAGGCCAACGGG GTGCGACACTC 60 
Tcs58           GTATTGGGAGCAAGTGTGGGTG CAAAAATAAAAAGACAAGGCCAACGGG GTGCGACGCTC 60 
                ********************** *************************** ******* *** 
      
Tcs49           CTCGCGGGTCAGTGGCAGCAGCGACTGTTGCCGTGGCC 98 
Tcs57           CTCGCGGGTCAGTGGCAGCAGCGACTGTTGCCGTGGCC 98 
Tcs66           CTCGCGGGTCAGTGGCAGCAGCGACTGTTGCCGTGGCC 98 
Tcs58           CTCGCGGGTCAGTGGTAGCAGCGACTGTTGCCGTGGCC 98 
                *************** ********************** 
 
 
